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I. Introduction
The aim of this chapter is to answer three questions, thereby defining the context of this
thesis:
a. Why is accuracy in radiotherapy, and especially in conformal therapy treatment
planning, crucial for advancements in treatment?
b. What accuracy is required in radiotherapy in general, and in treatment planning in
particular?
c. How can compliance to established accuracy criteria be verified? 
These questions correspond to section 1 through 3 of this chapter. Having set the context, the
objective and outline of the thesis follow in section 4.
1. Conformal treatment, treatment planning and accuracy:
conditions for advancements in radiotherapy
In this section the chain in dependencies is described between radiotherapy, conformal
treatment, treatment planning, calculation accuracy and verification of this accuracy. It starts
with a historical perspective.
1.1 Radiotherapy requires conformal treatment: a historical perspective 
Already one year after the discovery of X-rays by Röntgen in 1895, a first attempt for
radiotherapeutic treatment was made. The first documented cure by application of X-rays
dates from 1899.  Since then, increases in cure rate of patients with (mostly) malignant1
diseases treated with radiotherapy alone or in combination with surgery and/or chemotherapy
have often concurred with improvements in radiotherapy treatment techniques.  A milestone2
has been the introduction of cobalt-60 radiation and megavoltage radiation in the middle of
the previous century. As shown in a recent overview,  the new treatment techniques that3
became possible resulted in impressive increases in radiation treatment outcome in cases like
prostate cancer, various head and neck cancers, uterine cervic cancers, as well as Hodgkin
lymphoma. In the latter case, for example, the 10-years survival of M. Hodgkin patients
inclined from 23% to 62%,  and further increases have been reported since then.  In the3 4
Netherlands  approximately 50% of all cancer patients are presently cured, half of them by5
radiotherapy alone or by radiotherapy in combination with surgery. Further improvements are
highly needed, as another estimated 8%-10% of all cancer patients is expected to benefit from
improved local control.  Common factor in all advances in treatment techniques is that they6
help to achieve the primary objective of radiotherapy: to deliver a sufficiently high and as
homogeneous a dose as possible to the planning target volume (PTV), at the same time
diminishing the chances for complications in surrounding tissue to the lowest possible level.
In the mid-eighties of the previous century, developments such as the introduction of the
Beam’s-Eye-View projection tool facilitated the application of beams that much more
conformed to the projected shape of the PTV as observed from the beam direction under
consideration. Following the introduction of this tool the name ‘conformal radiotherapy’
became popular  to stress the importance of a high-dose region just covering the PTV,7,8
avoiding critical structures as much as possible. Conformal radiotherapy has been defined  as9
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a procedure of high-precision irradiation of a target volume where the 95% isodose of the
dose distribution, or more generally, the high-dose (treated) volume,  conforms as closely as10
possible to the shape of the target volume in three dimensions. Whereas initially conformal
radiotherapy was concerned with the optimal shape of radiation fields around the PTV,
nowadays the focus is shifting to define also an optimal intensity distribution of energy
fluence within the fields. This intensity-modulated radiotherapy (IMRT) opens the possibility
to escalate dose at (parts) of the target with equal or lower complication chances, thus aiming
at higher local control rate. A further step forward can be made by a combination of intensity
modulation and limitation of the range of the radiation to the depth of the target, as is done in
proton therapy.
Nearly a decade since the onset of this new generation of conformal techniques the first
clinical results are showing up.  Dose escalation in clinically localized prostate cancer has11
been reported to yield significant improvements. Initial clinical response in terms of prostate-
specific antigen (PSA) levels was 90% for patients that received 75.6 Gy or more minimum
dose to the PTV, compared to 76% and 56% for patients that received 70.2 Gy and 64.8 Gy,
respectively.  Improvements were also reported in the rate of positive biopsies at 2.5 years12
and later after radiotherapy and in the 5-years PSA relapse-free survival.  On the other12,13
hand, a dose escalation attempt in the nasopharynx did not show an improvement in treatment
results.  From a principal point of view, it is interesting to note that in these new techniques14
the objective of conformal treatment has been refined. The classical criterion of homogeneity
of dose to the PTV is now explicitly balanced in the optimization process against criteria of
maximum acceptable normal tissue dose. This extension of objective is sometimes indicated
by the term conformal avoidance technique.  15
As shown here, the concurrence in improvements in radiotherapy treatment techniques
and clinical outcomes can be expected to hold also for recently developed conformal
treatments. A safe and effective application of conformal radiotherapy, and IMRT in
particular, however, has profound consequences for treatment planning as well as for the
required accuracy levels.
1.2 Conformal radiotherapy requires treatment planning
Treatment planning can be defined as the radiotherapy preparation process in which treatment
strategies are defined in terms of planning target volumes, dose distributions tailored to these
volumes, and sets of treatment instructions to deliver the dose distributions. Treatment
planning plays a key-role in the advancement of radiotherapy. This key-role is underlined by
the observation that four out of six historical suggestions for radiotherapy improvement as
presented by Suit et al.  in 1988, are directly linked to treatment planning (a,b,e,f). Their16
shortlist of suggestions comprised: (a) better visualization of tumour and normal tissue, (b)
presentation of uncertainty bands around isodoses, (c) monitoring of target tissue during
treatment, (d) gating of treatment, (e) computer-controlled treatment and (f) reduced treatment
volumes.
The present status of advances in treatment technique can be assessed in the light of this
historical shortlist. The mentioned suggestions are now entering clinical practice. Modern
treatment planning systems indeed have much improved visualization facilities (a), although
especially accurate delineation of tumour and clinical target volumes remains to be one of the
greatest challenges. In this perspective multi-modality imaging, such as CT, MR and/or PET
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images, and image registration  can be of considerable value to better define and, if possible,17
reduce target volumes (f). Monitoring of targets (c) is readily approaching the realm of
practical feasibility, based on markers of clinically acceptable size that can be automatically
detected.  Gating of a linear accelerator (linac) (d) triggered by the breathing cycle is an18
emerging application.  The most evident example of computer-controlled treatment (e) is19,20
computer optimized IMRT, which can further improve conformation of the dose to the target
volume with smaller fields and thus less normal tissue dose.  When combined with21,22,23
protons as treatment modality, a further reduction in normal tissue dose is possible.24
As indicated by these developments, treatment planning plays a key-role in the
realization of enhanced conformal techniques.
1.3 Conformal treatment planning requires high and verified accuracy
The successful application of especially these enhanced conformal techniques depends
critically on a very high level of accuracy in both treatment planning and treatment
execution.  The relevance of research into the accuracy of radiotherapy techniques and25,26
treatment planning follows from the observation, discussed in section 2 of this chapter, that
optimal accuracy levels are currently mostly unachievable. Knowledge about the accuracy that
is actually achieved is then of major importance. This applies similarly to the presentation of
this accuracy.
Knowledge about the accuracy of treatment techniques is obtained by appropriate
verification. This can be a verification of an entire technique, usually by application of a
phantom in which calculated dose is compared to measurements, e.g. by film,  a27,28
combination of scans in a water phantom  and gel dosimetry.  In case of proton treatment28,29 30
the use of a PET scanner for dose verification has also been suggested.  Furthermore, a portal31
dose image can be calculated by the treatment planning system and compared to a measured
portal dose image.  Thus the overall accuracy of the relative or absolute dose at a32,33,34
particular point for a particular treatment technique is explored. The results are applicable to
the investigated technique only. The disclosure of the causes of any discrepancies thus found
then requires a subsequent ‘backward’ analysis to discriminate the constituting steps. 
Verification can also be confined to an individual treatment step, to assess whether
appropriate accuracy requirements for that step are complied to. It is evident that an
appropriate combination of both scopes of verification, overall and step-oriented, is most
powerful. Overall verification might point at weaknesses in the step-oriented verification.
Also, when results of subsequent steps can be combined, discrepancies might be anticipated
before their effects appear in overall treatment verification. 
It is important to note that discrepancies in treatment planning calculations, even when
relatively small in magnitude, constitute systematic errors in patient treatments and therefore
require proper attention. An extensive verification program is needed to explore the presence
and magnitude of such discrepancies. This is described in section 3 of this chapter.
The required knowledge of treatment (planning) accuracy implies the necessity to
present the treatment (planning) accuracy in a proper way. This requirement is resembled by
the second item of the above-mentioned shortlist, the presentation of uncertainty bands around
isodoses (b) or, more generally formulated, the presentation of uncertainty in treatment
planning.  35
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Ideally, a comprehensive presentation of all treatment uncertainties should be part of the
treatment planning process, preferably also expressed in radiobiological outcomes.  It has36,37
been shown that inclusion of treatment uncertainties in treatment planning effects the outcome
of treatment plan optimization  and treatment plan robustness.  Many studies have been38 39,40
dealing with organ motion and/or setup-error  and with methods to account for these41-43
uncertainties in radiotherapy treatment planning.  Also adaptation of a treatment plan39,44-52
based on portal image data is being considered.  However, the implementation in routine47
treatment planning has up till now not been specified.  Still further away is incorporation of49
uncertainty in radiobiological modelling, which is yet a rather novel area of research.  53
Surprisingly, the presentation of errors in treatment planning calculations in the
treatment planning process itself is uncommon. Doing first things first, there is conceptual
logic in an exploration of the uncertainties that originate in treatment planning itself, which is
the objective of this thesis, and in a presentation of these uncertainties in treatment planning,
which is discussed in chapter IX of this thesis.
Summarizing this introductory section, it has been shown that knowledge about the
accuracy of treatment planning calculations is a crucial requirement for the enhancement of
treatment planning capabilities, and thus an essential condition to achieve the expected
benefits of conformal radiotherapy treatment. This thesis aims at the acquisition of such
knowledge.
2. Accuracy requirements for treatment planning calculations
In this section a fundamental and a practical approach are followed to define requirements for
calculation accuracy, and an attempt is presented to bridge the gap between these approaches.
2.1 Fundamental approach
Accuracy requirements for radiotherapy treatment should basically be derived from
radiobiological behaviour of tumour cells and normal tissues, as well as from clinical
evidence that represents this behaviour. In this context it should be kept in mind that clinical
evidence obtained so far has been hampered by uncertainties in delivered and reported dose
and variations in tumour cell characteristics, so that requirements might need to be stricter to
resolve these effects in future. The latter effect has been studied by Webb and Nahum,  who54
indicate a much steeper dose-effect curve and thus much higher dose accuracy demands if
these variations would be taken into account. 
The wide diversity in tumour sensitivities and normal tissue tolerances found in practice
could lead to a range of accuracy requirements. As this is considered to be undesirable in
practice, requirements should be based upon the most critical situations encountered in regular
radiotherapy practice. Specific applications concerning, for example, single fraction
radiosurgery of benign diseases can be excluded as these might demand facilities such as
invasive stereotactic frames that are not compatible with fractionated radiotherapy. It is
interesting to note in this respect that fractionated treatment with a relocatable frame is
reportedly associated with a more accurate dose prediction than single fraction treatment with
an invasive frame.  55
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In a recent report  an overview is given of clinical evidence for the importance of26
radiotherapy accuracy, from which it is concluded that a difference in absorbed dose of 10% is
detectable for tumours and that a difference of 7% in absorbed dose can sometimes be
observed for normal tissue reactions. For the latter figure even 5% has been reported.  From56
an extensive review of dose-response data, noticing that this concerned cell and population
averages, Brahme et al.  concluded that the standard deviation in mean dose should be at57
most 3% (1 S.D.) to have a reasonable control of the treatment outcome (with a 5% action
level). This is in agreement with a review undertaken by Mijnheer et al.  of dose-response58
steepness data observed in normal tissue complications. They concluded that transfer of these
data between institutes requires the dose to be known at the specification point within 7%
accuracy, which they equated to 2 S.D., noting that equating it to 3 S.D. would be not
achievable, at least not at that time (1987). A critical interpretation of their most sensitive
data, neglecting practical feasibility would thus result in an even stricter requirement, for
example, 2% taken as 1 S.D., which has been suggested as the most critical requirement (no
standard deviation defined) in ICRU Report 24.  This is in reasonable agreement with a59
Nordic report  that suggests a dose accuracy of just 1 Gy (1 S.D.) for steep responding60
tumours, corresponding to approximately 1.5% for common dose prescriptions. 
Considerations of heterogeneity in dose and tumour cell characteristics over the target
volume have been used as an argument for less strict dose requirements in other points of the
target, leading to 5% (1 S.D.) over the entire target volume.  However, an assumed spread in26
tumour cell densities will not allow for much spread in dose, because studies show that even
large variations in tumour cell density only permit very modest variations in dose.54,61
Moreover, it is also noted in the same report  that it is likely that a better accuracy will be26
needed when better tumour control data is obtained. Thus the proposed relaxation of
requirements to 5% in other points than the specification point  is questionable. 26
It must in addition be stressed that these figures apply to the uncertainty for the total
radiotherapy treatment, so that requirements for treatment planning are necessarily stricter.
Another approach has been followed by Ahnesjö.  He defined a practical limit where62,63
further increase in dose calculation accuracy does not yield an increase in total treatment
accuracy, taken into account reported uncertainties in calibration and delivery technique. His
conclusion is that at present there is no need for a dose calculation accuracy better than 2%,
whereas this ultimately might be confined to 1%. Similarly, Mackie et al.  reasoned that dose64
calculation accuracy need not be as accurate as absolute dose calibration while, on the other
hand, calculated dose should not deviate too much from prescribed dose; they concluded that
dose calculation accuracy should be in the range of 2% to 5%.
In the absence of unambiguous conclusions from tumour control studies, a criterion of
4 mm (1 S.D.) has been formulated on the position of beam edges.  This criterion is stated to26
include all geometric and movement factors. In recent reviews  standard deviations down41,42,43
to approximately 1 mm have been given for both organ motion and setup-error for some
treatment sites and motion directions. Reasoning that treatment planning should not be the
weakest link in the chain, a criterion of 2 mm (1 S.D.) or less seems appropriate for treatment
planning alone. The stated total criterion of 4 mm may than be considered as too relaxed.
Specific requirements such as leaf position in some dynamic IMRT fields need to be tighter,
e.g. 1 mm.65
Concluding the fundamental approach, accuracy criteria of 2% (1 S.D.) in calculated
dose and 2 mm (1 S.D.) in field edge position can be seen as generally appropriate, whereas
1% or 1 mm might be required in specific circumstances.
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2.2 Practical approach
As the accuracy levels derived from this fundamental approach can not be achieved at
present,  practical approaches are frequently considered. These are based on expert opinions66
and clinical experience combined with assessments of practicability, resulting in a wide
variety of criteria for treatment planning accuracy. A comparative overview has been given by
Venselaar et al.,  and some references have also been included in chapter III. Published67
criteria cannot in a straight-forward way be compared to each other due to differences in
reference dose, local or absolute, isocentric or d , and to differences in situations in whichmax
the criteria should be applied. Venselaar et al. undertook a conversion of the most recent,
elaborated criteria to four beam geometries in a phantom, and reported many differences
between these criteria of up to a factor of 3 and incidently higher. Thus general consensus
based on expert opinion and experience is still far away. Consensus is, however, found to a
large extent in a high dose, low gradient region in a simple geometry in a homogeneous
phantom, where many authors/reports define 2% in local dose as criterion,  although26,63,67-70
others define criteria for this geometry in the range of 1% to 4%.  Strictly, the latter  is71-73 73
announced as a suggestion, not a requirement. Some of these references complement this
requirement with a 2 mm limit in cases of high dose gradients,  while others apply less26,67,69
strict criteria up to 4 mm.
In these practice-based approaches criteria are relaxed in cases where a planning system
is probably less accurate or where inaccuracies accumulate.  For instance, simple, complex67,71
and more complex or anthropomorphic phantom geometries, and central axis and off-axis
criteria are distinguished, and correspondingly relaxed criteria are applied.  Outside the67,71
beam, accuracy criteria of up to 5% relative to the central axis dose have been specified,67
whereas application of criteria from other reports to the same geometries may yield even
higher values.  This widening of tolerances thus resembles expected shortcomings in many67
present treatment planning systems. But it might be less appropriate for some other treatment
planning systems, depending on the sophistication of the algorithms used. For the time being
it can be seen as the best practical achievable solution, for example for treatment planning
intercomparisons or to identify unexpected large errors for any particular treatment planning
system. However, it is recognized that these (actual) tolerances should not reflect levels of
acceptability beyond which no further improvements are necessary,  but indeed should71
converge to the criteria derived from radiobiological and clinical data.  Furthermore, the67
presented practice-based accuracy criteria might already be too tolerant in the assessment of
advanced treatment techniques that aim at small, albeit possibly significant dose differences,
for example, a reduction of 1-3 Gy at the 70 Gy dose level in the rectum during a prostate
treatment.28 
If general limits are desired, values of 3% or 3 mm may be considered as representative.
These tolerance levels were recently specified  for a ‘complex geometry’ with wedge,67
inhomogeneity or asymmetry.
In the application of the criteria cited above, confusion can arise as to where the dose
and where the distance criterion should be applied. A boundary at a dose gradient of 30%/cm
has been proposed.  On the other hand, the IPEM Report 68 states that this confusion should71
be clarified in a department policy statement.  Although this yields clarity in an institute, it69
does not promote uniformity between institutes. Moreover, any choice for a boundary
inevitably has inherent arbitrariness. 
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Fig. 1 Illustration of the field accuracy concept. A calculated (thin
line) and a measured (thick line) schematic dose profile are shown
in (a). In (b) the difference in dose between calculation and
measurement is shown as a solid line. The distance-to-agreement
of calculation and measurement, carrying the ± sign of the dose
difference, is shown as a dashed line. The corresponding field
accuracy is shown in (c). Regions where the field accuracy curves
are determined by mm-curve distance are thickened. Crossings of
dashed horizontal lines indicate that an accuracy criterion, here
3 [%;mm], is exceeded.
Concluding this practical approach, accuracy criteria were found to vary widely between
reports/authors and between situations with more or less complexity. Especially in more
complex geometries a clear gap exists between the criteria set by the practical approach and
those defined by the fundamental approach. Furthermore no unambiguous transition exists
between dose and distance criteria.  
2.3 Bridging the gaps 
The two gaps that have been sketched in the previous section can (at present) not be
eliminated. The first, the different criteria resulting from the fundamental and the practical
approach, will exist until treatment planning has further evolved to let the criteria of both
approaches converge. The second, the transition between application of dose and distance
criteria, inherently depends on a subjective assessment as to what criterion has to be applied at
any specific location. In practice, it is experienced that the existence of these gaps diminishes
the efficacy of treatment planning verification.
Faced with their existence, a solution is sought in this thesis to bridge the gaps, namely
by application of a function that combines distance and dose discrepancies in an intuitive way,
prior to applying any criterion. Such a function is introduced in chapter III. This so-called
field accuracy, Fig. 1, is defined for comparison of calculated and measured dose distributions
as the difference in percent or the distance-to-agreement in millimetres, whichever is less. The
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combined pseudo-unity is indicated as [%;mm]. The intuitive element in this definition is that
use is made of the observation that distance and dose criteria in current units are numerically
close to each other, in many practical (near 3% and 3 mm) and ideal (near 2% and 2 mm)
criteria. A similar approach has been proposed by Harms et al.  The field accuracy data is not74
a priori reduced to a single ‘goodness’ quantity, but the accuracy level is verified a posteriori,
thus maintaining the possibility to compare to any criterion, e.g. 2 or 3 [%;mm], as long as the
assumed numerical equivalence of dose and distance holds. In case of large amounts of
verification data, which is common practice in a full dosimetric verification of a modern
treatment planning system, the use of this quantity should preferably be embedded in a
practical, dedicated procedure, which is presented in section 3. The application of this field
accuracy concept has markedly improved the efficacy of the verification procedure. 
A further advantage of the application of this field accuracy concept is that no
concession to accuracy requirements is accepted based on assumed computational weaknesses
of a treatment planning system’s algorithm. On the contrary, it is considered that in those
cases (treatment techniques) where less calculation accuracy is found, this should just be
presented as such, and then balanced against the clinical advantage, if any, of the application
of such a treatment technique. Such an error documentation without a priori concessions
should be an integral part of the verification data, section 3. Preferably the field accuracy
presentation should also be available in combination with any (kind of) treatment plan, to give
an impression of the overall (un)acceptability of treatment planning accuracies in targets and
tissues in such a treatment plan. The feasibility of this idea is discussed in Chapter IX.
A critical note to all quantities representing geometric accuracy, including field
accuracy, is that ultimately not distance-to-agreement but tumour control probability is the
most relevant quantity. But even when this would become an integrated element of treatment
planning, it is expected that verification practice will always also need handsome geometric
criteria.
In conclusion, accuracy criteria for treatment planning calculations would ideally be 2%
or 2 mm, and 1% or 1 mm in specific circumstances, whereas 3% or 3 mm is often seen as
presently acceptable. The field accuracy concept allows an adequate comparison to the
combined criteria.
3. Verification of treatment planning dose calculations
A verification programme (procedure) is required to check compliance to established accuracy
criteria. The extent of this programme and its implementation into a program (software) are
described in this section. The power of the program is illustrated by an example.
3.1 Combinatorial verification
The high level of treatment planning accuracy described above necessitates a well-structured
verification programme. The structure of such a verification of a treatment planning system
can be understood by the analogon of the defences of a medieval city based on several
concentric walls, Chapter II. In case the outer wall fails, the inner walls will hopefully stand
up. The outer wall in treatment planning verification is the verification work (release test)
provided by the manufacturer. The scope of the present section is the next inner wall, the in-
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hospital verification (acceptance procedure) of a new treatment planning system, a new
algorithm or just a new release of an existing system or algorithm. A further inward wall is
represented by system quality control such as checks that no changes have occurred in a
system which has been released for clinical use, and checks of, for instance, the correctness of
Hounsfield units of a CT scanner. The most inner wall is patient quality control such as a
check on monitor units in every treatment field of any patient.
In recent years many reports have been published about treatment planning
verification.  These reports provide tests and procedures for functional, geometric and26,69,72,73,75
dosimetric verification. This section is confined to verification in the sense of dosimetric
acceptance testing aimed at defining the level of accuracy of dose calculations in a treatment
planning system, and at identification of treatment techniques where sufficient accuracy
would not be warranted. (It must be noted that dosimetric and geometric verification cannot
be separated completely, because dose in the penumbra is directly linked to the definition of
beam edges, as will be shown in section 3.3.) The suggestions in the mentioned reports
provide a basis for such an acceptance test, a basis that has to be adapted to tailor it to the
characteristics of the local treatment planning system and possibly also to meet the
requirements of specific clinical applications. The model in our treatment planning system
(Helax-TMS, MDS Nordion, Canada) is an energy-fluence based model. The tailoring of the
verification program to the characteristics of this model is described in Chapter II.
The number of checks that has to be performed increases rapidly with the degrees of
freedom of a treatment planning system and the variety of desired clinical applications. A
typical set of parameters for water phantom scans used in our hospital for the photon beams of
a triple energy linac equipped with MLC is given in Table I. This set is to be extended with
situations of oblique incidence, missing tissue and tissue heterogeneities.
Table I. A typical set of parameters for water phantom scans used in the acceptance test of the photon beams of
a new linac for dose calculation in a treatment planning system.
Parameter Values Number
Energy 6, 10, 15 MV-X 3
Source-surface distance (SSD) 75, 90, 120 cm 3
Field sizes 3, 5, 10, 15, 20, 30, 40 cm 72
Field shape square, elongated, asymmetric (half/quarter) 3
Field edge collimator, block, MLC 3
Modulation open, wedge 2
Scan direction X, Y, Z 3
Depths d , 5, 10, 20 cm 4max
Although the number of parameters in this example is modest, merely representing
regular use of a modern linac, the number of combinations of these parameters is immense,
corresponding to over 10,000 scans. This resembles the observation that each separate
parameter might be interpreted as an extra dimension spanning a huge ‘verification space’. Of
course, an intelligent reduction of this number is well possible, because not all ‘grid points’ in
verification space need to be explored, but definitely much more has to be done than a
straight-forward exploration of the main axes of verification space. For instance, it might well
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Fig. 2 Calculated (dashed lines) and measured (solid lines) line dose profiles (upper part of each
panel) at 10 cm depth and SSD=90 cm in 15 MV-X fields: (a) open 20x20 cm , (b) wedge 20x20cm ,2 2
(c) blocked 20x22 cm  and (d) blocked wedge 20x22 cm . The corresponding field accuracy curves2 2
are plotted in the lower panels of (a), (b), (c) and (d), respectively. The inserts represent the applied
field shape, wedge direction, if applicable, and the position of the line dose profile.
be that calculations in open fields, and fields supplied with a shielding block or a wedge are
all in good agreement to measurements, however, this gives no guarantee that in a
combination like a wedged block field the dose is calculated with acceptable accuracy.
Moreover, the calculation of such a combination might happen to constitute the decisive
element in a clinical evaluation, for example, if rectum dose becomes the decisive criterion in
a prostate treatment.  28
In Fig. 2 the combination of wedge and blocks is illustrated in some verification results
of our treatment planning system, Helax-TMS 5.1. Measurements have been performed with a
ionization chamber (IC15, Wellhoefer, Germany) in a 15 MV-X beam in a water phantom
(Blue phantom, Wellhoefer, Germany). In combination with measurements in a reference field
(10x10 cm , depth 10 cm at SSD=90 cm) absolute dose values are obtained, only excluding2
variations in linac output. Calculations also relate to absolute dose, so that absolute dose
discrepancies, relative to 100% reference dose, are shown. In terms of a ‘classical’ treatment
planning system, errors in output, depth dose curves, off-axis ratios and block transmissions
are thus all included. The block used is an arrow-shaped shielding block, identical to that used
in chapter III. For clarity of display only scans at 10 cm depth in a scan direction defined by
the lower jaws are shown.
The lower curves in Fig. 2 represent the field accuracy. The field accuracy of the open
field and the fields supplied with a wedge or a block, Fig. 2a, b and c, respectively, are mostly
within ±3 [%;mm]. Under the shielding block the dose is overestimated by approximately
2.5%. In this case this slight overestimation is on the ‘safe side’, and probably of no clinical
meaning. In contrast, the combination of block and wedge, Fig. 2d, shows an underestimation
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of the dose under the block. At the thin side of the wedge the underestimation amounts to 8%
of the dose to the centre of the field. This underestimation was found to be confined to the
highest photon energy (15 MV-X) and appeared to increase with decreasing SSD.
This example illustrates that ‘combinatorial verification’, defined as exploration of all
relevant combinations of field parameters, is thus needed to discover situations of possibly
unacceptable inaccuracy. Illustrated by a metaphor, combinatorial verification is required to
find ‘dust traps’ that might otherwise remain hidden in the corners of parameter space.
In conclusion, combinatorial verification is required to check compliance to established
accuracy criteria. As a consequence, a multitude of geometries has to be verified. The field
accuracy concept is helpful to get a better overview of the results, but only with an adequate
implementation of verification procedures this undertaking can be successful.
3.2 Implementation of combinatorial verification
The feasibility of combinatorial verification depends on practical aspects of implementation,
concerning first of all the large amounts of data to be handled. For example, after thoughtful
reduction of  the set of parameters listed for one new linac in Table I, still approximately 1500
line dose profiles remained which had to be measured, in combination with approximately
200 beam output measurements to obtain absolute dose values. A thimble ionization chamber
(IC15, Wellhoefer, Germany) has been selected for this purpose, because of its reputation of
uncomplicated use, and the virtual absence of energy dependence and negligible direct photon
response. An array of such ion chambers is a good equivalent to reduce the required linac
time.  With this type of dosimeter a correction must be performed for the detector’s non-ideal76
spatial behaviour by application of the line spread profile, chapter VI. In addition, a correction
for small misalignments (assumed to be less or equal ± 1 mm) in the setup of the water
phantom might be required, and a transformation to account for a difference in coordinate
systems of water phantom and treatment planning system. The same amount of line dose
profiles were calculated by the treatment planning system, which had to be connected
correctly to the corresponding measured profiles and output factors. Comparison results
should include a field accuracy profile, and for consistency checks also the field size, the
penumbra steepness, and the manipulations performed on the data should be registered. The
results of the comparisons should be displayed, documented and archived in an easily
appreciable way. 
To achieve this purpose a profile comparison program and a profile database were
developed, as schematically represented in Fig. 3. A macro defines all actions to be performed
thus preventing possible errors caused by direct user interaction. The results are documented
in a library of comparison results with corresponding plots. Subsequently, the comparison
results can easily by used for further analysis.
This verification facility is now in use at our hospital since 1995. At present our profile
database contains approximately 3500 measured profiles which have been compared to
corresponding calculations of the current version of the treatment planning system. The
following results were obtained by this program so far:
• An appropriate verification of the calculations of an advanced treatment planning
system has been performed. 
• This verification is easily repeated when modifications in hardware (new linac) or
software (new releases) require to do so.
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Fig. 3 Schematic implementation of combinatorial
verification. The profile database and the comparison
program are presented by shaded boxes. The rounded
boxes represent data that have to be provided by the
user. The rectangular boxes represent the resulting
data.
• Errors in the calculation algorithm have been identified, leading to code analysis and
bug fixes in new releases. Dose errors down to 1% could thus be traced. For instance,
scatter from a part of a (small) wedge that was outside the projected maximum wedge
field size but within the beam cone defined by the primary collimator was found to be
omitted. This resulted in a local 1% dose error in the calculated output of wedge fields.
• Errors in linac field size were found in measurements that were made for the purpose of
a beam-fit for the treatment planning system, Chapter II. For instance, a 1.5 mm
positional error in the collimator position of a wedge field was identified in this way.
This influenced the gradient of the calculated wedge profiles, causing  a local 1.5% error
in dose.
In conclusion, the implementation of combinatorial verification into a profile
comparison facility and a profile database, as shown in Fig. 3, has proven to allow verification
of treatment planning calculations over all required dimensions of ‘verification space’ and has
contributed to improvements in both the calculation algorithm and the dosimetry for beam
commissioning in the treatment planning system.
3.3 An example of verification analysis: field sizes 
The data that result from the combinatorial verification procedure are fed into the database.
This database is well suited to perform more advanced analysis, as is shown in this section.
An extended application of this verification data is described in Chapter IX.
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Fig. 4 Field size differences in dose profiles of a 15 MV-X beam at SSD=90 cm at depths of 5 cm
(triangle), 10 cm (circles) and 20 cm (squares). (a) Differences between calculated and measured field
sizes, defined at 50% of the profile centre value. (b) Differences of expected (=geometrical) field size and
measured field size (at 50% height). The dashed lines indicate estimated differences at 5 cm and 20 cm
depth based on measurements at 10 cm depth. (c) Schematic dose profile (error function) of a single
source (thin solid line) and combination of two sources where the second source yields an extended 10%
dose contribution (thick solid line). The geometric field edge position is indicated by a vertical line. In the
single source geometry the positions of 50%-points and inflection points coincide with the field edge. In
the dual source geometry the 50% points are moved outwards. (d) Difference of geometrical field size
and measured field size, as determined by the position of the inflection points on the profile.
In Fig. 4 an example of analysis results is shown. In this figure differences in field sizes
(widths) are shown that were found in a 15 MV-X beam (SLi15, Elekta, Crawley) at 90 cm
SSD. The presented field sizes, in this figure indicated by W, are defined by the lower X-
diaphragm, which is a pair of focussed collimator jaws. In Fig. 4a the differences in field size
at 50% of the profile centre value of calculated and measured profiles are shown for
symmetric field sizes of 5x5 cm  to 30x30 cm , at depths of 5 cm, 10 cm (isocentre) and2 2
20 cm. The calculations were done with a pencil beam model in which no correction for off-
axis softening of the energy spectrum is applied. The calculated field size at 50% height is
seen to be systematically larger than the corresponding measured field size. Differences of up
to 1.3 mm were found, with the greater differences found in larger field sizes and at greater
depths. The deviations are less than 1.0 mm for field sizes up to 20 cm, and the systematic
character might have passed unnoticed with normal comparison of profiles. Nevertheless, as
this difference occurs in between all treatment plans and treatment executions a closer
inspection is appropriate.
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Further analysis yielded two causes for these deviations and one other was excluded. As
the mean difference over the range of field sizes between measured (50%) and expected
(=geometrical) field size at isocentric depth was 0.0 mm, Fig. 4b, an error in the regular
calibration procedure of the jaw positions could be excluded. Both at greater and smaller
depths slightly greater differences are found especially in larger fields. Based on the
differences at 10 cm depth and estimating the effect of off-axis softening on the position of
the 50% points at other depths,  the differences indicated by dashed lines in Fig. 4b were77
calculated, which mostly agree very well with the observed differences. This illustrates that
calibration of collimator position is strictly speaking only valid at one depth. This first cause,
field-size reduction at greater depths and off-axis position due to off-axis softening is not
taken into account in the pencil beam calculations, causing the fan out of lines in Fig. 4a.
The second cause was analysed to be linked to the average difference of 0.4 mm that
was found between the calculated width at 50% height and the geometrical field size. This
phenomenon is schematically explained in Fig. 4c. A collimator field edge originating from a
single source, such as the focus of a linac, is represented here by a sigmoid-like shape (thin
line) where the position at 50% height coincides with the inflection point of the profile and
with the geometrical field edge, i.e. the projection of the focus along the collimator edge.
However, additional fluence that emerges from a second source, located lower in the linac,
such as head scatter from the flattening filter, is associated with a broader field and thus
effectively raises locally the dose profile that originates from the linac focus. Therefore, while
the X-position of the inflection point remains almost fixed, the position that indicates height
at 50% is moved slightly outwards. The only physical correct correlation is thus between
geometric field size and inflection points. This correlation was checked for our treatment
planning system and found to be correct within 0.010± 0.013 mm over the presented range of
data. Ideally the calibration of the collimator position would use the inflection points. This is
illustrated by Fig. 4d, where the differences between the geometrical and measured field sizes
based on inflection points are shown. The close resemblance of these curves with Fig. 4a
indicates that this difference is indeed the main cause of the differences found in Fig. 4a.
However, a calibration at the 50% points has clear practical reasons. An additional correction
of 0.4 mm is then a good remedy. For a 6 MV-X beam also a correction of 0.4 mm was found.
It should be noted that these data are based on measurements in a water phantom, so that they
may not directly be applicable to film measurements, in particular at depths beyond dose
maximum where energy effects may play a role. 
An approach to account for these effects could be to apply a water phantom for the
collimator calibration, to define the depth at which the settings should be optimal (10 cm
depth is considered to be a good choice), to calibrate collimator settings at positions of 50%
height, and to add an extra 0.4 mm field width (if 10 cm depth was chosen) afterwards. The
remaining maximum discrepancy in this set of data is than 0.3 mm at the depth of calibration
and 0.9 mm elsewhere. Note that in this approach the calibration of the field sizes at the linac
is adapted to a geometric beam definition, rather than the common 50%-based definition.
However, a geometric beam definition is required to allow proper calculation of the
contribution of multiple sources of linac energy fluence. The fan out of lines in Fig. 4a is
expected to disappeare when off-axis softening is taken into account in the calculations.
In conclusion, the described implementation of combinatorial verification is shown to
provide a powerful tool for further analysis of beam data. In the example given a systematic
difference in mean width of 0.4 mm over all field sizes was found between measured and
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To define the accuracy of dose and volume calculations that are essential for
conformal radiotherapy treatment planning.
calculated profiles, that could be traced to the procedures for field size calibration applied at
the linac.
4. Objective and outline of this thesis
In the previous sections it has been shown that advancements in radiotherapy, especially in
conformal treatments, require that the accuracy of treatment planning calculations lays within
margins that can be derived with reasonable approximations from radiobiological and clinical
data. An extensive verification programme is necessary to check compliance of treatment
planning calculations with these accuracy limits. The accuracy of treatment planning
calculations can only be determined properly when the physics and mathematics involved in
all calculation and verification steps is understood. This thesis is intended to gain such
knowledge for calculations that are of fundamental importance for conformal radiotherapy
treatment planning. Thus, the objective of this thesis is:
The papers included in chapters II - VII meet various aspects of this objective.
Chapter II describes the verification programme that has been designed to check the
dose calculation accuracy in the treatment planning system that is applied at the Groningen
University Hospital. This treatment planning system is based on an energy transport model. In
this chapter the required tailoring of the verification programme to the physical characteristics
of the calculation model is presented. 
Chapter III is concerned with the first step, also in historic perspective, in conformal
radiotherapy: the confinement of treatment fields to the projected shape of the PTV by
individual shielding blocks. The accuracy of dose distributions calculated with pencil beam
kernels in blocked photon fields is verified in comparison to measurements in a water
phantom. In this chapter the concept of field accuracy is also introduced and shown to be a
valuable verification tool. 
Chapter IV focusses at one of the major challenges in treatment planning calculations:
the calculation of dose in and near tissue heterogeneities. Due to extended transport ranges of
recoiled electrons and scattered photons the penumbras of photon beams are considerably
widened in low density materials such as lung, in comparison to more water-like tissues like
muscle and adipose. This yields a lower dose near the edges of a beam and thus a possible too
low dose in, for instance, the PTV of a lung tumour. In this chapter dose calculations have
been verified by measurements in a phantom that simulates a lung tumour geometry. The
calculations were performed by several algorithms that are currently in use in modern
treatment planning systems, amongst others the pencil beam kernel algorithm with one-
dimensional convolution correction algorithm described in Chapter II. Recently, the
calculations were repeated in the same geometry with a point spread kernel algorithm, of
which results are included in chapter II.
Chapters V and VI are dedicated to the accurate determination of beam edges. The
conformance of a radiotherapy treatment depends on an accurate knowledge of the beam
edges. Thus accurate measurements of beam penumbras are required to customize and verify
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the calculation model of a treatment planning system. As outlined above, a large amount of
measurements is required for combinatorial verification. Therefore, well-established routine
dosimeters such as thimble ionization chambers and photon diodes are often preferred. The
non-ideal behaviour must than be corrected for. This behaviour originates from the detector
dimensions, and in case of ionization chambers, the alteration of electron transport and the
replacement of medium by the materials of chamber wall and electrode. In chapter V
analytical calculations are described that model the transport of Compton recoil electrons. The
model is verified with measurements using a diamond detector in a telescopic slit beam
geometry to be able to describe primary dose profiles of an elementary slit x-ray beam. In
chapter VI this model is extended to calculate detector response profiles of a thimble
ionization chamber. Calculated detector response profiles of ionization chambers and a photon
diode are experimentally verified in the telescopic slit-beam geometry. The combination of
detector response profiles and dose profiles yields the line spread function of this type of
detector.
Chapter VII is devoted to accuracy in proton beams. When photons are replaced by
protons as treatment modality, a further improvement in conformal radiotherapy can be
achieved, primarily because of the well-defined depth of penetration of protons. In addition,
very sharp lateral beam edges can be achieved with proton beams, especially close to the final
beam collimation. Collimator scatter becomes important at short distances. Its contribution
has been calculated with a Monte Carlo model. The calculations were verified by means of a
two-dimensional detector consisting of a scintillating screen and a CCD camera. The line
spread function of the detector was verified with a diamond detector.
Chapter VIII ends this series of papers by studying accuracy of volume calculations,
the step logically following dose calculations in treatment planning. The three-dimensional
dose distributions that result from treatment planning calculations are difficult to appreciate
for a human observer, for example to assess whether a distribution complies with dose and
volume criteria for targets and critical structures. Dose volume histograms are then a valuable
tool. To obtain a dose volume histogram, a sampling of dose over the volume must be
performed, usually based on a regular grid of dose points. The accuracy of this grid-based
volume sampling has been the subject of some controversy.   This controversy originated78,79
from a neglect of the influence of the shape of a structure on the accuracy of the volume
sampling, as is proved in chapter VIII.
Chapter IX, a future perspective, investigates the feasibility of a presentation of
calculation accuracy in a complete treatment plan. The importance of such a presentation
follows from the observation that any discrepancy in the calculated dose distribution
constitutes a systematic error in the treatment, and its magnitude should thus be known during
treatment planning. This presentation provides the links between the research conducted in
this thesis, the results of a verification programme on a treatment planning system’s
calculation accuracy, and a presentation of calculation accuracy in individual treatment plans
to help treatment decisions.
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Verification of an energy transport model for
dose calculation in a treatment planning system
Abstract
A procedure has been developed for verification of the radiation beam model in a modern
treatment planning system, Helax-TMS. Aiming at general applicability, the beam model for
photon dose calculations is based on a first principle description of the energy fluence components
that exit the head of a linear accelerator. The dose to a patient is calculated by an energy
deposition kernel that converts the incident energy fluence to deposited dose. The beam model is
constructed on the basis of measurements supplemented with Monte Carlo data and a geometric
description of the head of a linear accelerator. Because modelling steps are involved between
measured basic beam data and the model parameters, the model and its implementation require
specific attention during verification. In this paper the verification procedure is described with
emphasis on verifications that are tailored to the model characteristics. A ‘concentric wall’
structure is set up which is shown to serve well the purpose of verification, because very few
errors are found at the inner wall. Over a period of 5 years in 1% of all treatment plans a dose
difference larger than ±2%, as compared to an independent check, was found. 
1. Introduction
The treatment planning system (TPS) at a Radiation Oncology Department plays a key-role in
the preparation of a radiotherapy treatment. The system provides the means to design
treatment plans for delivery of the prescribed dose to the target volume (tumour with
appropriate margin) while sparing the surrounding normal tissue as much as possible. To meet
this requirement, the TPS should be able to exploit all degrees of freedom of the treatment
machine, usually a linear accelerator (linac). A minimal margin usually exists between an
eradicating dose to the tumour and a dose with unacceptable risks for complications. This
implies that the TPS must be able to calculate dose distributions with sufficient accuracy, for
all applied treatment techniques in any patient anatomy. As an indication, an accuracy in the
dose distribution of 2-3% (1 S.D.) is considered as presently acceptable, and 1% (1 S.D.) as a
possible future aim level.1,2
Many workers in the field agree that only a fundamental physical approach, based on first
principles, will allow high accuracy of calculated doses to be obtained for all present (and
future!) degrees of freedom in treatment delivery. The dose calculation model of the TPS
studied in this paper and installed at our hospital (Helax-TMS 5.1.1, MDS Nordion, Kanata,
Canada) is directly based on a description of the basic quantity in radiation: radiation energy
that is transported from the treatment machine to the patient, where it is deposited as dose
(energy per mass) in patient tissues. The transfer of this concept into a clinical TPS has been
documented in a large number of publications, as discussed in a recent review article.1
The aim of this paper is to present the verification procedure that we have developed to
verify the beam model of our TPS, section 3, taking into account its physical background to
describe energy transport, section 2. The scope is limited to megavoltage photons as generated
by a linac, the most common application of radiotherapy.
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Fig. 1 Schematic transection of the head of a linear accelerator
2. The physics of a beam model
When irradiated materials and tissues and their cross sections are known in sufficient detail,
Monte Carlo calculation provides the tools to calculate radiation interaction effects with any
required accuracy. However, on present hardware dose calculation times are prohibitively
long, thus urging simplified models for clinical purposes. The beam model in our TPS
therefore applies various pre-calculated Monte Carlo results that are matched to the properties
of the actual linac beam as defined by measurements and by the linac geometry.
Dose calculation in the TPS is performed in two distinct stages. In the first stage (section
2.1) the energy fluence is determined as it exits the linac in a particular field configuration.
Energy fluence is defined as the number of particles passing a sphere of unit cross-sectional
area, multiplied by the energy of the particles. Furthermore, in the first stage the relation is
determined between energy fluence and the number of monitor units, and thus absolute dose.
This is, however, outside the scope of this paper. In the second stage (section 2.2) the dose
distribution is calculated that is deposited in a patient by this energy fluence. The
determination of beam parameters to construct a beam model for an individual linac beam, the
‘beam-fit’, is subsequently described (section 2.3).
2.1 Description of the energy fluence of a linac
Megavoltage photons are generated as bremsstrahlung in the transmission target of a linac,
Fig. 1. The fraction of these photons that exit the linac without further interaction constitutes
the major contribution to the energy fluence. They represent the primary energy fluence, R  .prim
This fluence is defined at the level of the isocentre in the maximum field size, A , as amax
variation f(x,y|A ) upon a constant reference fluence R , thus: R (x,y|A ) =max 0 prim max
R @f(x,y|A ). The function f(x,y|A ) is being determined as a part of the beam-fit. When the0 max max
field size is limited by collimators and shielding blocks, A  has to be replaced by the actualmax
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Fig 2 (left) Determination of the view of a head scatter source from a dose calculation point.
(right). Example of such a view of the flattening filter. 
(1)
field size A. The fluence at other distances (the z-direction) can be derived by correction for
the distance (- 1/r ). For the purpose of clarity the present description is limited to isocentric2
distances only.
Another fraction of the bremsstrahlung photons will be scattered by the flatness filter, by
the primary collimator, by the wedge, by the edges of the collimator, and, if present, by blocks
and trays. This contribution to the fluence is called head scatter fluence, R (x,y|A). The headhsc
scatter contributes 4% to 15% of the total dose, dependent on the linac construction, the field
shape and accessories like compensators. The flatness filter and the primary collimator
dominate the head scatter fluence. The head scatter is a function of geometry and position of
all scattering parts of the linac head, as seen from the point of dose calculation (x,y,z), Fig. 2.
The algorithm that performs the projection calculations has to take care of numerous
interfaces, especially in the case of a multileaf collimator (MLC). Thus a robust
implementation is required with a careful balance between efficiency and accuracy.  The total3
energy fluence Q  is defined by:tot
A graphical representation of the dose distribution corresponding to a 6 MV-X MLC-
shaped field at the level of the isocentre at 10 cm depth is shown in Fig. 3. For matter of
clarity of display the dose distribution rather than the fluence distribution itself is shown, i.e.
the fluence convolved with a pencil beam kernel, section 2.2. Also included is the phantom
scatter dose, that is the dose resulting from photons that are scattered in the patient.
Inspection of Fig. 3 shows that the head scatter distribution is distinctly different from
the primary fluence, both in homogeneity and in steepness of the penumbra. The most
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Fig. 3 Dose distributions of a 6 MV-X 10x10 cm  MLC-2
shaped field at 10 cm depth in water. In the total dose
distribution (a) the area up to 20% is enhanced in the display.
Inside the field boundary the dose decreases with distance to
the centre. This is caused by the phantom scatter (c) and the
head scatter (d), whereas the primary dose distribution (b)
within the field is almost flat. The relative contributions of
the dose components is indicated by a dose profile through
the centre (e).
important causes of these differences are the location, near the field defining collimators, and
the extension of the flatness filter.
In Eq. (1) it can be seen that the energy spectrum of the photon beam is not explicitly
included. An integration over an effective energy spectrum has already been performed, as
described in section 2.3. This yields an increase in calculation speed of approximately a factor
of 10. As a consequence, however, effects of spectral changes as a function of depth in a
patient or as function of the off-axis position in the beam, can not be accounted for on the
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2.2 Description of the dose deposition in a patient
The dose that is delivered to a patient upon irradiation with megavoltage photons is deposited
by electrons (at higher energies also positrons) which induce tracks of ionization in tissue. The
two quantities that determine the conversion between energy fluence and dose deposition are
the total energy released to mass, terma, by the photon beam and the energy deposition pattern
(kernel) around a photon interaction point. Given a homogeneous mass density D and an
exponential decrease as a function of the trajectory length (depth) with attenuation coefficient
µ(E) at photon energy E, the terma differential in energy E, T , is defined as:E
Kernels can be determined by Monte Carlo calculation, and in good approximation also by
analytical calculations. In the calculations photons are forced to interact at a fixed location,
yielding a point spread kernel. A graphic representation of a point spread kernel due to 6 MeV
mono-energetic photon interactions is given in Fig. 4. A poly-energetic kernel can be
composed by weighting of a set of mono-energetic kernels over the effective spectrum, refer
to section 2.3. Such a poly-energetic point spread kernel can be described  accurately in a5
homogeneous medium (water) by an analytical expression: 
in which r indicates the distance to the point of interaction and  represents the azimuthal2
angle relative to the direction of the incoming photons. The parameters A, a, B and b are a
function of this angle. By good approximation the A-term corresponds to the dose deposition
of electrons recoiled at initial photon interaction (primary component), while the B-term
represents the dose deposition by scattered photons (phantom scatter component).  A5
correction on the B-term for off-axis spectral changes has recently been described.  Such an6
analytic kernel description is a very effective pre-calculated summary of the probability
distribution of ionization tracks. This yields a considerable reduction in calculation time in
comparison to a full calculation of transport. The disadvantage is a decreased accuracy in
cases where the kernel can not appropriately be scaled, in particular in electronic
disequilibrium near interfaces of different tissue densities. 
The calculation of the dose distribution in a patient can now be given by a single equation,
in which T  represents the terma differential in energy, thus prior to spectral weighting:E
At the right side of this equation a separation has been made in the primary and phantom
scatter component of both the terma (in P and S) and the kernel (in h  and h ), in analogy top s
Eq. (3). This separation allows by good approximation the described spectral weighting.  The1
head scatter component is then distributed over both components in the phantom.
II.  Verification of a model for dose calculation32
Fig. 4 Point spread kernel of
6 MeV-X photon interaction
(Compton scatter only). 4
Fig. 5 Point spread kernel
divided in 36 cones. The
respective transport axes
are indicated by solid
lines.
Eq. (4) describes in the case of an infinite homogeneous
medium a convolution that could efficiently be calculated by a
Fourier transform. Daily practice, however, presents finite media
(patients) and density heterogeneities (lungs, air cavities, bone).
In principle the kernel of Eq. (3) can be scaled for the density
variations, followed by a dose calculation with Eq. (4). In case of
a patient that is described by N points in each of three
dimensions this requires a number of calculations in the order of
N  (N  photon interaction points, scaling over in the order of N7 3
points, and N  dose deposition points). Calculation times would3
be prohibitively long. Therefore further approximations are
needed. In our TPS two further approximations are implemented,
a pencil beam kernel and a ‘Collapsed Cone’ kernel.
In the approximation based on a pencil beam kernel, also
called line spread kernel, the point spread kernel of Eq. (4) is
integrated along a ray-line of a beam. The results is stored as a
pre-calculated analytical expression in the beam model of the
particular linac/energy combination. With a line spread kernel
only density variations along the ray-lines can be accounted for
in the dose calculation. Also corrections for beam hardening can
be included. 
The Collapsed Cone approximation is based on a simplified
form of a point spread kernel. The kernel is then subdivided into
a number (M) cones that together constitute a 4  solid angle,π
Fig. 5. All the transport of recoil electrons as well as scattered
photons that occurs inside a cone is taken together, ‘collapsed’,
on the central, transport axis, of that cone. The orientation of the
transport axes coincides as good as possible with the grid of
point spread kernels, making axes of different kernels coincide
as much as possible. Transport is then calculated only along the
transport axes. By use of a recursive relation  each transport axis5
need to be considered only once. On the way along an axis the
energy of recoiled and scattered particles is ‘picked up’ and later
on ‘delivered’ in dose deposition points. An instructive metaphor for this process is a regular
bus service in which passengers are picked up and others delivered at every bus stop. In this
way  the number of dose calculations is reduced to an order of M@N . Beam hardening and off-3
axis spectral changes are corrected for in our TPS by adaptation of the effective attenuation
coefficients that are applied to calculate the primary and scatter component of the terma,
Eq. (4).
2.3 Data-acquisition for the beam model
Two fundamental quantities in the beam model are the energy fluence and the energy
spectrum to perform the spectral weighting of the kernels. These two quantities can not be
determined directly, and must thus be derived from other measurements, Fig. 6. The set of
required measurements for an open beam (without a wedge) consists of:
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Fig. 6 Data flow for the beam model in our TPS. The rounded boxes indicate data that is provided
by the user. At three points this data is fit to Monte Carlo data: mono-energetic depth dose curves,
point-spread kernels and line-spread kernels. The resulting model characteristics are shown in
rectangular boxes. Not shown is the spectral fit of the effective attenuation coefficients.
C Depth dose curves of four field sizes, 5x5, 10x10, 15x15 and 20x20 cm . Furthermore the2
output in a 10x10 cm  field in water and in air to exclude the head scatter component and2
to create phantom scatter normalized kernels. By comparison of a weighted set of depth
dose curves that have been determined by Monte Carlo simulation of mono-energetic
beams, the effective energy spectrum is determined. The remaining difference with
measured depth dose curves in the build-up regions is used to determine a kernel for
charged particle contamination, describing the dose of electrons and positrons that emerge
from irradiated parts of the linac head.
C Dose profiles in two directions in a 10x10 cm  field at 10 cm depth. These are used to2
determine the effective source size of the tungsten target, which is included by
convolution in the line spread and point spread kernels, Eq. (3). When a ionization
chamber is applied, it is recommended to correct for its non-ideal behaviour. Recently  we7
have derived line spread functions for this purpose, see also Chapter V and VI of this
thesis.
C Line dose profiles in a star-shaped pattern at isocentric distance in the maximum field.
With these profiles the function f(x,y|A ) of Eq. (1) can be determined.max
C Output factors in air for several field sizes. These are used to define the relative
contribution of the head scatter component.
C Output calibration (dose per monitor unit) in the reference geometry to provide the link
between fluence and dose.
Additional measurements are used by the vendor for quality assurance purposes, to check the
consistency of the measurements, the quality of the beam fit and the implementation. A
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Fig. 7 Effective energy spectra of 6 MV-X (circles), 10 MV-X (squares) en 15 MV-X (diamonds)
photon beams (SLi 15, Elekta, Crawley). The fractional energy fluence per energy is plotted as a
function of energy.
similar set of measurements has to be done for all wedges. Furthermore a geometrical
description of the linac head is required to model the head scatter calculation. 
An example of the effective energy spectrum that has been determined for 6, 10 and
15 MV-X beams (SLi-15, Elekta, Crawley, UK) is shown in Fig. 7. The energy spectrum
contains 28 bins spread over the range from 0.1 MeV to 50 MeV. This spread has been shown
to be sufficient because attenuation coefficients and kernels parameters vary slowly with
energy.8
3. Verification of the beam model
Prior to clinical application of a TPS, a verification programme, in this paper restricted to
dosimetric verification, must assure the correct implementation of the beam model and define
the accuracy of the dose calculations. This verification programme must be well-structured to
meet all clinical requirements and it must be tailored to the characteristics of the beam model.
In section 3.1 the structure of our verification programme is described. The characteristics of
the TPS and/or the extent of the verification work may require specific tools and methods to
be developed. The methods and tools that we have developed to advance the verification
process to a level that meets the needs of conformal radiotherapy are presented in section 3.2.
In section 3.3 the tailoring of the verification programme to the characteristics of the beam
model is depicted.
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Fig. 8 Schematic representation of the
concentric multi-layer structure of the
verification program of a treatment
planning system.
3.1 The structure of the verification programme
Safe application of a TPS requires a multi-layer system of quality assurance (QA), as no single
check procedure can be guaranteed to be completely fail-safe. The structure of such a QA-
system can be understood by the analogon of the defences of a medieval city based on several
concentric walls, Fig. 8. The outer wall, the verification work (release test) by the vendor is
outside the scope of this paper. The first inner wall represents the in-hospital verification
(acceptance test) of a TPS in which new releases of software and beam data are verified prior
to clinical use. Errors that might pass these walls should be caught by the most inner walls of
system-oriented and patient-oriented quality
control. In this section emphasis is placed on the
tailoring of the in-hospital verification process to
the characteristics of the TPS.
During the acceptance stage a set of tests is
constructed that should represent all combinations
of beam parameters that are clinically used. Each
independent parameter can be interpreted as a new
dimension in ‘verification space’. As is shown in
section 3.1 of Chapter I, this implies an immense
number of combinations to be verified. The
concept of exploring these combinations is called
‘combinatorial verification’. Although not all ‘grid
points’ in verification space need to be explored, it
is shown that a restriction to the main axes of this
space will miss unacceptable inaccuracies. The implementation of combinatorial verification
thus becomes an essential consideration that determines its feasibility. This has been described
in section 3.2 of Chapter I. The tools developed for this purpose are briefly reviewed in the
next section.
An example of system-oriented QA is an automated checksum procedure that is applied
on all patient-independent data in the TPS on a daily basis. Another example is a check of the
Hounsfield values of the CT scanner and its representation in the TPS. For this purpose two
reference bars, made of perspex and cork, have been mounted beneath the table insert on the
CT-scanner. A regular check on the consistency of the corresponding values in our TPS has
revealed an error of up to 15% in obese patients, which has been corrected for in a subsequent
release of the CT software.
The inner defence wall of the QA system consists of a check on the monitor units for each
patient and each field segment. An independent calculation based on an S , S  model  usingc p
9
independent measurements is implemented in a spreadsheet. All differences larger than ±2%
in comparison with the TPS are analysed. Over the period 1995-1999 discrepancies of more
than ±2% were found in approximately 1% of all treatment plans, which gives an indication of
the solidity of the outer walls. Examples of errors that were traced are: inadvertent inclusion
in the patient contour of marker catheters, incorrect use of block and tray material, and an
error in the head scatter calculations, that is illustrated in section 3.3.
This independent check is thus a valuable addition to the acceptance procedure, which can
realistically not be expected to be fail-safe in all cases.
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Fig. 9. Dose distribution of the field shown in Fig. 3. The difference in dose and
position between calculation (Helax-TMS 4.1B) (a) and measurement with a
shielded diode (b) is presented as a field accuracy distribution (c). The left two
distributions are shown with 10% per grey level, the right one with 1 [%;mm] per
grey level. The arrow indicates the location of the maximum discrepancy,
3.2 [%;mm]
3.2 Methods and tools for verification
Faced with the multitude of measurements and comparisons for combinatorial verification of
a TPS, we have developed dedicated tools and methods for this purpose.
Measurements are preferable done with a detector that is suited for routine use, without
the need for extensive handling and for calibration procedures. A thimble ionization chambers
meets these requirements well, except for its limited spatial resolution. This is caused by its
size and the replacement of phantom medium, usually water, by detector air. To overcome this
disadvantage, research has been done to define the Line Spread Function (LSF) of this type of
detector, Chapters V and VI of this thesis. It was concluded that with a correction for the LSF
a thimble ionization chamber is well suited for routine high-resolution dosimetry, which is
required for verification of conformal radiotherapy treatment planning.
All data selection, profile handling, comparison and documentation that has to be done for
combinatorial verification of a beam model has been implemented in a comparison program
based on a line dose profile database, as described in section 3.2 of Chapter I. A macro-
defined input prevents possible user interaction errors. The LSF-based correction is routinely
performed with a maximum likelihood reconstruction technique that has been implemented in
this profile comparison program.
A useful tool for the purpose of accuracy assessment is the field accuracy concept  which11
has also been described in more detail in section 2.3 of the first chapter of this thesis. The
field accuracy concept presents a practical method to handle the transition between dose
difference criteria in low dose gradient regions and distance to corresponding isodoses in
regions of high dose gradients. Field accuracy is defined as the smallest numerical value of
dose difference in percent or isodose distance in millimetres, with pseudo-unit [%;mm], thus
taking advantage of the close numerical correspondence of current dose and distance accuracy
requirements. In this concept the dose is always related to the dose in a reference, isocentric
geometry (SSD=90 cm, 10x10 cm  field at 10 cm depth in water), thus presenting absolute2
dose differences, including, in classical terms, discrepancies in output, depth dose curves and
off-axis ratios. By application of this concept it can directly be assessed whether or not a
criterion of 3 [%;mm], a common acceptance criterion, is met. As an example, Fig. 9 shows
calculated as well as measured dose distributions of a 10x10 cm  MLC-shaped field. By2
inspection of the corresponding field accuracy plot it is directly seen that only in a small spot
in the corner of the field the 3 [%;mm] criterion is slightly exceeded.
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Fig.10 Head scatter dose distribution in an arrow shaped test field (1% dose per
grey level) The distribution on the left shows irregularities up to 4% in dose,
relative to 100% total dose centrally in the field. To the right the same situation
in which the implementation error has been repaired.
Note that the mentioned criterion is used equally for all fields during the acceptance test.
The field configurations that were used for the beam-fit have no distinctive status, for instance
a requirement of exact reproduction of such fields. There is no argument for such a status in a
planning system that is based on a beam model rather than on reproduction of beam data.
Furthermore patients will seldom be exactly irradiated with any basic beam configuration. 
3.3 Verification tailored to the characteristics of the beam model
The beam model in our TPS has two distinct stages: the calculation of energy fluence exiting
the linac and the dose deposition in the patient. 
Three quantities contribute to the calculated energy fluence: primary and head scatter
photon contributions, Eq. (1), and charged particle contamination. Although a quantitative
verification of the individual contributions is difficult to perform within a verification
programme,  checks for consistency of data and qualitatively correct correlation of these10
contributions with, for example, field size and source-surface distance, are part of our routine
verification procedures. All line dose comparisons therefore not only include total dose but all
dose contributions, i.e. due to primary and head scatter fluence, phantom scatter and charged
particle contamination. 
The complexity of the projection algorithm in the head scatter calculation necessitates
specific attention during acceptance, in addition to profile based verification, for example, by
inspection of two-dimensional distribution to trace possible irregularities. In Fig. 10 two 2D
dose distributions are shown that are solely due to the head scatter component in the energy
fluence, the last term in Eq. (1). In this arrow shaped field head scatter dose discrepancies of
up to 4% were found. These appeared to be caused by an implementation error that has been
corrected in a subsequent release. Note that verification solely along the main scan axes might
have missed this dose calculation error.
Other elements of the acceptance procedure that are specifically tailored to this TPS are:
a check of intermediate results of the beam fit, such as the effective spectrum, Fig. 7.
Furthermore it is checked whether the beam parameters fall within reasonable physical limits
and correspond to parameters in similar beams of other linacs.
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Fig. 11 (Insert) Phantom simulating a solid tumour (polystyrene, i50 mm) embedded in lung (cork). Line dose
profiles are taken through the centre of this tumour. A single 6 MV-X beam is incident from above through the
thorax wall (polystyrene). (Graph) The black dose profile has been calculated with a pencil beam model. The
field dimensions were chosen to get the 95% isodose at the edge (± 40 mm) of the target (tumour+margin).
There a dose difference of 13% was found between film measurements, the dark grey profiles, and the pencil
beam calculated 95% isodose. A calculation with the Collapsed Cone algorithm, the light grey profile, is in
agreement with measurements within ± 2%.
The second stage in the dose calculation model is the calculation of dose deposition. The
most challenging situation for this part of the model is a geometry with tissue heterogeneities.
For this purpose the Collapsed Cone algorithm is specifically designed, Eq. (4) and Fig. 5. An
example of the improvement in accuracy that is achieved by the Collapsed Cone
representation of points spread kernels in comparison to pencil beam kernels is shown in
Fig. 11. This is an experiment in which a phantom that simulates a lung tumour geometry is
irradiated by a single beam, 6 MV-X or 15 MV-X. A multileaf collimator was used to make
the dose distribution in the central plane conformal to the planning target volume ( 80 mm), ai
spherical solid tumour of 50 mm diameter with 15 mm margin. This beam definition was
done on the TPS with a pencil beam algorithm to assess the (lack of) accuracy of this
calculation method. A detailed description of this study is given in Chapter IV of this thesis. A
large difference between pencil beam calculations and measurements was found, especially at
the edge of the target volume, 13% in a 6 MV-X beam and 21% in a 15 MV-X beam. This is
due to the limitations in the pencil beam model which can not properly account for the
extended transport range of recoil electrons and scattered photons in low density regions
(lung/cork). Calculations done with the Collapsed Cone representation of a point spread
kernel show close agreement with measurements, within ± 2% for both beam energies. This
illustrates the need for a proper selection per treatment type of the beam model to be applied.
In cases with large heterogeneities a pencil beam kernel results in unacceptable inaccuracy
whereas it shows adequate accuracy, combined with practicable calculation times, in tissues
with little variation in density. 
Dose deposition calculated by Monte Carlo methods will become available in our TPS in
the near future, but is expected to remain slower then Collapsed Cone calculations. The user
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will than have a choice of three algorithms for which the following applications can be
thought of:
C pencil beam for straight-forward applications in mostly homogeneous tissues like the
pelvic regions and the brain
C Collapsed Cone for heterogeneous environments like lungs, using multiple CT slices
C Monte Carlo for verification purposes and tumours near tissue interfaces such as occur in
the head and neck region
New applications as IMRT/optimization might take advantage of this choice in speed and
accuracy. For example, in optimization incidental Collapsed Cone iterations could be
alternated with many pencil beam iterations, providing an acceptable result in a reasonable
time span, also in heterogeneous environments.
Due to the separation in energy transport and dose deposition the increase in verification
work will be less than proportional to the increase in the number of dose deposition
algorithms, because they all have the first stage, energy transport, in common. Nevertheless,
further streamlining of the verification process is inevitable.
4. Conclusions
In this paper the verification procedure is presented that has been developed to verify the
beam model of our TPS, taking into account its physical background to describe energy
transport. The specific, and partly complex, characteristics of this model require a tailored
quality assurance programme. Methods and tools developed for this purpose include the
concept of  combinatorial verification implemented in a comparison program and a line dose
profile database, application of a routine dosimeter with correction for its Line Spread
Function, and the field accuracy concept to allow a direct comparison to current accuracy
criteria. The presented ‘concentric wall’ structure serves well this purpose of a structured
verification programme, because very few errors are found at the inner wall.
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Chapter V
Slit x-ray beam primary dose profiles
determined by analytical transport
of Compton recoil electrons
Med. Phys. 27, 923-934 (2000)
V

Slit x-ray beam primary dose profiles determined by analytical transport
of Compton recoil electrons
A. A. van’t Veld
Groningen University Hospital, Department of Radiation Oncology, 9700 RB Groningen, The Netherlands
P. van Luijk
Kernfysisch Versneller Instituut, 9747 AA Groningen, The Netherlands
F. Praamstra and P. C. van der Hulst
Groningen University Hospital, Department of Radiation Oncology, 9700 RB Groningen, The Netherlands
Received 14 September 1999; accepted for publication 18 February 2000
Accurate measurement of radiation beam penumbras is essential for conformal radiotherapy. For
this purpose a detailed knowledge of the dosimeter’s spatial response is required. However, experi-
mental determination of detector spatial response is cumbersome and restricted to the specific
detector type and beam spectrum used. A model has therefore been developed to calculate in slit
beam geometry both dose profiles and detector response profiles. Summations over representative
photon beam spectra yield profiles for polyenergetic beams. In the present study the model is
described and resulting dose profiles verified. The model combines Compton scattering of incident
photons, transport of resulting electrons by Fermi–Eyges small-angle multiple scattering theory,
and functions to limit electron transport. This analytic model thus yields line spread kernels of
primary dose in a water phantom. It is shown that the spatial response of an ideal point detector to
a primary photon beam can be well described by the model; the calculations are verified by
measurements with a diamond detector in a telescopic slit geometry in which all dose contributions
except for the primary dose can be excluded. Effects of photon detector behavior, source size of the
linear accelerator linac and detector size are studied. Measurements show that slit dose profiles
calculated by means of the kernel are accurate within 0.1 mm of the full-width at half-maximum.
For a theoretical point source and point detector combined with a 0.2 mm wide slit, the full-width
half-maximum values of the slit beam dose profiles are calculated as 0.37 mm and 0.42 mm in a 6
MV and 25 MV x-ray beam, respectively. The present study shows that the model is adequate to
calculate local dose effects that are dominated by approximately mono-directional, primary photon
fluence. The analytic model further provides directional electron fluence information and is de-
signed to be applied to various detectors and linac beam spectra. © 2000 American Association of
Physicists in Medicine. S0094-24050002805-4
Key words: analytic model, primary dose, electron transport, line spread function, detector spatial
response
I. INTRODUCTION
Conformal radiotherapy requires accurate knowledge of pen-
umbras of the various applied beams. Meanwhile, a blurring
of the real penumbra by a measurement of, for instance, 1
mm is likely to be introduced by the dimensions of many
current detectors. This artifact increases the volume of a 25
mm radius sphere of, for example, a planning target volume,
by 12%. Similar and larger blurring effects have been re-
ported for ionization chambers. Chambers with 4–6 mm in-
ternal diameter typically show an increase of 2 to 3 mm1–3 in
the 20%–80% distance of a megavoltage photon beam.
Other types of smaller detectors that have been applied in
high dose gradient regions are scintillator detectors,1,4–6
TLD,2,7 radiographic5,7 and radiochromic8–10 film. However,
general application of these detectors suffers from either en-
ergy dependence, limited spatial resolution, nonlinearity, ex-
tensive operation procedures or a combination of these fac-
tors. To compensate for the lack of spatial resolution of
ionization chambers, various correction methods have been
applied.5,11–14 Film measurements12,13 or Monte Carlo
calculations14 were taken as a standard for this purpose. The
first inevitably neglects, however, the dependence of film
results on calibration procedures. Monte Carlo calculations
have practical disadvantages at the required very high spatial
resolution, and always require an independent check, either
by experiment or by analytical methods. Furthermore the de-
pendence of the Monte Carlo data on the applied linear ac-
celerator linac model, such as the linac source size,2,14 has
not yet been studied. Corrections based solely on the size and
shape of the detector5,11 have proved to be insufficient.5 This
can be explained since these correction methods do not ac-
count for extended ranges of electron transport in detector air
relative to water. Furthermore, experimental determination
of spatial responses is cumbersome and restricted to the spe-
cific detector type and beam spectrum used, as the experi-
ments reported in this work underline. Diamond
detectors14–20 have recently been introduced as high resolu-
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tion tissue-equivalent detectors, but these detectors are not
easily available. Furthermore a distinct photon response of
these detectors has recently been reported,20 similar to pho-
ton detector effects reported in diodes.3 In summary, a better
knowledge of the spatial response of common dosimeters is
definitely needed to obtain a more accurate description of
radiotherapy photon beam penumbras.
To understand the spatial response of various types of
detectors, one may start with elementary dose spread kernels.
Determination of these kernels requires a well-defined geom-
etry, focusing as a starting point on what is dominant in
clinical radiation fields, namely primary dose contribution. In
this study a telescopic slit geometry is used in which the
effects of finite radiation source size, both focal and extra-
focal radiation, phantom scatter and collimator scatter are
minimized. Because of this minimization of the contribution
of especially extra-focal radiation and phantom scatter to
negligible proportions, the slit geometry is superior to half
beam edge geometries. The dose spread kernels must be
general enough to allow calculation of transection path
lengths in dosimeters of finite dimensions, for instance, ion-
ization chambers, as this will be needed to surpass correc-
tions based on size and shape. Thus a description of the
angular component of electron fluence is required, which is
not included in current pencil beam or point spread kernels,
for example, Refs. 21, 22.
In this study the dose is modeled using kernels that in-
clude the dominant physical processes in a waterlike phan-
tom material: Compton scattering according to Klein–
Nishina cross sections for the incident photons, Fermi–
Eyges small-angle multiple scattering to transport the
resulting electrons, and empirical functions modeling elec-
tron range-straggling and limited electron transport range. It
is interesting to note here a similarity to electron broad beam
calculations where, e.g., measured depth-dose curves serve
to limit the range of Fermi–Eyges calculations.23 As analytic
descriptions for the dominant processes are available, an ana-
lytic noise-free calculation model is defined. The analytic
nature of the model provides the possibility to calculate pro-
files in a water absorber with very high spatial resolution
within feasible calculation times. Calculated dose profiles
based on this model are compared to measured profiles in a
water phantom obtained with a diamond detector in a tele-
scopic slit geometry.
The aim of the present study is to derive slit x-ray beam
primary dose profiles by means of an analytic model, i.e., to
define the spatial response of an ideal point detector in a slit
beam, and to verify the model results experimentally. When
these dose profiles are combined with detector response pro-
files, one can obtain the spatial response of any radiation
dosimeter, and correct radiation beam penumbras using in-
version or deconvolution methods.5,13,14 The determination
of detector response profiles, e.g., for ionization chambers,
will be the subject of a subsequent study.
II. THEORY
In this section a theoretical formalism is derived to pro-
duce primary dose profiles. The formalism is based on a
combination of Compton scattering, Fermi–Eyges electron
transport and an electron range-straggling description. As
will be shown it is suitable for implementation in a calcula-
tional model. Similarities in methodology exist with a
study24 aimed at calculation of dose near inhomogeneities. In
that study Monte Carlo calculations were used to calculate
photon scatter, followed by Fermi–Eyges electron transport
and an energy based range limit.
A. Compton scattering
In Compton scattering, an incident photon interacts with a
nearly free atomic electron. As a result the recoil electron
gains kinetic energy whereas the photon is scattered. For
photons in soft tissue with an energy between 100 keV and
10 MeV, Compton interaction is much more important than
any other interaction.25,26 In a 5 MeV mono-energetic photon
beam,27 which is well above the mean photon energy of
clinical 6 MV-X photon beams, the contribution of Compton
interaction is 92%. In a 10 MeV photon beam, well above
the mean photon energy of a clinical 25 MV-X, the
contribution27 is still 77%. In the present work only Compton
scatter is assumed.
Let E
0 be a photon fluence in a mono-directional photon
slit beam incident on a water phantom, differential28 in
energy E, and let  be the linear attenuation coefficient. Let
N be the number of Compton recoil electrons, differential in
E, that originate in a volume in between x and xdx,
y and ydy, z and zdz.  represents the initial
angle of recoil. As a notation convention primes are used in
this study in relation to photon interaction, whereas quanti-
ties without primes are related to traveling electrons. When
e is the electron scattering cross section and 	e is the con-
stant electron density in the phantom, the number of elec-






d 	e dx dy dz. 1
The dependence of  and e on the incident photon energy
E is omitted here for brevity. The electron scattering cross
section is independent of the azimuthal recoil angle 
,
whereas its dependence on the polar angle  can be derived
using Klein–Nishina cross-sections25,29 and conservation of
momentum in two directions.30 An expression for the differ-
ential cross-section of Compton interaction de/d is in-
cluded in Appendix A.
B. Electron transport
Whereas Eq. 1 describes the electrons’ initial angular
distribution at the point of the Compton interaction, the re-
coil electrons subsequently travel away from the site of in-
teraction. In case of a field edge these electrons give rise to
dosimetric in addition to geometric penumbra blurring. To
describe this transport of recoil electrons, Fermi–Eyges
small-angle multiple scattering theory is used in the descrip-
tion given by Jette,31 especially his equations 142–144. For
transport depths up to the electron practical range he derived
analytic expressions that yield location and direction prob-
Medical Physics, Vol. 27, No. 5, May 2000
V.  Slit x-ray beam primary dose profiles68
ability, given the initial energy. Single large angle scattering
and the generation of bremsstrahlung is neglected in this
approach. Scattering power, stopping power and practical
range in water of the ICRU 35 Report32 were used by linear
interpolation of the Compton recoil energies. Values for the
parameters k0 and  in equations 142–144 are given for a
distinct number of energy values in Table I of Jette.31 Using
the method indicated in that study, the table was extended
over the full range of energies given by the ICRU 35 Report.
Interpolation errors were minimized by applying polynomial
fits of k0(E) and (E).
Furthermore, in Fermi-Eyges theory there is no limit im-
posed on the range of electrons, and therefore loss of elec-
trons near the end of the practical range is not accounted for.
To compensate for this an electron range straggling param-
eterization of Monte Carlo kernels from Ahnesjo¨33 was used
see Appendix B.
C. Compton electron transport
A calculation of Compton scattering and electron trans-
port, combining the preceding analytic descriptions, is pos-
sible when discrete energy spectra34 of the linac beams used
are known. The calculation can then be done separately for
different mono-energetic photon energy bins of the discrete
spectrum. Mono-energetic photons entering a Compton scat-
ter process yield mono-energetic electrons for each scatter
angle. Electron transport theory can then be applied to each
energy and scatter angle interval separately. Some approxi-
mations are required which are discussed in Sec. V A.
The choice of the calculation coordinate system reflects
the geometric symmetry that applies to our aim to determine
a one-dimensional dose profile of a small slit photon beam in
a water phantom, as shown in Fig. 1. The dimensions of the
nondivergent slit beam in the phantom are width w, length l
and depth of the phantom d. The full experimental geometry
will be described in the Methods section in conjunction with
Fig. 2.
The calculation coordinate system combines Cartesian
and spherical coordinates. A Cartesian coordinate system
X,Y,Z connects primary photon interaction points K with
coordinates (x,y,z) inside the slit beam volume and dose
deposition points L with coordinates x,y,z in a lateral plane
(y0) perpendicular to the slit. The X-axis is the direction
of the required dose profile, the Y-axis runs along the slit
length, the Z-axis runs in depth perpendicular to the phantom
entrance surface and the origin is at the depth of the profile
under the middle of the slit.
FIG. 1. Calculation coordinate system used in this study. A volume wl
d in a water phantom is irradiated by photons. A Cartesian coordinate
system X,Y,Z is aligned to the symmetry axes of this volume. In the pri-
mary photon beam Compton interaction is calculated in points called K on a
regular grid. Only three K-points are shown. Recoil Compton electrons
leave any point K with an initial direction defined by a polar angle  and an
azimuthal angle 
. The directional electron fluence is calculated in points
named L, distributed along a grid in the XZ plane. The incident electron
traveling direction is defined by a polar angle , with respect to the Z-axis,
and an azimuthal angle 
, relative to the X-axis.
FIG. 2. Experimental geometry used in this study, drawn in an orientation
similar to the calculation coordinate system in Fig. 1. A linac with horizon-
tal gantry angle, represented here by its source, flatness filter and upper
jaws, is used to irradiate a slit mounted on the side wall spacing dm) of a
water phantom at a large distance to the source dps . The width of the field,
w, is defined by the slit collimators, its length by a pinhole block placed on
the linac’s block tray holder. At a depth dd in the phantom a detector scans
the dose profile of the slit beam. The viewing aperture from the detector on
the source and the flatness filter is defined by the telescopic slit plus jaw
geometry.
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Centered at K a spherical (r,,
) coordinate system is
defined in which the initial particle fluence of Compton elec-
trons is calculated. The polar angle  is the angle with the
downward Z-axis, and the azimuthal angle 
 is the angle
with the X-axis in the XY-plane. Only polar angles  less
than 90° need to be considered, because Compton scattered
electrons initially travel only in a forward direction. Due to
the rotational symmetry, the fluence does not vary over the
azimuthal angle 
. For brevity the solid angle  is used
here instead of  and 
, which thus has to be evaluated
over 2.
Let P(x ,y ,z ,;x,y,z,,E)dx dy d be the prob-
ability that an electron with initial Compton recoil energy E
is found in an area in between x and xdx , and in between
y and ydy and traveling in a direction , when arriving at
depth z, relative to an initial Compton recoil position
(x,y,z) and a recoil direction . Under the small-angle,
multiple-scatter approximation this probability was defined
by Jette et al.,35 Eq. 10. Note that the evaluation of this
probability requires a rotated calculation coordinate system
so that the polar axis is along the electrons’ initial direction
of travel .
Let further  be the electron fluence, differential in
solid angle , so that (x ,y ,z)d is the number of elec-
trons per unit area traveling in the direction between  and
d at position x,y,z. In the small-angle approximation
this spherical fluence is equal to planar fluence. This elec-
tron fluence  , differential in , is the basic quantity to be
evaluated in the dose deposition points L, as from this quan-
tity the local dose as well as the local detector response, in
case of ionization chambers, can easily be calculated. For a
mono-energetic incident photon beam this quantity is given
by:






2Px ,y ,z ,;x,y,z,
 d4Nd dx dy dz
Hr Rr d dx dy dz, 2
where the function R(r), with r((xx)2(yy)2(z
z)2)1/2, represents the range-straggling correction applied
according to Eq. B1 Appendix, and H(r) is a practical
range cutoff function required to avoid the singularities in
Jette’s parameterization31 at distances greater than Rp , hence
H(r)1 if rRp and zero elsewhere.
Dose D at any point (x,y,z) can be calculated by integra-
tion over all local electron traveling directions and over all
energies in the photon spectrum:
Dx ,y ,z 
hspectrum4 ,Ex ,y ,z 

Scx ,y ,z ,E 
	
d dE, 3
where Sc(x ,y ,z ,E)/	 is the mass collision stopping power
for electrons that arrive with energy E at (x,y,z). Values for
Sc /	 from the ICRU 35 Report32 were used by linear inter-
polation of the electron energy E. When the detector re-
sponse output of an ionization chamber is required, an ex-
tra factor has to be evaluated within Eq. 3 that accounts for
the electron trajectory lengths within the chamber, as that
length can be assumed to be proportional to the amount of
ionization, and thus to the chamber output.
In a recent study, Mobit et al.20 published Monte Carlo
data about the direct photon response of a diamond detector.
They specify the dose contribution from photon interaction
in the cavity material, c , in terms of percentage, which they
calculated in a simulated broad beam. These data provide the
link to compare dose profiles as calculated with Eq. 3 to
experimental diamond profile measurements, by adding di-
rect photon interaction to Eq. 3. To do so, a partial volume
factor f (x) is needed to account for the fraction of a dia-
mond detector that is directly irradiated, given the position
of the detector in the field, x, and the maximum fraction, ,
of detector volume irradiated. Furthermore, it is convenient
to transform the contribution in terms of percentage c , into
an additional, absolute signal, Ac , representing the extra sig-
nal due to photon interaction relative to a unit signal of an
ideal waterlike detector. Finally the dose output factor F of
the slit beam relative to the primary dose in a broad beam is
required. The quantities Ac , f  and F are given in Appendix
C where it also shown that the output O(x ,y ,z ,) of such a
detector in our slit beam geometry as a response to local dose
D(x ,y ,z) and direct photon interaction is given by:
Ox ,y ,z Dx ,y ,z D0,0,0 
Ac f x 
F . 4
In the numerical application of this Compton electron
transport model the angular electron particle fluence is cal-
culated in a spherical coordinate system (r , ,
) at points L
for the purpose placed on a x ,z grid in the XZ plane. The
grid is restricted to a rectangular area determined by the
practical range of the highest energy electrons. An expres-
sion for this energy E is given in Appendix A. Angular
fluence in points L at the lateral XZ-plane, i.e., a four-
dimensional matrix Lxz
 , has to be precalculated only once
for every energy bin and with K for the purpose located at
the origin. By proper summation of contributions from points
K elsewhere in the slit beam volume (w*l*d) the total an-
gular fluence in any point L is found.
When the traveling direction at points L is not of interest,
like in our point detector study, a simpler representation of
the probability function P without , also given by Jette35
Eq. 12, can be used. However, as we intend to build a
more general analytic model, the full integration summa-
tion is used.
The integration over E in Eq. 3 is numerically done by
proper weighting of the dose contributions due to the various
bin contents, E , in the discrete energy fluence spectrum,
EE
0 •h , with h representing photon energy.
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III. METHODS
A. Calculational methods
Compton scatter and electron transport are calculated
separately for each photon energy bin based on the effective
energy spectra34 of our linac beams, which are presented in
Fig. 3. These spectra have been determined via minimization
of the difference between a set of measured depth dose
curves and weighted mono-energetic calculated depth-dose
curves and are a part of the basic data in our treatment plan-
ning system, Helax TMS MDS Nordion, Canada.
The theoretical framework developed in Sec. II C is used.
In point K, located at the origin, a spherical (r,,
) co-
ordinate system is defined with 90 cones separated by a 1°
polar () angle relative to the direction of the incoming
photon. These cones cover the whole range of Compton elec-
tron scatter 0° to 90°; each cone is further separated in 18
azimuthal (
) segments 20° wide. Dose deposition points L
are placed on a 0.075 mm grid in the XZ plane. A minimal
shift 0.0375 mm in x and z direction is applied to the
K-point position to avoid singularities in the dose deposition
points. In each dose deposition point (x,z) a spherical ,

coordinate system (90°) is defined with 18 cones sepa-
rated by 5° polar angle, each divided into nine azimuthal
segments separated by 20° where incident forward electron
fluence is calculated according to Eq. 2. Similarly a second
part of this spherical coordinate system (90°) is defined
with three cones separated by a 30° polar angle, each divided
into eight azimuthal segments separated by 22.5° where in-
coming backward electron fluence is calculated. Backward
traveling occurs in this calculation model only when low-
energy Compton electrons ( nearly 90° are further de-
flected as described by Fermi–Eyges theory. The relative
incidence is low, which justifies the coarse sampling of back-
ward fluence. As mentioned already in the Theory section,
calculation of the incident electrons in the L-points requires a
rotated calculation coordinate system (,
) at the Comp-
ton interaction site so that its polar axis is along the elec-
trons’ initial direction of travel (). Furthermore a restric-
tion in the maximum angle in Fermi–Eyges transport of 60°
is applied. Although this is about twice the limit indicated by
Andreo et al.,36 it is felt that a wide angle contribution of low
accuracy is probably better than completely neglecting this
contribution, whereas the contribution of widely scattered
electrons is small.
Once this precalculation has been done for one point K,
the data are stored in memory, which has a similarity to
methods of phase-space calculations.37,38 The final dose pro-
file is calculated with a 0.025 mm grid along the x-axis by
sampling the contributions from other locations of K-points
on a 0.075 mm grid within the slit beam volume.
B. Geometry
The determination of a detector’s spatial response re-
quires a well-defined beam edge in which the geometric pen-
umbra size is well-known and preferably small. Geometric
penumbra is caused by the finite size of the linac’s primary
source and flatness filter, where almost all photons in a clini-
cal photon beam originate.39 The effect of extra-focal radia-
tion on beam profiles is most apparent just outside the geo-
metric field edge, because in that region the focus is already
‘‘eclipsed’’ by the collimator whereas the flatness filter is
still partially unshielded.40 The maximum extent of the geo-
metric penumbra can be estimated by simple projection cal-
culations for the actual experimental dimensions. If the geo-
metric penumbra is not negligible, corrections14 are required.
Such corrections with their implicit uncertainties can, how-
ever, be avoided by a proper setup of the experimental ge-
ometry. In our study a telescopic geometry41 was used with a
slit defined by the upper collimator jaws and with a second
slit at a large distance from the primary source just in front of
the detector Fig. 2. The upper jaws were used as these are
best located to limit the view on the extensive flatness filter.
A field defining block, with a pinhole of 6 mm diameter at
675 mm distance from the source, is used to define the field
length, l, on the slit, to limit the extent of the field that falls
on and is partly transmitted by the secondary slit, and to
guarantee reproducibility between sessions. The slit beam
length was 27 mm at 3.0 m distance from the primary source.
The relevant parameters to assess this geometry Fig. 2
are primary source size sp , physical upper jaw width w j ,
source to upper jaw distance dp j , primary source to slit dis-
tance dps , slit thickness t, slit width w, distance between slit
and phantom dm and detector depth in the phantom dd . The
maximum extents of the projected primary source size, pp ,
and the size of the visible part of the flatness filter, p f , at









The smallest feasible slit width, w, of 0.2 mm was chosen.
Some experiments were repeated with a slit width of 0.4 mm
to assess the effect of slit collimator scatter. The primary
source size is estimated to be at maximum sp3 mm, its
FIG. 3. Effective energy spectra of Philips SL25 6 MV circles and 25 MV
squares photon beams used in this study. The fractional energy fluence per
energy is plotted as a function of bin energy.
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actual size is probably less,39 dependent on type and even
commissioning of the linac.42 At the detector depth chosen,
dd88 mm, there is no effect of contaminant electrons from
the treatment head.34
Data from Ahnesjo¨43 show that the ratio of energy fluence
from flattening filter scattered photons relative to the primary
energy fluence is 0.02 and 0.06 in a 4 MV-X and 24 MV-X
beam, respectively. These figures apply for our linac’s pri-
mary collimator opening of 14° conical angle Philips SL 25
and at SSD1.00 m. At larger SSD’s these ratios are even
smaller due to the different inverse square attenuations in-
volved. Combining these ratios with Eqs. 5 and 6 and the
dimensions of the experimental setup see next section it is
readily seen that the effect of the flatness filter projection can
be neglected in our experimental setup due to the large pri-
mary source to slit distance dps and the small upper jaw
width w j . By application of Eq. 5 it follows that minimum
primary source to slit distances of approximately 1.90 m and
3.70 m are required to limit the geometrical beam broaden-
ing to 0.2 mm and 0.1 mm, respectively. In our experiments
primary source to phantom distances of 3.00 m and 4.00 m
are chosen, yielding 0.12 mm and 0.09 mm extra beam
broadening, respectively, i.e., smaller than the detector’s sen-
sitive element. These distances were taken as the optimum in
a compromise between projected source size and fluence rate
at the detector i.e., signal amplitude.
C. Experiments
Photon beams of 6 MV and 25 MV x-rays, representative
for both practical ends of the clinical energy spectrum, were
generated by a Philips SL 25 linear accelerator. In the linac
tray holder a 80 mm thick metal alloy block Billiton FA 11,
Billiton Witmetaal, The Netherlands was placed blocking
the entire (1515 mm2) field size except for a 6 mm diam-
eter central pinhole, yielding a field length of 27 mm at 3.0
m distance. The other end of the telescopic geometry con-
sisted of a slit made of two high-precision fabricated 20 mm
thick tungsten blocks, mounted in an adjustable frame44 and
attached to the side of a water phantom. The slit width was
defined by calibrated spacers of 0.20 mm0.01 mm and
0.40 mm0.01 mm thickness. The slit was carefully aligned
within 0.15° 1 s.d. with the field light source and its
in-beam position checked with verification films. The repro-
ducibility of the alignment was checked with laser beam re-
flection in a separate setup.
The water phantom system was constructed by one of the
authors PvL and the detector was scanned in 0.05 mm in-
crements. The zero position of the detector was calibrated
prior to every scan by setting the step number equal to zero
when the stepping motor reached a calibration switch toler-
ance 4 m.
A PTW 60003 diamond detector was mounted with its
sensitive disk parallel to the slit. This orientation minimizes
the effective detector size in accordance with the manufac-
turer’s recommendations. The thickness of the sensitive disk
was specified by PTW as between 0.1 and 0.4 mm; measure-
ments on a 40 kV simulator radiograph yielded 0.3 mm elec-
trode spacing. Short term linac output fluctuations were cor-
rected for by a 600 cm3 reference ionization chamber
Nuclear Enterprises 2511/3 placed in the neighborhood of
the water phantom, because no space for an in-beam refer-
ence detector was available in the small beams applied. This
reference detector collected leakage and room scattered ra-
diation proportional to linac output. The reference detector
was omitted in some measurements; the noise on the profiles
and the variation in between successive scans increased but
otherwise no difference of any meaning was found in the
measured profiles.
The diamond detector was operated at 100 V generated by
a PTW Unidos PTW, Germany electrometer and power
supply, pre-irradiated prior to measurements in accordance
to recommendations, and read out via a current-to-voltage
QSX, TRIUMF Cyclotron, Canada and a voltage-to-
frequency Hytec, UK converter by a PC counter card PC-
TIO-10, National Instruments, TX USA. The reference de-
tector was operated at 300 V generated by a Wellhoefer
WP5006 Wellhoefer, Germany electrometer and power
supply which was read out via the same multi-channel
voltage-to-frequency converter and PC counter card. Cross-
talk between measurements channels and saturation were
checked prior to the measurements.
Scans crossing the open slit width were made with 1 s
integration time per step 0.05 mm. Scans with the slit
closed were made to define the transmission of the tungsten
slit blocks. Open-slit and closed-slit scans were sandwiched
to check long-term linac field stability. Slit profiles were de-
fined as the difference between open-slit and closed-slit
scans. Measurements using the 0.2 mm slit width were re-
peated in a separate session to exclude experimental setup




Dose profiles in a 0.2 mm slit beam field are shown in
Fig. 4. These were calculated according to Eq. 3 for several
incident mono-energetic photon energies, i.e., prior to inte-
gration over the photon energy spectrum. The profiles run
along the x-axis of Fig. 1.
Once these profiles have been calculated for each energy
bin, the dose profiles for any photon beam with known ef-
fective energy spectrum are easily calculated, by integration
summation over the energy spectrum. The dose profiles for
our 6 MV and 25 MV x-ray beams are plotted in Fig. 5. The
physical width of the slit, 0.2 mm, is indicated at the bottom
of this figure. The corresponding profile widths are given in
Table I, setup type A, which, in addition to the 0.2 mm slit
beam profile, also includes the profile widths of calculated
0.4 mm slit beam profiles. Because the full-width half-
maximum FWHM values of the profiles are much broader
than the physical slit widths, due to the electron transport, it
is to be expected that the width of the doubled slit 0.4 mm
profile is much less than twice the width of the 0.2 mm slit
profile, as is shown in Table I. Primary beam output factors,
as defined in Appendix C, were calculated by adding slit
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beams geometrically side-by-side to form 1010 cm2 fields,
which yielded primary dose output factors of 0.201 and
0.122, for a 6 MV-X and 25 MV-X 0.2 mm slit beam, re-
spectively. The 6 MV-X output factor can be compared to
literature45 and found to agree well, considering the uncer-
tainty in conversion of our slit beam to an equivalent field
radius.
B. Experiments
An example of a set of five measured profiles obtained in
one session prior to any data processing is shown in Fig. 6.
The broad base (FWHM35 mm) field in all profiles corre-
sponds to the divergent projection of the 6 mm pinhole field
after attenuation by the tungsten slit collimators. The peak on
top of this broad field in three profiles is the measured slit
field; this peak is absent in the two profiles measured with
closed slit. The ratio of peak to background broad field is
1.8 to 1 in this figure. This is close to an estimated ratio of 2
to 1, based on 6 MV-X calculated primary dose output factor
and tungsten transmission.
In Figs. 7a and 7b experimental 6 MV and 25 MV
x-ray profiles in a 0.2 mm slit beam are shown as points with
error bars, which represent average and standard error of the
mean of all corresponding profiles in two sessions. The full-
width half-maximum widths of the dose profiles measured in
two separate sessions are indicated in Table II. The solid
lines in Figs. 7a and 7b represent the dose profiles of Fig.
5 corrected for direct photon response of a diamond detector
as defined by Eq. 4, using recent data of Mobit et al.20 and
the calculated primary dose output factors as mentioned in
Sec. IV A. This yielded as numerical values of Ac f (0)/F
Eq. 4: 0.82 and 0.34 for 6 MV-X and 25 MV-X, respec-
tively.
To assess the effect of collimator scatter measurements
were repeated in one session with a slit width of 0.4 mm and
identical setup alignment. In Fig. 8 slit beam profiles are
shown as measured in a 6 MV x-ray 0.2 mm and 0.4 mm slit
beam, respectively.
FIG. 4. Calculated electron fluence profiles  along the x-axis see Fig. 1,
per unit incident photon fluence (0), as a result of a mono-energetic (E)
photon beam through a 0.2 mm slit. Mono-energetic incident photon beams
of 0.6 lower curve, 1.25, 2.5, 5, 10 and 25 MeV upper curve are used. All
curves are normalized to the maximum of the 25 MeV profile, which was set
to 1.
FIG. 5. Calculated dose profile along the x-axis see Fig. 1 in a 6 MV solid
line and 25 MV dashed line x-ray beam through a 0.2 mm slit. The
geometry used is shown in Fig. 2.
FIG. 6. Example of measured dose profiles using a diamond detector in a 6
MV x-ray beam through a 0.2 mm slit. Three slit beam profiles were alter-
nated with two profiles in which the slit was closed. In this way the real slit
dose profiles can be corrected for transmission through the tungsten slit
collimators. Scan direction is the x-axis in Fig. 1, i.e., perpendicular to the
slit width.
TABLE I. Full-width half-maxima FWHM of calculated slit profiles. In the
second column type A indicates a pointlike linac source and a pointlike
detector; type B indicates a linac source type with a normal distributed
emission (1.5 mm), projected through the slit and convoluted with a
finite detector 0.3 mm; type C indicates a pointlike linac source and a
detector that behaves as a point to measure incident electrons while it be-









6 A 0.37 0.58
6 B 0.55
6 C 0.34 0.51
25 A 0.42 0.66
25 B 0.63
25 C 0.38 0.57
Medical Physics, Vol. 27, No. 5, May 2000
V.  Slit x-ray beam primary dose profiles 73
V. DISCUSSION
In this section we discuss the model and its implementa-
tion part A, the experimental verification part B, results of
other studies and the suitability of the model as a basis to
derive convolution kernels for dosimetry detectors used in
radiotherapy practice part C.
A. Calculational model
Assumptions that were made in the model are: electron
energy is assumed to decrease linearly with distance, elec-
tron transport is described by small-angle multiple-scattering
theory and is restricted to the electron practical range.
The first assumption about linear energy decrease is
strictly speaking an approximation for broad electron
beams.46 Concerning the second assumption, the accuracy of
the used small-angle multiple-scattering description has been
reported47 in comparison to Monte Carlo calculations. Maxi-
mum deviations with Monte Carlo calculations of 14% at 20
MeV to 19% at 5 MeV at dose maximum of mono-
energetic electron pencil beams were shown, which can re-
portedly be reduced to 9% at 20 MeV to 3% at 5 MeV by
application of more sophisticated transport models.47 The re-
striction on the electron range is further discussed in part C.
The inaccuracy of all these assumptions in conjunction
with each other is assessed in a recent study27 in which point
dose kernels were derived to calculate primary photon dose
as a result of Compton interaction followed by electron
transport in the description by Jette31 of Fermi–Eyges
theory, similar to our study. In comparison with Compton
primary point dose kernels determined by Monte Carlo cal-
culations, absolute differences mostly less than 1.2% in total
energy deposited were reported for incident photon energies
in between 5 and 20 MeV, with two exceptions of 3.4% and
6.6% for 6 MeV and 20 MeV photons, respectively.
An apparent discrepancy can be noted between the total
inaccuracy, as described typically less than 1.2%, and inac-
curacies in the separate assumptions, reportedly up to 19%.
However, the latter occurs locally in a specific situation of
mono-energetic and mono-directional electron beams. On the
contrary, the reported total inaccuracy applies to a variety of
electron energies and recoil directions inherent to photon
beam interaction. In our case the distributions of sources of
Compton interaction over the slit geometry might further de-
crease the maximum inaccuracy. The best estimate of inac-
FIG. 7. Calculated solid line and measured points dose profile along the
x-axis see Fig. 1 in a 6 MV a and 25 MV b x-ray beam through a 0.2
mm slit. The geometry used is shown in Fig. 2. All profiles have been
normalized to 100% maximum value. At the bottom a slit width of 0.2 mm
is indicated. Presented measurement values are averages of all correspond-
ing profiles in two sessions. The error bars represent one standard deviation
in all underlying measurement profiles. The calculations in this figure in-
clude photon detector behavior according to Eq. 4 using data of Mobit
Ref. 20.
FIG. 8. Measured profiles of various slit widths. Measured profiles in a 6
MV x-ray beam through a 0.2 mm open diamonds and 0.4 mm closed
squares slit are shown together with a side-by-side addition of two 0.2 mm
slit profiles solid line. As noted in Sec. IV A, the FWHM of the profiles
does not double with doubled slit width.











6 2 0.38 0.54
6 Average 0.39
25 1 0.41
25 2 0.48 0.62
25 Average 0.44
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curacy of the model can therefore be derived from compari-
son to experimental data, as will be done in the next section.
As the calculational model describes fluence on a small,
sub-millimeter scale with high gradients near the points of
Compton interaction, in particular effects of grid size and
singularities in the model’s implementation and use have to
be validated. These effects were assessed by repeating the
calculation with coarser grids, 0.15 mm and 0.3 mm in the
distribution of K-points and L-points and corresponding in-
crease of the offset of the K-points. Finer grids were prohib-
ited by the available computer resources. Differences in
FWHM width of typically about 0.05 mm as compared to the
results of Table I were found. The inaccuracy in FWHM
caused by the implementation of the model at grid size 0.025
mm on the scoring axis x-axis and 0.075 mm grid size in
the distribution of K-points and L-points is therefore esti-
mated to be less than 0.05 mm.
The efficiency of the total calculation, which takes from
26 h for the lowest photon energy bins up to 47 h for the 25
MeV bin on a 333 MHz Pentium PC, can be improved by
calculation of the weighted sum of only a very selected set of
a few energy bins, as recently reported.48 However, an error
estimate of this reduction method is as yet unclear, whereas
its results are only applicable to those linac spectra for which
the selected bins are representative. On the other hand, the
results of this work can be rapidly applied to any other pho-
ton beam of which the effective energy spectrum is known.
B. Experiments
The experimental setup has been selected to match as
closely as possible the situation for which the calculational
model has been designed. The effects in the experimental
setup of phantom scatter, collimator scatter, linac x-ray
source size, detector size, and photon absorption in the de-
tector, none of which was intended to be addressed by the
model, have thus to be assessed.
The phantom scatter contribution to the slit beam dose is
evidently negligible; this follows from an approximate cal-
culation of the scatter-to-primary KERMA ratio,45 using an
equivalent square field of, e.g., 1 mm2, which is larger than
the equivalent square of the slit beam. Collimator scatter is
less than 1% of total dose in a regular therapy beam.49 Be-
cause the studied slit beam has much more collimator edges
relative to its beam area than a regular therapy beam, a spe-
cific check on collimator scatter is required. For this purpose
profiles were measured in a slit beam of double width, 0.4
mm. These have then been compared to doubled slit profiles,
obtained by adding 0.2 mm slit profiles to identical 0.2 mm
shifted profiles, thus including any collimator scatter twice.
Figure 8 shows the comparison for a 6 MV x-ray beam. As
can be seen in this figure, the sum of two 0.2 mm slit profiles
is comparable to a measured 0.4 mm slit profile, taking into
account the experimental uncertainty as indicated in Fig. 6.
The same was found in a 25 MV x-ray beam. It can thus be
concluded that collimator scatter is negligible in our setup.
With the precautions taken as described in Sec. III B the
effect of the flatness filter can be neglected. The effect of the
linac’s source size as well as the detector dimension is ana-
lyzed mathematically. A normal distributed source emission
(1.5 mm), truncated at 2.2 mm from the center by the
upper collimators, was projected through a 0.2 mm slit and
convolved with a 0.3 mm rectangular detector response func-
tion. The resulting effective source projection, which had a
FWHM of 0.31 mm and a Full-Width-at-10% of 0.50 mm,
was convolved with a calculated slit beam kernel. The
widths FWHM of the resulting profiles are indicated in
Table I, setup type B, and are up to 0.2 mm wider than the
point source plus point detector calculations setup type A.
In reality the effect is presumably somewhat less, because
the width of the source39 is probably less than 3 mm, and the
effective size of the detector might be less than 0.3 mm,
which was the measured distance between the electronic con-
tacts. By comparison of Tables I and II it follows that the
measured FWHM values are well in between the calculated
FWHM values for setup types A and B.
Diamond detectors are very suitable for this type of high-
gradient, high-precision scans, because their mass energy ab-
sorption coefficient ratio18 and mass collision stopping
power ratio19 relative to water are nearly constant over the
energy range of interest. However, it has been noted that the
diamond mass density (	3.5 g/cm3) makes it behave as a
photon detector.18,20 The corresponding local interaction
would sharpen the measured profile. Using the results of a
Monte Carlo study by Mobit et al.20 and our Eq. 4, this
effect can be incorporated in the calculations. As can be seen
by comparing calculation types A and C in Table I, this
effect accounts for 0.03 mm to 0.09 mm sharpening at
FWHM of the 0.2 and 0.4 mm slit beam profiles, respec-
tively, both for the 6 MV and the 25 MV x-ray beams.
The alignment of the slit was found to be a critical param-
eter. The indicated estimated alignment error 0.15°, 1 s.d.
can cause an unintended narrowing of the slit of approxi-
mately 0.05 mm and can thus explain the difference found in
the profile widths between sessions 1 and 2, Table II.
Considering the magnitude of the uncertainties, it can be
concluded that the measurements are in good agreement with
the calculations. The inaccuracy in FWHM is estimated to be
less than 0.1 mm.
C. General
A proper description of electron transport, like the Fermi–
Eyges model employed in this study, is essential in cases of
electronic disequilibrium, such as the narrow slit geometry.
This is clearly illustrated by a study in which zero range and
finite range electron transport have been compared.50
Whereas the first can be assumed to be approximately 10%
correct in dose in cases of electronic equilibrium, the dis-
crepancy with the second type and with Monte Carlo calcu-
lations grows orders of magnitude near the interaction point
in a point spread kernel. Another illustration was the prelimi-
nary result of our model based on outdated values of the
scattering power in the electron transport model,35 which
yielded slit dose profiles that had FWHM values approxi-
mately 0.05 mm less than those presented in Table I.
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In a recent study14 Monte Carlo techniques were used to
calculate dose profiles for a 3030 mm2 6 MV photon beam
at 15 mm depth in water. By differentiation of these dose
profiles the line spread function of a detector of 0.1 mm
radius was determined which had a FWHM of 0.17 mm.
Taking into account the 0.5 mm size of the scoring bins used
in that study, this width corresponds to what can be expected
from extrapolation of the data of Table I to a slit of zero
width. On the other hand a reported14 20%–80% penumbra
size of 1.8 mm in the macroscopic (3030 mm2) field is
higher than the penumbra size, 1.6 mm, that we found by
convolution of our slit profiles to create a similar macro-
scopic field. The most probable cause for this difference was
identified in the cutoff in electron transport range, R(r), as
defined by Eq. 2. In an assessment of full electron transport
range, an enhancement for this purpose of the tail of our slit
dose profile by less then 1% could already eliminate the
difference in penumbra. Meanwhile, this addition had a neg-
ligible influence on the FWHM value of the slit dose profile.
From this assessment we concluded that the cutoff in elec-
tron range may become apparent in fields of macroscopic
size, but for our intended use of determining slit beam pri-
mary dose profiles the effects of this approximation can be
neglected.
Compared to Monte Carlo techniques, which provide full
dose data, the analytic approach followed here is an indepen-
dent check50 and provides furthermore, in comparable calcu-
lation times, a much higher spatial resolution and separate
spectral components that can be applied to other beams of
known effective spectrum. Moreover, our model yields di-
rectional electron fluence information which remained un-
used in this study. While this directional information is an
integral part of the analytic method, line spread kernels for
cavity detectors, such as ionization chambers, can easily
been obtained, in contrast to the note that ‘‘Monte Carlo
calculations of photon beams in a small volume of air is
nontrivial.’’ 51 The application of this analytic method to
cavity detectors is foreseen for a subsequent study.
Upon the basis laid in the present study it will then be
possible to define the detector spatial response of cavity de-
tectors to primary photon beams and to define a proper cor-
rection function. For several reasons the concentration on
primary dose is considered not to be disadvantageous. First,
primary photon fluence has a negligible angular spread,
which is implicitly assumed in our study. Moreover, primary
dose is not only the main contribution to clinical megavolt-
age photon dose, but also the contribution which has the
sharpest penumbra. Thus in practice, correction of the pri-
mary component of the dose profile for detector spatial re-
sponse is likely equivalent to correction of the total dose
profile.
VI. CONCLUSION
In this study it has been shown that the spatial response of
an ideal point detector in a primary photon beam can be well
described by analytic modeling of the transport of Compton
electrons. The calculations have been verified by measure-
ments in a telescopic geometry in which all but the primary
dose contributions could be excluded. The calculated slit
dose profiles for primary x-rays are shown to be accurate for
calculation of local dose effects that define spatial detector
response within 0.1 mm full-width half-maximum. For a the-
oretical point source and a point detector combined with a
0.2 mm slit width, the full-width half-maximum values of the
slit beam dose profiles are calculated as 0.37 mm and 0.42
mm in a 6 MV and 25 MV x-ray beam, respectively. The
analytic model also provides directional electron fluence in-
formation and as the photon spectral contributions are pre-
served, the model is designed to be applied to finite size
detectors and other linac beam x-ray spectra, and to yield
thus a better penumbra description for conformal radio-
therapy.
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APPENDIX A: COMPTON SCATTERING
An expression for the differential cross-section for a
Compton interaction de/d as a function of only incident
photon energy hv and electron recoil angle  can be derived
using Klein–Nishina cross-sections25,29 and conservation of
momentum in two directions.30 The prime on  is further





1 2 sin •cos 
12 sin2 2 . A1
The dimensionless quantity  represents the energy of the
incident photon, hv/m0c2, with m0c2 the electron rest
energy 0.511 MeV, re is the classical electron radius
(2.821015 m, and the fraction of scattered photon energy





122 sin2  . A2
The factor sin(()) with  the scattered photon angle can be
expressed as function of  and :
sin
21 sin •cos 
122sin2  . A3
Applying goniometric calculus it can be shown that Eq. A1
corresponds to Eq. 12 of Jette,48 noting that in the last two
terms in the last factor in braces of the right-hand-side of
his equation the numerators should have cos4() rather than
just cos(). D. Jette, Personal communication, Aug. 1999.
The required goniometric transformations are facilitated by
substituting:
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A122 sin2  ,
B12 sin2 A2 cos2  .
From Eq. A2 it is furthermore directly seen that the




122 sin2  h . A4
APPENDIX B: ELECTRON RANGE STRAGGLING
An expression for electron range straggling has been de-
scribed by Ahnesjo¨33 using parameterization of Monte Carlo
calculations. This range straggling correction function is
given as:
Rr 
1 f 1E  f 2E 2 f 3E 3
1e10 f 4E 
 f 5E  1 11e10 f 4E  , B1
with functions f 1 .. f 5 defined as
f 1E 0.463 082.8544•103E ,
f 2E 1.37545.3112•102E7.4163•104E2,
f 3E 0.909 110.135 45E4.2304•103E2
3.6100•105E3, B2
f 4E 1.00830.028 518E1.9170•103E24.4681
•105E33.5560•107E4,
f 5E 0.259 787.2283•103E1.2396•104E2,
and E the initial electron energy in MeV. The depth variable






APPENDIX C: CONTRIBUTION OF PHOTON
INTERACTION IN THE DETECTOR
In this appendix the output is derived of a small, dense
(	d1 g/cm3) detector, as a response to both local dose to
water D as well as direct photon interaction in a slit beam
geometry in a water phantom (	w1 g/cm3). The percent-
age of the detector output due to direct photon interaction in
the sensitive material ‘‘cavity’’ of such a detector is
given20 to be c in a reference geometry, e.g., a 10
10 cm2 field at 3 cm depth.20 It is furthermore assumed
that Compton interaction is the dominant process of photon
interaction. Because Compton interaction is proportional to
electron density, the percentage of detector output which is






in which (Z/A)d and (Z/A)w represent the ratio of atomic to
mass number of detector material and water, respectively.
This can also be expressed as the fractional increase of de-








Assume a slit beam that has small dimensions, such that
only primary photon fluence exists, and let the fraction of
primary fluence to total fluence in the broad reference beam
be f p . Define the primary dose output factor F as the ratio of
the primary dose centrally under the slit to the primary
dose centrally in the reference field: FD/ f pD ref . If the slit
width, w, is smaller than the corresponding dimension of the
detector’s sensitive element, d, a partial volume function, f  ,
has to account for the fraction of the detector, , that is
irradiated by primary photons. At a distance x from the cen-
ter of the slit, this partial volume function is:
f x 0 if xwd /2,








The dose measured by the detector, M, assuming a unit
dose to output calibration factor, in central position due to
dose to water and direct photon interaction is now given as:
MF f pD refD refAc f p f D 1 Ac f F  . C3
The second of the two terms in braces can be applied to any
position x, using Eq. C2; it defines the contribution to the
detector output by direct photon interaction in the detector,
normalized to dose to water, as used in Eq. 4.
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To achieve the maximum benefit of conformal radiation therapy it is necessary to obtain accurate
knowledge of radiation beam penumbras based on high-resolution relative dosimetry of beam
profiles. For this purpose there is a need to perform high-resolution dosimetry with well-established
routine dosimeters, such as ionization chambers or diodes. Profiles measured with these detectors
must be corrected for the dosimeter’s nonideal response, caused by finite dimensions and, in the
case of an ionization chamber, the alteration of electron transport and a contribution of electrons
recoiled in the chamber wall and the central electrode. For this purpose the line spread function
LSF of the detector is needed. The experimental determination of LSFs is cumbersome and
restricted to the specific detector and beam energy spectrum used. Therefore, a previously reported
analytical model Med. Phys. 27, 923–934 2000 has been extended to determine response pro-
files of routine dosimeters: shielded diodes and, in particular, ionization chambers, in primary dose
slit beams. The model combines Compton scattering of incident photons, the transport of recoiled
electrons by Fermi–Eyges small-angle multiple scattering theory, and functions to limit electron
transport. It yields the traveling direction and the energy of electrons upon incidence on the detector
surface. In the case of ionization chambers, geometrical considerations are then sufficient to calcu-
late the relative amount of ionization in chamber air, i.e., the detector response, as a function of the
detector location in the slit beam. In combination with the previously reported slit beam dose
profiles, the LSF can then readily be derived by reconstruction techniques. Since the spectral
contributions are preserved, the LSF of a dosimeter is defined for any beam for which the effective
spectrum is known. The detector response profiles calculated in this study have been verified in a
telescopic slit beam geometry, and were found to correspond to experimental profiles within 0.2 and
0.3 mm full width at half-maximum for a Wellhoefer IC15 chamber in a 6 and 25 MV-X x-ray
beam, respectively. For a shielded diode these figures were found to be 0.2 and 0.1 mm, respec-
tively. It is shown that a shielded diode in a primary beam needs only a small size-based correction
of measured profiles. The effect of the LSF of an IC15 chamber on penumbra width has been
determined for a set of model penumbras. The LSFs calculated by the application of the analytical
model yield a broadening by 2 mm of a 3 mm wide penumbra 20%–80%. This is 0.5 mm 6
MV-X to 1 mm 25 MV-X smaller than found with the experimental LSFs. With a spatial
correction based on the LSFs that were determined in this study, this broadening of up to 2 mm is
eliminated, so that ionization chambers like the IC15 can be used for high-resolution relative
dosimetry on a routine basis. © 2001 American Association of Physicists in Medicine.
DOI: 10.1118/1.1366665
Key words: relative dosimetry, ionization chamber, detector response, line spread function,
penumbra broadening
I. INTRODUCTION
Accurate knowledge of penumbras of the applied photon
beams is a prerequisite in the treatment planning of confor-
mal radiation therapy as well as in stereotactic radiotherapy.
High-resolution relative dosimetry of beam profiles is needed
to obtain this knowledge during commissioning and verifica-
tion of beam data in the local treatment planning system. A
large amount of measurements is usually involved, in par-
ticular during verification, and there is thus a demand for
routine dosimetry methods with high spatial resolution. Do-
simeters used for this purpose exhibit phenomena of non-
ideal detector behavior, such as limited spatial resolution,
nonlinearity, direct photon response, energy dependence,
and, often, a combination of these factors.1 These phenom-
ena are caused by finite detector size, by detector construc-
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tion, and by characteristics of the applied detector materials.
The density and effective atomic number of the sensitive
element are usually different from the surrounding medium
of interest, and thus photon interaction and electron transport
are altered. Measured profiles can be corrected for these de-
tector phenomena when the detector’s line spread function
LSF is known.
This LSF can be defined as the transfer function that
transforms the ‘‘real’’ dose profile, D(x), into the measured
detector response profile, O(x), as schematically illustrated
in Fig. 1. Note that the LSF, as defined here, is not equal to
the response to a mathematical line or delta function, be-
cause elementary dose profiles differ from delta functions in
megavoltage photon beams due to electron transport effects.
The LSF, however, describes the broadening of elementary
dose profiles that result from slit x-ray beams.
Several types of detectors are available for high-
resolution dosimetry, for instance, natural diamond detectors,
liquid ionization chambers, plastic scintillators, and radio-
graphic and radiochromic film. A comparative study1 on the
use of several of these detectors in small photon beams has
recently been published. These detectors have a small dimen-
sion of the sensitive element in common, and consequently a
limited correction for their size is needed. However, all suf-
fer from either spectral dependence, extensive operation pro-
cedures, nonlinearity, direct photon response, restricted ap-
plicability, or a combination of these limitations.
In practice, two other types of dosimeters are most com-
monly used in megavoltage photon beams for routine pur-
poses including commissioning and verification: ionization
chambers and shielded diodes. These two types of direct
reading dosimeters are presently applicable for dosimetric
verification in dynamic wedge beams2 since one-dimensional
arrays of these detectors have become available. Ionization
chambers have clear advantages as a dosimetric standard in
regions with electronic equilibrium, because of the direct
proportionality between output and dose, in addition to their
solid reputation of uncomplicated use in scanning devices.
Note, however, that this proportionality only holds for nearly
water-like chambers.3 Diodes are often used in the build-up
region4 because of the small dimension in the scan direc-
tion of the sensitive element. Moreover, ionization cham-
bers and shielded diodes are frequently used as ‘‘all-round’’
dosimeters, including use in the penumbra region, albeit usu-
ally without correction for the unknown LSF. The magni-
tude of this omitted correction can be assessed from
studies5–7 that indicate that ionization chambers with 4–6
mm internal diameter typically show a broadening of the
20%–80% penumbra width of 2–3 mm. Especially in the
penumbra region a considerable gain in accuracy in the do-
simetry can thus be achieved when the LSF of these dosim-
eters is known and corrected for. However, experimental de-
termination of the LSF is cumbersome8 and restricted to the
specific detector type and beam spectrum applied.
The LSF of an ionization chamber can be expected to be
governed by the detector size, change in electron fluence
caused by the replacement of water by air in its interior, and
the generation of an increased number of electrons in the
detector wall and central electrode, which often have a den-
sity higher than unity water. The LSF of a diode is ex-
pected to be determined mainly by its size, but the diode
response may show an energy dependence,9 especially if not
properly shielded.
In a previous study,10 a model has been developed and
applied to calculate dose profiles in a telescopic slit beam
geometry. The analytical model combines Compton scatter-
ing of incident photons, transport of resulting electrons by
Fermi–Eyges small-angle multiple scattering theory, and
functions to limit electron transport. In this slit beam geom-
etry all dose contributions except the primary dose could be
excluded. It has been verified that the model is suitable to
calculate slit beam dose profiles in situations that are domi-
nated by monodirectional primary photon fluence. Discrete
photon spectral contributions are preserved, which allows an
application of the results to other linear accelerator linac
beam x-ray spectra. As will be shown in this study, the
model can be extended to yield slit-beam detector response
profiles, in particular, ionization profiles in the case of an
ionization chamber. From the combination of slit dose pro-
files and slit response profiles, the LSF of a specific dosim-
eter can then readily be derived.
Our aim in the present study is to extend the application
of the model to the determination of slit response profiles of
two common dosimeters, shielded diodes, and thimble ion-
ization chambers, and to verify these slit response profiles in
experiments with telescopic slit geometry. The emphasis in
this study lies on ionization chambers. The modeled slit re-
sponse profiles of ionization chambers include electron trans-
port in air, and an increased recoil of Compton electrons in
the chamber wall and the central electrode. Our further ob-
jective in this study is to define parametrizations of LSFs that
are suited for use in deconvolution or reconstruction tech-
niques and to quantify the effect of calculated and experi-
mental LSFs on penumbra width, thus enabling a more ac-
curate penumbra determination.
FIG. 1. A schematic illustration of photon fluence profiles (x) left col-
umn with corresponding dose profiles D(x) middle column and detector
output profiles O(x) right column. The top row shows an ideal slit fluence
profile, an elementary dose profile, and a corresponding detector output
profile; the bottom row represents a macroscopic beam size representative
for radiotherapy practice. The line spread function S(x) relates D(x) to
O(x) by convolution; Eq. 3. Note that the x scale of the lower row of
graphs is compressed with respect to the upper row.
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II. THEORY
In the first part of this section the theoretical framework
of the previous study10 is extended to allow a calculation of
the response profile of an air-filled cylindrical ionization
chamber, whereas in the second part the theoretical LSF is
determined and a parameterization defined that accounts for
the dimensions and construction of the chamber.
A. Slit beam response profile of a thimble ionization
chamber
The reported theoretical formalism10 allows the analytical
calculation of electron fluence in a water phantom irradiated
by a narrow primary x-ray slit beam. The analytical model
combines Compton scattering of incident photons, using
Klein–Nishina cross sections,11,12 transport of resulting elec-
trons by Fermi–Eyges small-angle multiple scattering theory
in the description of Jette,13 a function to account for elec-
tron range straggling as described by Ahnesjo¨,14 and a func-
tion to limit the electron transport range.10 In combination
with the mass collision stopping power of the traveling elec-
trons, derived from the ICRU35 Report15 under the
continuous-slowing-down-approximation, dose profiles were
calculated. The coordinate system used has previously been
described10 and is merely summarized here in Fig. 2. As a
notation convention primes are used in this study in relation
to Compton photon interaction, quantities without primes re-
late to traveling electrons, whereas coordinates with double
primes represent the position of the detector center.
One effect that has to be taken into account when extend-
ing the previous formalism to ionization chamber measure-
ments is the modification in the generation of Compton scat-
tering caused by the presence of the chamber, in particular,
the replacement of phantom material water by air and by
materials applied in chamber wall and central electrode that
differ in density and atomic number from water. Since
Compton scattering is proportional to electron density, the
wall and electrode materials affect the amount of recoil elec-
trons when exposed to the primary photon fluence in the slit
beam. On the other hand, the air in the chamber interior will
produce very little Compton scattering. Any Compton scat-
tering in chamber air is therefore neglected. A cylindrical
symmetry is assumed for the chamber geometry, as illus-
trated in Fig. 3. The effect of detector construction on Comp-
ton scatter can now mathematically be represented by a rela-
tive Compton scattering intensity function Idet , which is
defined as the electron density of detector material relative to
water, i.e., 	water
material•(Z/A)watermaterial , with 	 the mass density and
Z/A the ratio of atomic to mass number. Let R in be the
internal radius of the ionization chamber, let W be the thick-
ness of the wall, let L in be the length of the chamber,
whereas Rced and Lced represent the radius and length of the
central electrode, respectively. Furthermore r(x,y,z)
and r(x,y,z) indicate the location of Compton inter-
action and the location of the center of the ionization cham-
ber in Cartesian coordinates, respectively. The following
conditions represent the relative intensity, Idet(r,r) of
Compton interaction in water, wall cylinder, wall caps, cen-
tral electrode, and chamber air, respectively:




FIG. 2. The calculation coordinate system used in the present and previous
Ref. 10 study. A volume wld in a water phantom is irradiated by
photons. A Cartesian coordinate system X, Y, Z is aligned to the symmetry
axes of this volume. In the primary photon beam Compton interaction is
calculated in points called K on a regular grid. Only three K points are
shown. Recoil Compton electrons leave any point K with an initial direction
defined by a polar angle  and an azimuthal angle 
. The directional
electron fluence is calculated in points named L, distributed along a grid in
the XZ plane. The incident electron traveling direction is defined by a polar
angle , with respect to the Z axis, and an azimuthal angle 
, relative to the
X axis.
FIG. 3. A schematic drawing of ionization chamber geometry. Upper row:
Axial and longitudinal transection of the IC15 chamber not to scale. Lower
row: Approximation of this geometry used in this study. A cylindrical ge-
ometry is assumed in which R in represents the internal radius of the cham-
ber, W the wall thickness, L in the effective internal length of the chamber,
Rced the radius of the central electrode, and Lced its length. The chamber is
aligned along the y axis Fig. 2. The slit beam is incident from above in
these pictures.
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Another effect that has to be accounted for is the obser-
vation that an ionization chamber does not directly measure
dose, but has an output that is defined by the amount of
ionization that occurs in its sensitive element, the chamber
air. In this study this amount is assumed to be proportional to
the total track lengths of all electrons that enter the chamber
air, coming from either the phantom material, the wall, or the
central electrode, multiplied by the mass collision stopping
power associated with the electron energy upon entrance.
First, the track lengths of electrons coming from the phan-
tom and the wall material are to be modeled. These can be
treated identical, except for the difference in Idet . An effec-
tive trajectory length Tdet inside chamber air is defined, ne-
glecting the presence of the central electrode for this purpose
and assuming straight electron trajectories in the few milli-
meters of chamber air. Then straightforward geometrical
considerations suffice to define Tdet(r,)drA d as the air
volume traversed by electrons that arrive in the areal element
drA around r on the chamber inner wall, while traveling in a
direction in between  and d .
The equations 1–3 of the previous study10 can now be
extended to incorporate the response of cylindrical ionization
chambers. For this purpose it is assumed that the fluence of
electrons that travel toward the chamber air is not influenced
by the replacement of water by chamber air. The effect of
this assumption is limited to electrons that reenter chamber
air. Restating briefly the quantities used, let dNE /d be
the number of Compton electrons recoiled per solid angle
; let P(r,;r,,E)dx dy d be the probability that
an electron with initial Compton recoil energy E is found in
an area in between x and xdx , and in between y and y
dy and traveling in direction , when arriving at depth z,
relative to an initial Compton recoil position r and recoil
direction ; let rr/Rp , with Rp the electron prac-
tical range, represent the fractional traveled distance by the
electron; let R() represent a range-straggling correction and
H() be a range cutoff function; and, finally, let
Sair„E( ,E)…/	 be the mass collision stopping power in de-
tector air of electrons with remaining energy E after a recoil
with energy E and a traveled range  through water. In-
creased electron energy loss in wall material (	wall1) is
thus neglected. The detector response output at position
r,O(r), can now, in analogy to Eqs. 1–3 of the previ-





















HRd dr d drA dE. 2
The integration limits in this equation indicate the primary
x-ray spectrum in the slit beam, the detector inner wall sur-
face (Adet), the spherical range of electron travel directions,
the dimensions of the slit beam in the phantom d,l,w, and
the hemisphere of forward only Compton recoil directions.
In the numerical implementation of this transport model cal-
culation efficiency is considerably improved by calculation









H rRpR rRp d. 2a
Second, electrons recoiled in the central electrode in a
thimble ionization chamber have to be modeled. These con-
stitute a small contribution in total detector response in com-
parison to the contribution of electrons recoiled from the
surrounding phantom and the detector wall, as will be shown
in this study. Because of this small contribution some ap-
proximations could be introduced in the modeling of elec-
trons coming from the central electrode to simplify and
speed up calculations. In this study it is assumed that for all
Compton interactions in the electrode the electrons recoil
from the center of the electrode, and that in the calculation of
Tdet for these electrons the diffusion of electron trajectories
between the center and the surface of the central electrode
can be neglected (). Under these assumptions the tra-
jectory length Tdet for electrons recoiled in the central elec-
trode can be incorporated in the precalculated integral, Eq.
2a, which can be evaluated a priori using the values for the
mass collision stopping power at distance rRced•	ced /	water , i.e., by scaling the electrode radius by its den-
sity.
B. Line spread functions
The slit dose and slit response profiles of the previous and
present study, respectively, can now be combined to define a
LSF of any dosimeter for which the slit response profile is
known. For a specific beam energy spectrum and slit geom-
Medical Physics, Vol. 28, No. 5, May 2001
VI.  Detector Line Spread Functions84
etry the slit dose profile, D(x), and slit response detector
output profile, O(x), are defined, Fig. 1. The LSF S(x) is,
then, defined by a convolution:
Ox Dx *Sx . 3
Furthermore, when the LSF, S(x), for a specific detector
is known, deconvolution or reconstruction techniques can
subsequently be applied to this equation to recover a dose
profile in any x-ray field in which a response profile is mea-
sured. This assumes that the LSF that has been determined
for a primary beam spectrum is also valid in the local beam
spectrum. This assumption is discussed in Sec. V A.
For numerical applications, a fitting function of the LSF is
defined with a limited set of parameters that are related to
relevant detector characteristics. In the case of a thimble ion-
ization chamber, these parameters define elliptic
functions16,17 for the cross sectional areas of an effective
detector radius,7 Reff , the inner radius, R in , and outer radius,
Rout , of the chamber wall, and the radius, Rced , of the central
electrode. Furthermore a Gaussian kernel, with half-width ,
is added, because some studies8,18 indicate that this would
give a better description of spatial response. The fitting func-
tion Sfit(x) of the LSF of a thimble ionization chamber thus
becomes
Sfit




In this and the next equation, terms of the form (R2x2)
are to be replaced by zero if xR . In the case of a shielded
diode, the most important parameter is the radius of the sen-
sitive element, Rdet , yielding
Sfit
Six A1Rdet2 x2. 5
Note that the square root terms in Eqs. 4 and 5 describe
sections of ellipses, like S2/A2x2R2 or in generalized




Two types of thimble ionization chambers are modeled: a
common size chamber IC15, Wellhoefer, Germany, 130
mm3 and a small chamber NAC, National Accelerator In-
stitute, South Africa, 7 mm3.20 The properties of these de-
tectors are summarized in Table I. For the purpose of mod-
eling, the thimble detectors are approximated by cylinders
with a flat top and bottom surface, Fig. 3. Compton scatter
and electron transport are precalculated as described
previously,10 schematically indicated in Fig. 2, and the re-
sults of the calculation of Eq. 2a are stored in a matrix of
points L in the XZ plane. Available memory allowed a grid
size for the dose deposition points L of 0.2 mm, with a
corresponding shift in the K points of 0.1 mm in the X and Z
direction to avoid singularities in the dose deposition points.
A contribution to the detector response electron fluence
times track length times stopping power in air according to
Eq. 2 is sampled in points on the dosimeter wall inner
surface distributed along the midcircular transection of the
detector and along the cap surface. Along the upper half of
the midcircular transection, 100 points are used, along the
lower half 50 points. Furthermore, the contribution to the
detector response was determined in 51 points evenly distrib-
uted over the flat top surface of the dosimeter. Because of the
symmetry in the calculation geometry and the extended
length of the slit, this set of points can represent the entire
wall–air interface of the outer detector electrode. The rela-
tive weighting of the detector points is proportional to the
fractional wall area that each point represents.
The contribution of electrons recoiled in the central elec-
trode is calculated with the approximations described at the
end of Sec. II A and is added to the contribution of electrons
recoiled in the phantom and detector wall.
Detector response profiles of the ionization chambers are
calculated separately for all photon energy bins that consti-
tute the effective energy spectra of our linac beams, Fig. 3 in
the previous study.10 Afterward these monoenergetic profiles
are integrated over the photon spectra. Due to the trade-off
TABLE I. Characteristics of thimble ionization chambers used in this study.
Detector IC15 NAC
Manufacturer Wellhoefer, Germany National Accelerator Center, South Africa
Detector length mm 5.8 3
Wall Inner wall Outer wall
Material Shonka C552 A150 VESPEL
Density g/cm3 1.7 1.127 1.43
Outer radius mm 3.4 1.4 3.15
Inner radius mm 3 0.95 1.4
(Z/A)waterwall 0.9002 0.9891 0.9235
Central electrode
Material Shonka C552 Copper
Density g/cm3 1.7 8.96
Radius mm 0.5 0.15
Length mm 3.3 2
(Z/A)waterelectrode 0.9002 0.8222
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between the resolution and size of the matrix of L points
within available memory, the calculated response profiles
this study and dose profiles previous study have limited
lengths of 2 and 1 cm, respectively, and consequently low,
but non-negligible, start and stop values, typically 1% 6
MV-X to 3% 25 MV-X of the profile maximum. To mini-
mize artefacts in the determination of LSFs, the tails of the
dose profiles and the detector response profiles have been
extended using a fit to the sum of two Gaussians. The valid-
ity of this procedure is assessed in Sec. V A.
The calculation took from 28 h for the lowest-energy bin
to 36 h for the highest-energy bin on a 333 MHz Pentium
PC.
Detector response profiles of a silicon diode are calculated
by convolution of the previously10 calculated slit beam dose
profiles with the circular shape of the diode’s sensitive ele-
ment radius 1.25 mm.
B. Experiments
A telescopic slit beam geometry that excludes all dose
contributions except the primary photon dose, has previously
been reported in detail,10 and is described briefly here. Pho-
ton beams of 6 MV-X and 25 MV-X with a 9 mm diam
isocentric field size were used, generated by a Philips SL25
linear accelerator. Slit widths of 0.20 and 0.40 mm thickness
were defined by calibrated spacers. Aiming at optimal spatial
resolution, scans were made with a dedicated water phantom.
In this high-resolution setup, scans crossing the slit width
were made with 1 s integration time per step 0.05 mm at a
depth of 50 mm at 3.00 m source to phantom distance. Scans
with the slit closed were made to define the transmission of
the tungsten slit blocks. Per slit width, beam energy and
detector type two slit-open and two slit-closed scans were
averaged. By mounting a yoke to the scanning arm of the
water phantom, a diamond,10 an IC15, and a diode were
applied successively in the same scans, i.e., without any
change in geometry.
The diode is a p-type Scanditronix photon diode with a
high-density tungsten-epoxy shielding directly behind the
sensitive element to decrease the low-energy response due to
backscatter.21 The diode was oriented pointing toward the
linac source. The radius of the sensitive element was speci-
fied as 1.25 mm. The ionization chambers were oriented with
the symmetry axis parallel to the slit direction, the Y axis in
Fig. 2. Linac fluctuations were recorded with a 600 cm3 ref-
erence ionization chamber placed near the water phantom,
because no place for a reference detector inside the small
beam was available. Reference and scanning ionization
chambers were operated at 300 V generated by a Wellhoefer
WP5006 electrometer, the diode was operated without bias
voltage via another WP5006 electrometer. All electrometer
channels were read out via a four-channel voltage-to-
frequency converter Hytec, UK by a PC counter card PC-
TIO-10, National Instruments, TX. During slit scanning
with the IC15, the diamond detector signal, although low in
magnitude, was thus simultaneously available for some ref-
erence purposes.
Compared to the diamond detector scans in the previous
study, the ratio of the peak slit open to background slit
closed signal in ionization chamber scans is much lower,
typically a ratio of 1.2:1. Therefore, specific measures were
taken in acquisition and processing: sandwich of slit-open
and slit-closed scans, the exclusion of transients based on a
first-derivative criterion, the detection and verification of
small drifts in linac output by a comparison of integrated
output of the reference chamber and diamond second refer-
ence, and correction for verified small drifts in linac output
in between repeated scans.
A standard water phantom Wellhoefer WP700 was used
in separate sessions in which many repeated scans 12–64
scans depending on the peak-to-background ratio were
made with scan speeds of 0.9–1.8 mm/s and distances be-
tween measuring points of 0.3–0.5 mm, indicated here as
standard resolution scans. The source to phantom distance
for these scans was 4.00 m. Per scan, this standard resolution
procedure is much faster and thus less sensitive to linac out-
put variations than the high-resolution setup, but at the ex-
pense of less resolution and more noise. In the same setup
detector response profiles of the small NAC chamber were
measured.
C. Line spread functions and penumbra broadening
For each combination of ionization chamber and beam
energy, the line spread function has been determined using
the calculated or measured response profile and the corre-
sponding calculated slit beam dose profile. Only calculated
slit beam dose profiles were used because of the absence of
experimental noise. This is justified by the fact that these
profiles show close agreement to experimental profiles.10 The
LSFs S(x) in Eq. 3 have been calculated. Theoretically this
equation can be solved for the unknown function S(x) by
application of the convolution theorem in the Fourier do-
main. However, the limited knowledge of the other two func-
tions in the equation, which are defined at discrete points
over a finite length and in case of experiments supplied with
noise, often yields impracticable outcomes with much high-
frequency noise.18 Therefore the maximum likelihood itera-
tive reconstruction method22 was used, which is especially
suited for cases with limited knowledge of the input func-
tion. Iteration was terminated when the sum of squared dif-
ferences between the left-hand and right-hand side of Eq. 3
changed less than 1% in between two iterations. However,
the maximum likelihood method has reported artefacts.23 To
decrease the impact of these artefacts in our case, a least-
square fit procedure was imposed on the reconstructed LSFs,
using Eq. 4 and thus bounding the result to physical char-
acteristics of the detector. The accuracy of the eventual LSFs
is assessed in relation to the intended use, the deconvolu-
tion of penumbras.
For the purpose of this assessment, the steepest possible
penumbras in a macroscopic field have been created by add-
ing slit beam dose profiles geometrically side to side to form
5030 mm2 primary beam profiles. ‘‘Real’’ detector beam
response profiles, i.e., without the effects of reconstruction
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and of fit of LSFs, were constructed by a similar geometrical
addition of detector slit beam response profiles. Alterna-
tively, detector slit beam response profiles that include ef-
fects of maximum likelihood reconstruction and the imposed
fit procedure of LSFs were constructed by convolution of the
slit beam dose profiles with these LSFs, followed by geomet-
ric addition. The difference between the penumbras of both
beam profiles is an indication of the effect of the reconstruc-
tion and fit procedure on the outcome of deconvolution
procedures.
The most important clinical implication of the LSFs,
namely their effect on penumbras, was assessed by studying
the broadening of a set of model penumbras, defined as 1/2
1/2 erf(x), where erf represents the error function, and in
which  was varied to yield the penumbra widths 20%–
80% in between 1.5 and 11 mm.
IV. RESULTS
A. Slit beam response profiles
Detector response profiles of an IC15 chamber in a 6
MV-X and a 25 MV-X slit beam are shown in Figs. 4a and
Fig. 4b, respectively. The profiles run in the X direction of
Fig. 2. The calculated profiles were obtained by application
of the analytical electron transport model, Eq. 2, in a 0.2
mm slit beam, indicated at the bottom of Fig. 4. Experimen-
tal slit response profiles obtained in a 0.2 mm as well as in a
0.4 mm slit beam are also shown. All profiles were normal-
ized to 100% peak level. Experimental data points have been
pooled per 0.2 mm interval, except for the standard resolu-
tion scans, which have been pooled per 0.5 mm. The points
and error bars represent the mean and standard error of the
mean of the underlying signals. Full width at half-maximum
values of the detector response profiles, measured in the 0.4
mm slit beam, are indicated in Table II. Except for the region
from 4 to 7 mm distance from the center, which will be
discussed in Sec. V B, the calculated 6 MV-X model profile
agrees well with the measurements, and the 6 MV-X experi-
mental 0.2 and 0.4 mm slit profiles are also mutually in good
agreement. The slit response profiles of both experimental
setups, high resolution, and standard resolution, are in rea-
sonable agreement with each other for both 6 MV-X and 25
MV-X. Experimental setup errors can thus be excluded. The
calculated 25 MV-X model profile is mostly lower and less
wide than the experimental profiles. The 25 MV-X slit beam
scans in the high-resolution setup were not completed be-
cause poor linac cooling has limited 25 MV-X beam-on
time.
In Fig. 5, calculated and experimental response profiles of
a NAC chamber in a 6 MV-X 0.2 mm slit beam are shown.
The noise level and the peak to background level in these
experiments were so poor, that repetition of the scans in the
high-resolution setup was not attempted, as this would im-
pose too high demands on linac stability.
Model and experimental diode slit response profiles in 6
MV-X and 25 MV-X 0.4 mm slit beams are shown in Fig. 6.
The model slit response profiles were obtained by convolu-
tion of the slit beam dose profiles10 with the transection of
the sensitive area of the diode, Eq. 5.
B. Line spread functions
Line spread functions of the IC15 detector obtained with
the maximum likelihood iterative restoration technique are
shown in Figs. 7a and 7b, for 6 MV-X and 25 MV-X
beams, respectively. Calculated LSFs were based on 0.2 mm
FIG. 4. Calculated solid lines and measured points slit detector response
profiles along the x axis Fig. 2 of an IC15 ionization chamber in a 6 MV
a and 25 MV b x-ray beam. All profiles have been normalized to 100%
maximum value. At the bottom, slit widths of 0.2 and 0.4 mm are indicated.
The internal diameter of the IC15 chamber of 6.0 mm is also indicated. The
zero response level is represented by a full horizontal line. A slit width of
0.2 mm applies for the model calculations. Open symbols represent experi-
ments with a 0.2 mm slit width, closed symbols with a 0.4 mm slit width.
Experimental checks in the standard resolution SR setup are marked with
crosses a and triangles b. The error bars represent one standard deviation
in the underlying signals.
TABLE II. Full width half-maxima FWHM of calculated and measured








IC15 6 6.8 6.6
IC15 25 6.6 6.9
NAC 6 2.2 2.6
Shielded diode 6 2.4 2.6
Shielded diode 25 2.6 2.7
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slit beam data, whereas the presented measured LSFs were
derived from the less noisy 0.4 mm slit beam data. The pa-
rameter values that result from a fit of Eq. 4 to the LSFs are
listed in Table III. No wall effect was noticed in the experi-
mental 25 MV-X response profile. For this case a simplified
fitting function, Eq. 4 without wall effects, was used. The
table also presents the LSF parameters for the NAC chamber
in a 6 MV-X beam based on calculated response functions.
The corresponding measured response function, Fig. 5, was
not suited to yield a meaningful LSF, due to the large uncer-
FIG. 5. Calculated solid lines and measured points slit detector response
profiles along the x axis Fig. 2 of a NAC ionization chamber in a 6 MV
x-ray beam. The internal diameter of the NAC chamber of 1.9 mm and the
slit width of 0.2 mm are indicated by horizontal lines. The zero response
level is represented by a full horizontal line. The error bars represent one
standard deviation in the underlying signals.
FIG. 6. Calculated solid lines and measured points slit detector response
profiles along the x axis Fig. 2 of a shielded photon diode in a 6 a and 25
MV b x-ray beam. All profiles have been normalized to 100% maximum
value. At the bottom, the slit width of 0.4 mm is indicated by a horizontal
line. The zero response level is represented by a full horizontal line.
FIG. 7. Calculated solid lines and measured dashed lines line spread
functions LSFs of an IC15 ionization chamber based on 0.2 and 0.4 mm
slit beams, respectively, in a 6 MV a and 25 MV b x-ray beam. The
points represent the calculated LSF after the application of Eq. 3 using a
maximum likelihood iterative reconstruction MLIR algorithm; the lines
represent the LSFs after a fit according to Eq. 4. The calculated and fitted
LSFs have been normalized to a central value of 1.0; the other LSFs were
normalized to the same area under the curves.
TABLE III. Fit parametrization of calculated and measured where available
line spread function, following Eq. 4, for two types of thimble ionization
chambers IC15 and NAC and two effective energy spectra, indicated by




















A1(mm1) 0.29 0.27 0.4 0.32 3.7
Reff(mm) 3.6 3.2 3.5 3.6 1.2
A2(mm1) 0.77 0.77 0.21 - 0.032
Rout(mm) 3.4 3.4 3.4 - 3.15
R in(mm) 3 3 3 - 0.95
A3(mm1) 1 0.67 0.83 0.14 21
Rced(mm) 0.5 0.5 0.5 0.5 0.15
A4 0.047 0.23 0.064 0.2 -
 mm 6 4 7.5 6.8 -
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tainty in the measurements. The effect of reconstruction and
subsequent fit of LSFs is discussed in Sec. V C.
The penumbra broadening caused by the measured and
calculated LSFs, expressed as an increase in 20%–80%
width of model penumbras, is shown in Figs. 8a and 8b,
for 6 MV-X and 25 MV-X, respectively. The solid line in-
dicates the broadening of these model penumbra when the
model-based LSF is used; the dashed lines indicate the
broadening when various measured LSFs are applied. The
marked points and the dash–dotted line are discussed in Sec.
V C.
V. DISCUSSION
Aspects treated in this section are the model and its imple-
mentation Sec. V A, the experimental verification Sec.
V B, the reconstruction of the line spread functions and the
penumbra broadening caused by ionization chambers Sec.
V C, and general aspects such as the applicability of the
derived line spread functions in macroscopic fields that are
representative for conformal radiation therapy practice Sec.
V D.
A. Calculational model
In the previous study10 the assumptions have been dis-
cussed that were made in the modeling of electron transport:
small-angle multiple scattering, linear energy loss, and trans-
port restricted to the electron practical range. It was shown
there that these approximations can have distinct localized
discrepancies in special situations with, for instance, mo-
noenergetic, monodirectional, or localized electron sources,
but present good accuracy in the local dose in an x-ray slit
beam geometry. This was attributed to the distribution of
Compton electron sources over slit beam volume, initial trav-
eling directions, and initial electron energies, which levels
off any local inaccuracy. In the present study with macro-
scopic detectors, local inaccuracies are further reduced be-
cause electron fluence is integrated over the detector exten-
sion. On the other hand, only a small strip of the detector is
actually in the high dose region near the slit beam, whereas
inaccuracies that extend over a range comparable to the de-
tector dimension will be accumulated over the entire detector
surface. These inaccuracies will thus be more dominant in
the output of a macroscopic detector. An example of such a
discrepancy over an extended range is the effect of the elec-
tron range cutoff approximation in the model. The error lev-
eling and error accumulation effects may partly compensate
each other, thus the net effect on the calculation accuracy
will be assessed in comparison with experiments in the next
section.
The calculated model response profiles reveal some note-
worthy characteristics of the response of a thimble ionization
chamber in water, that are reflected in similar characteristics
found in the experimental profiles and in the corresponding
LSFs. The calculated 6 MV-X IC15 profile is taken here as
the clearest example, Fig. 4a. First, the width at 50% is
larger than the diameter of the chamber air volume, 6.8 mm
versus 6.0 mm, with a corresponding LSF in Fig. 7a that
has a FWHM of 6.7 mm. This implies that the ionization
chamber has a greater effective radius than can be ascribed to
the dimension of its sensitive volume alone. The explanation
for this phenomenon lies in the chamber air in which elec-
trons that approach the end of their range can travel a longer
distance than electrons traveling entirely in water. Second,
an enhanced response is seen over the central 1.0 mm of the
profiles. This enhancement is caused by electrons recoiled
from photon interaction in the central electrode diameter 1.0
mm. A similar effect of smaller magnitude is seen at a dis-
tance of 3 mm from the central position. Near this position
the detector presents the longest transection of its wall ma-
terial in the Z direction, which is the direction of the incident
photons. Because Compton electrons are, in particular, re-
coiled in a forward direction, this explains why near this
position an increased response to the slit beam is seen. Both
phenomena further indicate that the response of this type of
ionization chamber is to a small extent caused by direct pho-
ton response, due to the presence of materials with a density
FIG. 8. The effect of various IC15 LSFs, determined for 6 MV-X a and 25
MV-X b, on the broadening of 20%–80% penumbra width of model low-
tail penumbras of various widths. The solid lines represent the effect of
calculated LSFs; the dashed lines indicate the effect of measurement-based
LSFs in various experimental setups. The upper dashed lines correspond to
0.2 mm 6 MV-X and 0.4 mm 25 MV-X slit width experiments; the lower
dashed lines to the other slit width. The dash–dotted lines, labeled S, rep-
resent the effect of a LSF solely based on the dimension of the IC15 cham-
ber. The labeled points correspond to penumbra broadening results reported
in the literature, as summarized in Table IV and discussed in Sec. V C.
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higher than chamber air central electrode or the surround-
ing medium chamber wall. In the slit beam response pro-
files, the contribution of the central electrode is approxi-
mately 12% and 9% of the maximum response at 6 MV-X
and 25 MV-X, respectively, which was calculated to corre-
spond to a 1.9% and 1.1% contribution to the maximum
response, respectively, in beams larger than 3030 mm2.
This photon response is thus much lower than the photon
response that was reported for a diamond detector.24
As was described in Sec. II, the limited calculated profile
lengths were extended by a sum of two Gaussian functions to
minimize artifacts in the calculation of LSFs. The influence
of the choice for a particular extension type has been as-
sessed by a comparison to LSFs that were extended by a
much shorter extension, a linear tail fit until zero value is
reached. In a 5030 mm2 primary beam, this yielded a dif-
ference in 20%–80% penumbra broadening of less than 0.05
and 0.2 mm, for a 6 MV-X and 25 MV-X beam, respec-
tively. For practical purposes the particular choice of applied
extension thus has a negligible influence.
An assumption that is implicit in the intended use of LSFs
in macroscopic fields is the appropriateness of the effective
primary photon beam spectrum at off-axis positions, while
the effective spectrum has been determined25 on the basis of
central-axis depth dose curves. By a comparison of Figs. 8a
and 8b it can be seen that the different LSFs found for
primary beams with 6 MV-X and 25 MV-X energy spectra
lead to broadening of model penumbras that differ less than
0.25 mm. Noticing this small difference for two distinctly
different energy spectra, it is concluded that the inaccuracy
caused by application of the LSFs for an off-axis penumbra
correction can be neglected.
B. Experiments
The experimental 0.2 and 0.4 mm slit response profiles,
Fig. 4, are mutually in good agreement, in particular, con-
cerning the width at half-height. This is to be expected con-
sidering the negligible slit size in comparison to the detector
dimension.
Peak slit-open to background slit-closed ratios in the
experiments ranged from 1.08:1 to 1.25:1 depending on slit
width, chamber type, and energy. Two causes for these low
ratios, the large source-to-phantom distance and the small slit
widths, are essential requirements for good spatial resolution
and negligible geometric beam edge blurring.10 The third
factor is the macroscopic detector dimension with respect to
the slit width. This causes the entire detector to be irradiated
by the ‘‘background’’ beam, i.e., the beam transmitted
through the tertiary collimators, whereas at any time effec-
tively only a thin slice of the detector can be found in or near
the slit beam. Considering the reported peak to background
ratio and the width of the slit beam dose profiles, the above-
mentioned low peak to background ratios were estimated and
had to be accepted as inherent to the required experimental
setup. Therefore the measures described in Sec. III B were
applied. As the first measure, sandwiching, is obvious, and
the second measure, transient exclusion, is confined to local
effects, especially the effects of the last measure, a correction
for linac drift, needs to be assessed. The applied corrections
of the closed-slit background by a factor of up to 1.01 imply
up to a 4% and 6% decrease in the tails of the 6 MV-X and
25 MV-X detector response profiles, respectively. At the
peaks no changes occur due to the normalization to 100%.
The effect of a closed-slit background correction factor of
1.01 in a 6 MV-X beam was calculated to correspond to 0.6
mm less 20%–80% penumbra broadening at original model
penumbra widths up to 7 mm. Hypothesizing a worst case in
which the applied correction is just better than no correction
at all, an associated maximum inaccuracy in penumbra
broadening of half of this value, i.e., 0.3 mm, is estimated.
In the previous study, the influence of the phantom scatter
induced by the slit beam was reported to be negligible. In the
present study this cannot a priori be assumed due to the
macroscopic detector size and the low peak-to-background
ratios. Approximating the 0.2 mm27 mm slit beam by an
effective radius of 1.3 mm, and reading Fig. 4 of Bja¨rngard
et al.,26 a phantom scatter dose contribution of 1.0% in a 6
MV-X beam is found on the beam axis. By application of
data from the previous study10 in the slit geometry, it has
been estimated that in the 0.2 mm slit beam approximately
0.5% of the total peak output of the measured IC15 profile
was caused by slit beam induced phantom scatter. At the
location of the reference detector, upstream and with an ab-
sorber thickness in between the slit beam and reference de-
tector of approximately 20 g/cm2, this scatter is virtually ab-
sent. Because it is thus not included in the background
correction factor, it presents a small additional uncertainty to
the response functions.
Both effects together, the background correction with its
inherent uncertainty and the phantom scatter for which no
correction is applied, may account for an estimated uncer-
tainty in the tails of the measured response profiles of 3%,
which is not included in the indicated standard error in the
measurements. This corresponds to an uncertainty in the
model penumbra broadening of approximately 0.5 mm.
Some asymmetries with respect to the central axis of up to
approximately 3% can be seen in the experimental high-
resolution response profiles of Fig. 4a. By an analysis of
the reference signal, these could partly be traced to increases
in linac output presenting asymmetries of less than 0.5% in
some measurements, which show up with enhanced magni-
tude in the response profiles due to the low peak-to-
background ratios. A point-to-point correction based on the
reference signal could have remedied this, but was rejected
because of artifacts that could then possibly be introduced by
small beam steering instabilities in conjunction with the off-
axis position of the reference detector. Thus these asymme-
tries were accepted as a consequence of the applied geom-
etry. Furthermore, it was taken into consideration that as
long as these artifacts result in anti- or odd-symmetric addi-
tions to the response profiles, as was found to be the main
contribution in the asymmetry in the 0.2 mm high-resolution
profile of Fig. 4a, these artifacts will have little effect on
the fit parameters of the even-symmetric LSF, with even
symmetric to be defined schematically as f (x) f (x).
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Even with these estimated uncertainties taken into ac-
count, it can be seen in Figs. 4a and 4b that the modeled
IC15 response profiles have lower tails than the experimental
profiles. Furthermore, the 25 MV-X modeled profile has a
slightly smaller width 0.3 mm FWHM than the correspond-
ing experimental profile. The assumptions in the model cal-
culations, electron transport by multiple small-angle scatter
only and the cutoff in electron range, are most probably the
main causes for these remaining differences. An additional
cause in the case of 25 MV-X is the neglect of pair creation,
which has been reported27 to show less elongated dose ker-
nels than Compton scatter. However, apart from these ef-
fects, the calculated IC15 response profiles, especially at 6
MV-X, agree very well with the experimental verification.
The calculated and experimental NAC response profiles
agree moderately well with a difference in the FWHM of 0.4
mm. The large uncertainty in the measurements, however,
does not allow for a detailed analysis of discrepancies.
The experimental diode response profiles are generally in
good agreement with the calculated profiles, the difference in
FWHM amounts up to 0.2 mm. This indicates that the spatial
response of the diode is governed by the dimension of its
sensitive element, possibly with a small contribution from
the detector housing. Nevertheless, in this context it should
be noted that the applied experimental geometry is ideal for
diode measurements, since factors that can reportedly affect
diode output, such as low-energy scattered photons,9 and
directional dependence,21 have been minimized in the tele-
scopic slit-beam geometry.
C. Line spread functions and penumbra broadening
The effect of reconstruction and fit of the LSFs, using
Eqs. 3 and 4, on the penumbra width was assessed by a
comparison of two types of detector response profiles asso-
ciated with a 5030 mm2 primary beam: geometric addition
of slit beam detector response profiles, i.e., the ‘‘real’’ pro-
files, versus the geometric addition of slit beam dose profiles
convolved with reconstructed and fitted LSFs. In the latter
case, with calculated LSFs, penumbras were found that were
in excellent agreement to the penumbras of the ‘‘real’’ pro-
files, the largest difference was a 0.02 mm too wide penum-
bra for 25 MV-X. Penumbras obtained with measured LSFs
were 0.3 and 0.8 mm smaller than the ‘‘real’’ penumbras, for
6 MV-X and 25 MV-X, respectively. Note, however, that
these are worst case data, since these data apply to the steep-
est possible penumbras.
Another factor that was checked in the reconstruction pro-
cedure was the level of the iterative stop criterion. A stop
criterion of less than 0.1% change in the squared difference
of the left-hand and right-hand side of Eq. 3 yielded LSFs
with higher oscillations in the central part of the curves than
shown in Fig. 4, obtained with a 1% stop criterion. However,
no significant difference in fitted parameters or resulting
model penumbra broadening was found.
The effect of these LSFs on penumbra widths as encoun-
tered in practical situations was investigated by the calcula-
tion of the broadening of model penumbras of various steep-
ness; Fig. 8. For both energies, 6 MV-X in Fig. 8a and 25
MV-X in Fig. 8b, two experimental penumbra broadening
curves are shown, based on different experimental setups.
The distance between the experimental curves is indicative
for the experimental uncertainty. Taking this uncertainty into
account, it is concluded that the LSFs as calculated by our
analytical model underestimate the penumbra broadening of
an IC15 detector by approximately 0.5 mm in a 6 MV-X
primary x-ray beam and by 1 mm in a 25 MV-X primary
x-ray beam.
Equation 4 was directly derived from geometrical con-
siderations. Nevertheless, it can be questioned whether the
various terms are meaningful for the determination of beam
penumbras of regular, macroscopic fields. This was studied
by fitting the reconstructed, calculated LSF 6 MV-X to
various simplifications of Eq. 4, subsequently excluding the
terms that represent the wall, central electrode, and Gaussian
tail. The results, shown in Fig. 9, indicate that the wall and
central electrode need not be included in the fit for this pur-
pose, in contrast to the Gaussian tail. However, the terms that
represent the wall and central electrode can become impor-
tant in the deconvolution of highly modulated fields, for in-
stance, near the thin end of a wedge.
In the literature a variety of methods have been applied to
study detector-induced penumbra broadening, and several
correction methods have been defined. A schematic over-
view of these methods is presented in Table IV, whereas
results derived from the literature are marked and included in
Fig. 8. Some results are discussed more extensively hereaf-
ter.
Detector size extrapolation of thimble ionization cham-
bers in air was employed by Dawson et al.,7 who came up
with an empirical rule for primary beam penumbra broaden-
ing of 0.5 cm per centimeter internal detector size. Strictly
speaking, the derived rule applies only for the studied experi-
mental penumbra width. The results of their study in 6
MV-X and 31 MV-X beams have been indicated with points
FIG. 9. The effect of the respective terms of the LSF Eq. 4, 6 MV-X to
the broadening of model penumbras. The two marked solid lines represent
penumbra broadening due to a LSF that was fitted without wall and central
electrode terms no wall, no ced, and to a LSF that was fitted to an elliptic
function only eff. radius based, respectively. The other lines are identical
to the lines in Fig. 8a.
Medical Physics, Vol. 28, No. 5, May 2001
VI.  Detector Line Spread Functions 91
marked D in Figs. 8a and 8b, ignoring in the latter case
the difference in beam energy. As indicated in subsequent
studies,28,29 the underlying assumption that detector size is
the dominant factor in penumbra broadening becomes ques-
tionable at small detector sizes. The real dose penumbra
width is thus expected to be larger than their extrapolated
measured penumbra width. Based on another study,6 a dif-
ference of 0.3 mm seems a realistic estimate. The arrows in
Fig. 8 indicate the direction in which the result is expected to
move when considering this difference.
Garcı´a-Vicente et al.8 concluded that a Gaussian LSF
gives a better agreement between the convolved dose profile
and the fitted chamber profile than an elliptic LSF. Their
results might seem to be in contrast with our study, in which
the elliptic term dominates the small Gaussian term in the
central part of both the experiment-based LSFs and the
model-based LSFs. However, the explanation for this con-
trast lies probably in the sensitivity of the resulting penumbra
broadening for the height of the tail of the LSF profiles, as is
illustrated in the difference between the experimental curves
in Figs. 8a and 8b, which was mainly caused by a small
difference in the tail height of the response profiles, Fig. 4.
From the results of our study we consider the combination of
elliptic and Gaussian terms, Eq. 4, as optimal.
Charland et al.19 approached the determination of LSFs
by using EGS4 Monte Carlo calculations for a point x-ray
source in combination with measured detector profiles in a 6
MV-X 3030 mm2 beam at 15 mm depth. The penumbra
broadening that they found for an IC10 detector in this way
is included in Fig. 8a and marked with C. The best corre-
spondence of calculations and measurements was found with
an elliptic LSF with radius 4.6 mm. However, as they indi-
cated, the finite size of the linac source is inevitably included
in this LSF. The arrow in Fig. 8a indicates the direction in
which the result will move when the source size would be
taken into account.
It can be concluded that the penumbra broadening curves,
Fig. 8, as derived with the experiment-based LSFs are in
good agreement with the reported data, taking the in-between
distance of the curves as an indication for the experimental
uncertainty. While the curves were intended to assess impact
and accuracy of LSFs and to allow a comparison to litera-
ture, it must be clearly noted that the curves, in contrast to
the LSFs, apply only to field edges with a low out-of-field
tail, such as found in practice at the depth of dose maximum.
In penumbras with higher tails, the curves do no longer rep-
resent the actual penumbra broadening. Nevertheless, taking
Fig. 8 as a critical example, it can be concluded that the
model-based LSFs underestimate penumbra broadening by
approximately up to 0.5 and 1.0 mm for 6 MV-X and 25
MV-X, respectively. This presents for a dose penumbra
width of 3 mm typically for a profile at dose maximum an
improvement of approximately 1 mm in comparison to a
size-based  6 mm LSF and typically 2 mm in comparison
to the use of uncorrected IC15 profiles. A further improve-
ment would require a better description of the tails of the
LSFs, which is restricted in this analytical model by the ap-
proximations of small-angle multiple-scattering and electron
range cutoff.
D. General applicability
The present and previous10 study concentrate on detector
response of dosimeters in a primary x-ray beam, which is
clinically best comparable to the situation at dose maximum.
In this section, the general applicability of the studied dosim-
eters, ionization chamber, diode, and diamond, also at other
depths, is discussed.
The primary dose is the component with the sharpest
edge,30 and at depths of practical interest it is the dominant
contribution. It can thus be hypothesized that a correction for
the detector LSF of the total dose profile is a good approxi-
mation for the application of this correction on the primary
dose profile only. This hypothesis was tested for the IC15
chamber by deconvolution of various calculated 6 MV-X
dose profiles at depths in between 15 and 200 mm in square
fields of 50 up to 200 mm size. The profiles were calculated
by our treatment planning system, Helax TMS 5.1 MDS
Nordion, Canada, using IC15 measurements as basic beam
data. As this treatment planning system provides a separate
calculation of the primary dose,30 corrections applied to the
total dose profile or to the primary dose component only
TABLE IV. A schematic overview of studies of penumbra broadening caused by detector effects. The results of
this table are included in Fig. 8 as points that are labeled according to the first column. The second column
shows the corresponding literature reference numbers. Refer to the text for a more detailed discussion. Lines
marked  present additional measurements that were performed at dose maximum in square fields of 50, 100,
and 200 mm width. The subsequent columns indicate the applied method and beam energy, the detector and the
reference detector. When multiple detectors were used, the detector most similar to the IC15 chamber is
included.
Label Ref. Method Detector Reference detector
M 6 Measurement 6 MV-X Farmer chamber Diode corrected for size
D 7 Measurement 6, 31 MV-X Various chambers Size extrapolation
S 16 Geometrical considerations
C 19 Measurement 6 MV-X IC10 Monte Carlo calculation
R 31 Measurement 6 MV-X IC10 Diode
E  Measurement 6 MV-X IC15 Diode corrected for size
L  Measurement 6 MV-X IC15 IC15 corrected for LSF
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could be compared. The effect on the resulting 20%–80%
penumbra width differed on average less than 0.1 mm.
Therefore the important conclusion can be drawn that in
practice a correction of the total measured dose profile is
equivalent to a correction of the primary dose only.
Diodes, especially the unshielded types, are known to ex-
hibit an increased response at lower energies of which the
relative contribution grows with greater depths due to phan-
tom scattering. As this energy dependence is not studied
here, no general conclusions about the applicability of diode
LSFs at depths beyond the dose maximum can be drawn
from our study. Nevertheless, it can be stated that shielded
diode measurements can provide at the depth of dose maxi-
mum a valuable check of, e.g., deconvolved ionization
chamber measurements.
Diamond detectors show a direct photon response, which
has been reported24 to contribute 27% to the detector re-
sponse in a 6 MV-X macroscopic beam. The effect of this
direct photon response on fictitious penumbra sharpening
was assessed in the constructed macroscopic primary beam
that was described in Sec. V C. In this beam, with 1.5 mm
20%–80% penumbra the diamond detector would measure
0.5 mm too little penumbra width. In this case, the magni-
tude of this fictitious penumbra sharpening is comparable to
the lack of penumbra sharpening of a profile measured by an
IC15 and corrected for its modeled LSF.
VI. CONCLUSIONS
The analytical model that was described in the previous
study10 has been extended successfully to include effects of
ionization chamber response in primary x-ray beams. In this
extension several physical aspects have been taken into ac-
count: the electron traveling direction at the entrance surface
of the detector and the corresponding expected pathlengths
through the dosimeter, the replacement of medium by detec-
tor air, and the effect of the detector wall and central elec-
trode density on the recoil of Compton electrons. The re-
placement of the medium by air and the presence of a wall
and a central electrode were seen to affect the calculated
detector response functions. A verification of these response
functions with experiments in the telescopic slit geometry
yields experimental detector response curves with a maxi-
mum uncertainty of 3%, which occurs in the tails of the
curves. The model-based response profiles agree with the
experimental profiles to within 0.2–0.4 mm width FWHM,
depending on detector and energy.
The shielded diode was shown to require only a small
size-based correction in a beam in which contributions other
than primary dose are negligible, i.e., comparable to a depth
of dose maximum. Shielded diode measured profiles can
thus, at least at the dose maximum, be used to check LSF-
deconvolved ionization chamber measurements. From this
study conclusions about the use of diodes at other depths
cannot be drawn.
Line spread functions have been determined and a set of
model penumbras has been constructed to assess the effect of
these model-based LSFs on penumbra broadening. These
model penumbras have a low tail level, comparable to beam
dose profiles that exist at a depth of dose maximum. At a
dose penumbra with a width of 3 mm typical for profiles at
the depth of dose maximum, the model-based LSF yields a
penumbra broadening of approximately 2 mm, while experi-
mentally 2.5 mm is found in a 6 MV-X beam. In a 25 MV-X
beam the corresponding figures are 2 vs 3 mm. With the
readily applicable correction for the LSF, this broadening of
up to 2 mm is eliminated, so that an ionization chamber like
the IC15 can be well applied as a routine dosimeter in con-
formal radiation therapy, thus combining a well-established
standard for dosimetric measurements with an accurate de-
scription of penumbras.
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Abstract
Monte Carlo simulations have been performed to determine the influence
of collimator-scattered protons from a 150 MeV proton beam on the dose
distribution behind a collimator. Slit-shaped collimators with apertures between
2 and 20 mm have been simulated. The Monte Carlo code GEANT 3.21 has
been validated against one-dimensional dose measurements with a scintillating
screen, observed by a CCD camera.
In order to account for the effects of the spatial response of
the CCD/scintillator system, the line-spread function was determined by
comparison with measurements made with a diamond detector. The line-spread
function of the CCD/scintillator system is described by a Gaussian distribution
with a standard deviation of 0.22 mm.
The Monte Carlo simulations show that protons that hit the collimator on
the entrance face and leave it through the wall of the aperture make the largest
scatter contribution. Scatter on air is the major contribution to the extent of the
penumbra.
From the energy spectra it is derived that protons with a relative biological
effectiveness greater than 1 cause at most 1% more damage in tissue than what
would be expected from the physical dose.
1. Introduction
Accurate dosimetry with high resolution in small (∅ < 3 cm) radiation fields can be subject to
various perturbations (Beddar et al 1994, Chang et al 1996, Garcia-Vincente et al 1998, van ’t
Veld et al 2000). A frequently occurring effect in such situations is an (apparent) decrease of
the maximum observed dose Dmax in the centre of the field, which may be several tens per
cent. The observed decrease in Dmax can be a real decrease in the dose caused by phantom
scattering, air scattering or secondary particles, but it may also be an instrumental effect in the
dosimetry system. Profiles of radiation fields with dimensions of the same order or smaller than
0031-9155/01/030653+18$30.00 © 2001 IOP Publishing Ltd Printed in the UK 653
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the ionization chamber (typically 5 mm) show a decrease in the measured Dmax, a broadened
dose distribution and a larger penumbra.
Irradiation treatments with small proton fields are usually applied in radiosurgery
(Vatnitsky et al 1999), treatment of ocular melanoma (Bonnet et al 1993) and recently also
in treatment of macular degeneration (Moyers et al 1999). Non-clinical applications of small
proton fields can be found in radiobiology. At the Kernfysisch Versneller Instituut (KVI)
radiobiology experiments are performed on the spinal cord of the rat, using 150 MeV protons.
The aim of these experiments is to determine the tolerance dose of the spinal cord for different
sizes of irradiation field. The field size varies from 2 mm to 20 mm along the spinal cord.
Dosimetric data needed for those experiments are Dmax and an accurate knowledge of the
dose profiles along the spinal cord. Since collimator scatter has a large influence on the shape
of the dose distribution in small proton fields, it should be understood in detail to be able to
control (e.g. minimize) the penumbra. This is in contrast to photon therapy beams, for which
collimator scatter generally accounts for less than 1% of the primary fluence (Ahnesjo¨ 1995).
A lot of work has been done to investigate similar effects in electron beams (Mills et al 1981,
ICRU 1984, Nilsson and Brahme 1986, Sandison and Huda 1989). However, the magnitude
of the influence of the scatter processes with electrons differs with protons due to the large
difference in mass.
Another effect of interest is the energy loss of the scattered protons, since low-energy
protons are known to have a relative biological effectiveness (RBE) greater than 1 (Paganetti
et al 1997). This paper reports on a Monte Carlo simulation study of the KVI radiobiology
beam line to investigate the formation of the penumbra and the effects of collimator scatter.
Simulation results have been compared with profiles through 2D measurements of the dose
distribution, on planes downstream of the collimator.
Dosimetry with high spatial resolution (Westermark et al 2000) is usually performed by
diodes, small ionization chambers (Schreuder et al 1997), film (Daftari et al 1999, Niroomand-
Rad et al 1996, Vatnitsky et al 1997), diamond detectors (Vatnitsky et al 1999) and recently
a miniature scintillating detector (Fluhs et al 1996, Le´tourneau et al 1999). Disadvantages of
these systems (except film) are the long measuring time for obtaining a complete 2D distribution
and in the case of film the time between measurement and read-out and its nonlinear dose–
signal relation. Here we present the application of a CCD/scintillator system (Boon 1998, Boon
et al 1998) for 2D dosimetry in small radiation fields. The system consists of a fluorescent
(scintillating) screen and a CCD camera, which makes images of the distribution of light on
the screen. The system was originally developed for dosimetry applications in scanning beams
(Boon et al 2000), but it was found to be very useful and accurate for dosimetry in scattered
beams as well. Recently this system has also been used in electron beam dosimetry with small
applicators (Wilks and Soni 2000).
Since spatial resolution is essential in this work, a study of the spatial response of
this system has been performed. In the work of Boon et al it has been shown that the
influence of the spatial response of the system can be neglected for typical clinical field
sizes of 3 cm and larger. For smaller field applications, more accurate information on the
dependence on the collimator of the relationship of dose to monitor units was needed. Therefore
dedicated measurements of the spatial response have been performed by comparing profiles
of small fields obtained with the CCD/scintillator system with those measured with a diamond
detector.
The aim of this study was to determine the spatial response of the CCD/scintillator system
and to use the system to verify Monte Carlo simulations. These simulations calculate the
influence of collimator scatter on the homogeneity and penumbra of irradiation fields. The
results of these measurements were compared with Monte Carlo simulations.
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2. Materials and methods
2.1. The beamline
One of the beamlines from the AGOR cyclotron (Gale`s 1987) at the KVI has been set-up for
radiobiology studies as well as for investigations of instrumentation aspects of proton therapy
(van Luijk and Schippers 1997). Proton beams of 150 MeV are extracted from the AGOR
cyclotron. The proton beam energy was not degraded or modulated. A fast electrostatic beam
stop was placed between the ion source and the cyclotron to start and stop the irradiation.
A homogeneous irradiation field with a maximum diameter of 8 cm is obtained by a
dual-scattering system, consisting of a flat lead foil (1.44 mm thick) and a tungsten foil which
decreases in thickness from the beam axis towards the edges (Grusell et al 1994) (maximum
thickness 1.03 mm). The distance between the scatter foils is 35 cm. A collimator between
the scatter foils confines the beam radius to the radius of the second foil.
In the radiobiology experiments, the rat spinal cord is positioned 15 cm downstream of the
final, field shaping collimator. In this paper we will refer to this point as ‘the isocentre’. The
45 mm thick brass collimator will be referred to as ‘the patient collimator’. The distance from
the rat to the virtual proton source, located approximately half-way between the two scatter
foils, is 3.0 m. Between the second scatter foil and the patient collimator several additional
collimators are placed to intercept tails of the beam and to confine the beam to the outer maxi-
mum radius of the patient collimator. Measurements of the spatial resolution were made at the
isocentre, using a patient collimator of 2×100 mm2. For the collimator-scatter study the aper-
tures used were in the range from 2×100 mm2 to 20×100 mm2. The slit length of 100 mm was
chosen to minimize the effects of alignment errors and to allow effectively a one-dimensional
analysis of the dose profiles perpendicular to the slit. These measurements were performed
with the CCD/scintillator system, with screen positions at 2.5, 7.5 and 15 cm downstream of
the patient collimator. We therefore report the dose to the scintillator placed in air.
2.2. Dosimetry equipment
In the beamline two home-made parallel-plate ionization chambers are used as dose monitors.
The current from these air-filled ion chambers is proportional to the beam intensity. Therefore,
the integrated current from the ionization chamber is proportional to the deposited dose in the
target volume (e.g. the spinal cord).
For small fields in particular it is well known that the conversion factor from monitor units
into target dose depends on the size of the irradiation field. In the spinal cord experiments at
the KVI a system consisting of a scintillating screen and a CCD camera is used (Boon et al
1998). The scintillating screen (Lanex fine, Kodak, Gd2O2S:Tb), converts dose to light and the
CCD camera provides a 2D image of the light pattern. The camera is equipped with a 100 mm
lens that yields a resolution of 0.175 mm at the screen per camera pixel. The screen was
mounted perpendicular to the beam direction and attached to the back of a 0.5 mm thick sheet
of polystyrene. The total distance between the screen and the camera via the mirror was 220 cm.
The images taken with the CCD camera need some processing before the dose profiles
can be extracted. Offsets are compensated by subtraction of an image taken without the beam.
Isolated pixels with a large signal due to direct interactions of neutrons and gamma rays with
the CCD are corrected by filtering the image with a median filter (Mathworks 1997). This
filter replaces a pixel value by the median value of the 3× 3 pixel environment. It is important
to note that this filtering process does not influence the important features of the image, such
as amplitudes and gradients (Barkhof et al 1999). When necessary the light output can be
calibrated to absolute dose by comparison with a reference dosimeter. Scintillators show a
VII.  Collimator scatter and 2D dosimetry in small proton beams 99
nonlinear response as a function of stopping power (Boon et al 1998). In the discussion
section it will be shown for Lanex and the energy spectrum at the KVI that this nonlinearity
can be neglected in this study.
In general, the presence of a non-negligible spatial response causes a ‘blurring’ of the
signal over a larger area in the image, which results in a decrease of the signal in the centre of
the field and an increase in the penumbra. For fields down to diameter of 30 mm, the study
of Boon et al (1998) showed that the spatial response of the CCD/scintillator system did not
decrease the measurement of Dmax by more than the measurement accuracy of 1% per pixel.
As a worst-case estimate this would correspond to a Gaussian spatial response function with a
full width at half maximum (FWHM) of 5.5 mm, in one dimension. In the case of a 2×100 mm
field this would cause a decrease in output of 66%. This illustrates that more accurate data on
the spatial response are needed for use in the required field size range.
To measure the spatial response of the CCD/scintillator system, the dose profile measured
with the CCD/scintillator system is compared with measurements made with a diamond
detector. We have chosen to use a diamond detector because of its high output and good
linearity compared with a diode. Note that a spatial response measured like this includes all
blurring effects in the set-up, such as light scatter in the scintillator, distortions in the lens and
blurring due to possible imperfect surface conditions of the mirror.
The diamond detector (PTW 60003) has a sensitive volume of a few cubic millimetres.
Its spatial resolution is optimal when it is irradiated perpendicular to the axis of the cylinder
containing the sensitive volume. In that direction, the detector size is specified to be between
0.1 and 0.4 mm. An x-ray image (van ’t Veld et al 2000) indicated that the thickness of the
sensitive volume of our diamond detector is at most 0.3 mm.
2.3. Spatial response
Due to the long length of the slit perpendicular to the scan direction, the spatial response can
be studied in one dimension. Note that for analysing one-dimensional profiles it is sufficient
to use the line spread function (LSF) of the system instead of the point-spread function. First it
has been investigated whether the diamond detector behaves sufficiently like a ‘point detector’
for field sizes down to the smallest field size we use (2 mm). To a good approximation the
following detector LSF applies when the detector axis is perpendicular to the beam and along
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in which a is the width of the sensitive volume (0.3 mm) and the subscript d refers to the
diamond detector. In principle the beam profile, as measured with the diamond detector, can
be deconvolved with this LSF. But since such a procedure is very sensitive to noise in the
measurement, an iterative approach is used. First an estimate of the real dose distribution is
made. This estimated distribution is convolved with the LSF given by equation (1). The initial
estimate is subsequently improved based on the difference from the measurement, until the
change of the mean absolute difference of the convolved estimate with the measurement is less
than 0.01% per iteration. The difference between the best estimate of the real dose distribution
and the measurement indicates the influence of the spatial response of the diamond detector.
In the results section it will be shown that the influence of the LSF of the diamond detector
is small and can be corrected for, so the corrected profiles can serve as a reference for the
CCD/scintillator system.
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The LSF of the CCD/scintillator system may be derived from the difference between each
detector measurement for the same collimator. To model the LSF the sum of a broad and
a narrow Gaussian is often used. However, for the CCD/scintillator system under study no
indication was found for a broad component (Boon et al 1998). Therefore, it can be assumed
that the LSF of the CCD/scintillator (subscript s) system may be described by a single Gaussian
distribution:





2/2σ 2 . (2)
A reference profile (deduced from the measurement with the diamond detector) is
convolved with the assumed LSF. In an iterative process the parameter σ of the LSF is
changed until the mean absolute difference of the convolved diamond profile and the screen
measurement is minimized. This yields the LSF of the CCD/scintillator system, which is used
to correct the CCD/scintillator profiles prior to comparison with the simulation results.
The method applied to do this correction is an iterative reconstruction algorithm normally
used in SPECT reconstruction (Shepp and Vardi 1982).
2.4. Monte Carlo simulations
In a Monte Carlo simulation all types of scatter contributions can be registered separately.
Collimator scatter can be divided into several categories (figure 1) that define the particle
trajectories to and from the collimator. Scattered particles in each category have a different
effect on the dose distribution downstream of the collimator. Part of the simulation has been
implemented using the Monte Carlo code library GEANT version 3.21. This code has been
developed for nuclear and high-energy physics applications and it has been shown that it can
also be applied successfully in the energy range used for proton therapy (Paganetti 1998,
Gottschalk et al 1999).
The simulated set-up is depicted in figure 1. Protons start their trajectory at the entrance
face of the first scatter foil. Different diameters of the simulated proton source were used to
investigate the influence of the initial beam size and it was found to be negligible. Also the
initial angular spread of the beam was set to zero, since it was very small compared with the
angular spread introduced by the scattering process. The interaction of the beam with the
dual-scattering system was simulated in 3D with a separate code that is based on Highland’s
approximation (Highland 1975, Gottschalk et al 1993) of multiple scattering theory (Molie`re
1948), labelled ‘foil code’. In this ‘condensed history’ approach, the actual scatter angles of
the protons were calculated using a random generator with a normal distribution. The random
generator is based on the random generator GRNDM in the GEANT library. The known
starting positions and the first scattering angles determine the incident spatial positions of the
protons on the second scatter foil. The second foil has an inhomogeneous shape, designed
to obtain a homogeneous dose distribution at the isocentre. Therefore, the second scattering
process is sensitive to the position of the impact on this foil.
The output of the foil code is interfaced as input to GEANT for further transportation of
the protons through air towards the patient collimator. Both the energy loss and number of
protons that arrive downstream of the patient collimator are scored in a 1.0 mm thick layer of
water to determine their contribution to the dose. We thus calculate the dose as measured with
a water equivalent detector of 1 mm thickness, placed in air.
Three distinct categories are sampled. The first category is for protons that did not have
any interaction with the collimator (region 1 in figure 1). The second category is for protons
that hit the collimator, but scatter out of the material through the collimator inner face to reach
the plane of measurement. The protons from this second category are subcategorized into 2a,











Figure 1. The geometry simulated in GEANT consists of the dual scatter foil system and the patient
collimator. The particles arriving at the detector are scored in three categories: the unperturbed
beam (1), the entrance face scatter (2b) and the inner face scatter (2a). Category 3 consists of the
particles not arriving at the detector.
those that are initially incident upon the collimator inner face, and 2b, those that are incident
upon the collimator face at the source side (entrance face). The third category consists of
those protons that are incident on the collimator source-side face at more than 4 mm from
the edge of the aperture (figure 1). The simulations show that a proton in the third category
never reaches the plane of measurement and so it is discarded without further simulation or
registration. Note that the patient collimator is the only collimator in the simulation. All other
beam-limiting devices are designed for a beam of 8 cm diameter and their influence on a small
field is considered negligible.
The simulations were performed for different collimator to detector distances. The
influence of the air in the set-up on the penumbra has been investigated by comparison with
simulations with a set-up in vacuum. To investigate the influence of collimator scatter on the
RBE and its spatial distribution, the energy of the protons after interaction with the collimator
was registered.
A typical simulation used 107 proton histories, of which about 10–20% reached region 1
or 2. It required 7 h on a DEC 500 MHz Alpha station.
3. Results
3.1. Spatial response of the detector
A profile of a 2 mm field was measured with a diamond detector at the isocentre. Using the
iterative method described in paragraph 2.3 the LSF d,0.3 mm (equation (1)) was convolved
with a estimated shape of the real dose profile. The resulting profile is shown in figure 2 and



























Figure 2. The dose profile of a 2 mm field, 15 cm behind the collimator as measured with the
diamond detector. The profile corrected for the spatial response of the diamond detector shows a
dose which is less than 1% higher.
it can be seen that the deviation introduced by the instrument response function is about 0.6%
at maximum dose. This indicates that the diamond detector’s spatial response has only a very
small influence on the measured profile and this influence can be corrected for. The corrected
profile is used as the reference profile for the CCD/scintillator measurements.
Using the iterative method described in paragraph 2.3, the LSF of the CCD/scintillator
system has been found to be a Gaussian distribution with σ = 0.22 mm (see equation (2)).
Figure 3 shows a comparison between the reference profile and the (deconvolved)
CCD/scintillator measurement. For the optimal LSF the mean deviation of the convolved
reference profile and the CCD/scintillator measurement is only 0.75%.
3.2. Comparison of the Monte Carlo simulations with measurements
To validate the Monte Carlo simulation of the scatter process, the simulations are compared
with measurements. Figure 4 shows examples of this comparison for several fields at several
distances from the collimator. In figure 4(a), profiles at the collimator exit are shown. In
this figure it can be seen that the correspondence of the simulations to the measurements is
excellent, apart from a slight deviation in the penumbra. This can be explained by the extreme
sensitivity of the penumbra to the actual distance to the collimator at the collimator exit and
the spatial resolution of the detector. The latter effect is corrected for, but some small artefacts
may have remained (Snyder et al 1987).
In figure 4(c) dose profiles at 15 cm from the collimator are shown. The agreement of
the simulations with the measurements is good. This includes the steepness of the penumbra.
The maximum error is found in the tails of the 20 mm field. In figure 4(b) the intermediate
distributions at 7.5 cm behind the collimator are shown, for the 20 mm and 2 mm fields, which
also show good agreement.
3.3. Scatter contributions
In the simulation the different scatter contributions have been scored. The dose distribution
immediately at the exit of a 20 mm slit is depicted in figure 5. Here it can be seen that protons




















Figure 3. The dose profile of a 2 mm field, 15 cm behind the collimator as measured with
the CCD/scintillator system. From this measurement the true dose profile is obtained by the
deconvolution procedure as described in the text. For comparison the measurement with the
diamond detector, corrected for its LSF, is also shown.
entering the collimator through the entrance face and leaving it on the inner face makes a rather
large contribution to the dose distribution: the contribution of the ‘scatter ears’ or ‘horns’ is
20% of the total dose. The scatter on the inner face of the slit only has a contribution of
comparable magnitude (15%) in a small region in the direct proximity of the collimator edge.
A close inspection of the spatial distribution shows that this contribution is also present behind
the collimator material, although not more than 3 mm from the aperture.
Figure 6 shows the dose distribution 15 cm downstream of the slit. Here, it can be seen
that the inhomogeneity caused by the entrance face scatter has disappeared. The entrance face
scatter is spread over the entire field, adding about 5% to the dose of the unperturbed beam.
The spread in the inner face scatter is much less. It is still concentrated close to the projection
of the collimator wall and contributes locally about 2.5–3% to the total dose.
The contribution of entrance face scatter to the dose distribution thus changes with distance
from the collimator. Figure 7 shows a plot of the dose on the central axis as a function of
the distance to the collimator. Figure 8 gives a complete overview of the evolution of the
different contributions to the dose distributions. Note that the grey scales are normalized per
contribution. In the undisturbed part of the beam it can be seen that the penumbra increases
gradually when moving away from the collimator. Also the maximum dose decreases due
to the divergence from the virtual source. The scatter contribution of the entrance face is
well localized, but spreads over the dose distribution very fast. The inner face scatter is very
localized and shows little spread.
3.4. Air scatter
By default the simulations were carried out with the beam travelling through air. To investigate
the influence of air on the penumbra, simulations of the beamline in a vacuum were also
performed.
The variation of the penumbra (20–80%) as a function of the distance to the collimator
is shown in figure 9. In air the penumbra increases by 0.054 mm per cm distance from the
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apertures 2, 4, 8 and 20 mm
c)  15 cm behind collimator
Figure 4. Comparison of measurements (CCD/screen, dots) and simulations (curves) for several
field sizes and distances to the collimator. Note that for clarity of display the 4 mm, 8 mm and
20 mm profiles were given an offset of 0.2, 0.4 and 0.6 respectively.
collimator. In vacuum the penumbra increases by 0.013 mm per cm. The offset of about
0.12 mm is caused by the fact that the bin size in the simulations was 0.2 mm.
In the same plot the penumbra of the total dose distribution is also plotted for air. It can be
seen that the maximum difference from the penumbra of the direct beam is only 0.08 mm. Note
that the variation in difference is fully explained by the bin size and noise in the simulations.
The position of the virtual source can be derived (ICRU 1984) from the change in lateral
position of the 50% dose level. The virtual source is at the position where the extrapolation of
the 50% dose crosses the beam axis. In a vacuum we find the source to collimator exit distance
to be 3.2 m, and in air it is 3.0 m. Backprojection of the 20% and 80% dose levels gives an









































Figure 6. A cumulative plot of the dose components in a simulated 20 mm field at 15 cm behind
the collimator.
estimate of the virtual source size. For the simulations in vacuum the effective source size is
4 mm. In the set-up in air it is found to be 18 mm.
3.5. Position versus energy distribution of the scattered protons
In a simulation of a 20 mm field the energy of the scattered protons was registered 2.5 cm
behind the collimator. The dotted curve in figure 10 shows the energy spectrum in the dose
distribution for the entrance face scatter. The dashed curve shows the energy spectrum of the
protons scattered from the inner face. Both are expressed in particle fluence per energy bin.
From this figure it can be seen that the energy of the protons emerging from the inner face
scatter remains greater than 40 MeV for 96% of the protons. For the entrance face scatter the
distribution is much broader. The mean energy after entrance face scattering is about 50% of
the beam energy.
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Figure 7. Relative dose on the beam axis as a function of the distance from the collimator in a
4 mm field and a 20 mm field.
Figure 8. Evolution of the different components of the dose distribution of a 20 mm field as a
function of the distance from the collimator. Note that each plot is normalized to its own maximum.
To investigate the contribution of the different proton energies to the dose, the particle
fluence curves were multiplied with the energy-dependent stopping power of protons in water.
The resulting curves were normalized to the maximum of the sum of both scatter contributions
and plotted with a dash-dotted curve (inner face scatter) and a dashed curve (entrance face
scatter) (figure 10). The plots show that although the number of low energy protons is small
they contribute most to the dose.
Figure 12 shows the positional dependence of the energy spectrum for both scatter
contributions. Here, it can be seen that the majority of the protons in the scatter ears have
energies above 40 MeV. Also, it can be seen that the protons with an energy lower than
40 MeV are spread rather homogeneously over the dose distribution.
4. Discussion
4.1. The spatial response of the detector
In this study it is shown that the spatial response of the diamond detector has a small (0.5%)
correctable influence on the measured Dmax of a 2 mm profile. To get an indication of the
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Figure 9. Evolution of the penumbra (20–80%) as a function of the distance to the collimator. The
undisturbed beam consists of particles that are in region 1 in figure 1.
Figure 10. Energy spectra expressed in relative particle fluence per energy bin, integrated over a
20 mm field resolved for the different scatter contributions (solid curve and dotted curve) at 2.5 cm
behind the collimator. The relative dose deposited for each particle energy is also plotted (dashed
curve and dash-dotted curve). Both the energy spectrum and the dose curves are normalized to the
maximum of the sum of the absolute curves. Thus the relative contributions of the inner face and
entrance face scatter curves can directly be read from the plot.
influence on measurements in smaller fields, dose profiles were constructed using two error
functions to describe both penumbras. The penumbra of the larger fields was matched to the
20 mm slit measurement. These profiles were convolved with the LSF of the diamond detector.
The result of the measured value ofDmax as a percentage of the realDmax is shown in figure 13.
Here it can be seen how the detector effect on the measured Dmax increases for fields smaller
than 2 mm. With a slit size of 1 mm its magnitude is about 1%.
The LSF of the CCD/scintillator system is well described by a Gaussian distribution with
σ = 0.22 mm. For applications in small-field dosimetry it is important to know how this
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Figure 11. Simulated dose profile 1.25 cm downstream of a collimator tilted by 1◦.
Figure 12. Spectral maps of the 20 mm field at 1.25 cm behind the collimator for both scatter
contributions. Note that the grey scale is normalized separately for each plot.
influences the results as a function of the field size. In figure 13 the measured value of the
maximum dose in a profile is shown as a function of the slit size. These values were calculated
using the same method as described for the diamond detector. It can be seen that for slit
sizes larger than 2 mm the deviation is less than 2% and for field sizes larger than 2.5 mm the
deviation becomes negligible.
4.2. Verification of the Monte Carlo simulations
From the data presented in figure 4 it was concluded that the Monte Carlo simulations are in
agreement with the measurements to within 2.5%. The penumbra is very sensitive property
of the simulated dose distributions. In the same figure it can already be seen that a very good
agreement is found. Also the significant (up to 7%) local dose increase outside the 2 mm field
agrees with the measurements both in level and in structure within the noise of the simulation.
It may thus be expected that other geometries can also be simulated with similar accuracy.
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Figure 13. Influence of the spatial response on the Dmax as a function of the field size as would be
measured by a 0.3 mm thick diamond detector (dotted curve) and the CCD/scintillator (full curve).
4.3. Analysis of collimator scatter
One of the aims of this study was to determine how the collimator scatter influenced the
penumbra and the field shape in general. From the simulations it was found that the penumbra of
the undisturbed beam mostly determines the penumbra of the total dose distribution. Therefore
we conclude that in our set-up the penumbra is totally determined by geometrical and air-scatter
effects of the primary beam. This means that optimization of the penumbra is achieved by
simply staying close to the collimator. However, when coming closer to the collimator the
dose distribution becomes inhomogeneous and the RBE may vary across the field. Therefore
the collimator scatter contributions need to be taken into account.
If one looks at the two scatter contributions in a 20 mm field (figures 5 and 6), the main
contribution is the entrance face scatter. In general it can be described as a separate beam
which contributes about 20% to the total dose at the collimator exit and it is aimed at an angle
of 6◦ towards the centre of the direct beam (figure 8). When moving further away from the
collimator, this scattered beam spreads fast and its contribution to the dose decreases. However,
it is important to note that the dose on the beam axis first increases to a maximum at ∼2.5 cm
(figure 7) (Gottschalk 1999) and decreases slowly at larger distances to the collimator. In a
larger field (e.g. 20 mm) the dose increases until the ‘scatter ears’ have merged. In smaller
fields the peaks already coincide at the collimator exit and the dose on the central axis will
only decrease for increasing distance (see figure 4).
Note that in a scatter ear the relative dose increases due to the scattered particles is in
principle independent of the aperture size. At any distance it contributes with a flux to the
direct beam which is independent of aperture size and which has a fixed flux as well, because
the amount of irradiated collimator material that contributes to the dose remains the same (in
one dimension).
The relative contributions of the different types of collimator scatter are dependent on
set-up parameters. For example in a set-up where the virtual source is closer to the patient
collimator the importance of inner face scatter will become more important.
The thickness of the collimator only influences the inner face scatter contribution, as it
increases the solid angle of the inner face of the collimator but not the escape probability of
the protons entering the entrance face of the collimator.
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Collimator alignment also has some influence on the field shape. The inner face scatter
is proportional to the number of protons that hit the inside. Misalignment of the collimator
increases the solid angle covered by one collimator edge and decreases the solid angle of
the opposing edge, thus introducing an asymmetric contribution from the inside scatter. The
entrance face scatter is dependent on the probability that a proton escapes from the edge after
entering from the entrance face. This probability depends on the range of multiple scatter angle
that results in escape. At one edge a tilt of the collimator decreases the size of the angular
range in which a proton would escape. At the opposing edge, however, it increases.
To show the influence of misalignment on both scatter contributions a 40 mm field was
used, in order to separate the scatter contributions on both edges of the field. In figure 11 a
profile at 1.25 cm behind a collimator tilted by 1◦ is shown. This reduces the entrance face
scatter and increases the inside scatter on the right-hand side of the field. The dose tail behind
the collimator on the right-hand side of the field is characteristic for misalignment, since inside
scattering is increased a lot on one side. This was not observed in the measurements. Therefore
it is concluded that the alignment of the collimator was better than 1◦.
4.4. Analysis of air scatter
As expected, we found that the penumbra increases much faster with the distance to the
collimator when the beam goes through air as compared with a vacuum. In section 3.4 we
showed that the influence of air can roughly be described by a small change in virtual source
position and a large change in effective source size. The beam in a vacuum can be described
by a source of 4 mm at about 3 m distance. This corresponds to an angular spread of 1.3 mrad.
According to Highland’s formula the standard deviation of the Gaussian-shaped scatter cone
due to 3 m of air is 4 mrad. So air scatter between source and collimator makes a contribution
which is at least as large as the contribution of the source size to the penumbra. This implies
that insertion of vacuum sections to the beamline will improve the penumbra. Alternatively
one may use helium-filled beamline sections, similar to that already applied in the Scanditronix
MM50 racetrack microtron (Masterson et al 1994, Karlsson et al 1991).
4.5. Energy and RBE considerations
If we use the model as employed by Paganetti et al (1997), it can be assumed that the RBE
is 1 for protons over 40 MeV. The RBE increases more or less linearly to 1.2 as the energy
decreases towards zero. The absolute RBE values of course depend on the biological endpoint.
From figure 10 it can be seen that about 40% of the scatter dose is deposited by protons with
RBE > 1. At 1.25 cm from the collimator the dose contribution from collimator scatter is
about 13%. From figure 12 it can be derived that 40% of the dose of these protons comes
from protons with increased RBE. However, it is also found that these low-energy protons are
spread homogeneously over the field, so that the RBE effects are diluted. At a distance of
1.25 cm from the collimator only about 5% of the dose is deposited by protons with RBE > 1.
If we adopt the assumption that the maximum RBE for protons of more than 5 MeV is 1.2, the
biological damage to tissue would be only 1% larger than expected from the physical dose.
4.6. Nonlinear response of the screen to low-energy protons
It is well known that scintilators show nonlinear behaviour as a function of stopping power. In
a study of collimator scatter it is therefore important to have a closer look at the response of the
screen to different proton energies to get an impression of the accuracy of the CCD/scintillator
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system for collimator scatter measurements. For a worst-case estimate of the deviation between
the CCD/scintillator measurement and the dose distribution the profile of a 20 mm field at the
collimator exit was used.
The energy spectra presented in figure 12 were used to determine the stopping power
distribution. Quenching was applied on these stopping power distributions using Birk’s formula
(Boon et al 1998, Birks 1967). The quenched profile was normalized on the dose profile. The
maximum difference between those profiles was found outside the field. The difference was
10% of the local dose. There the dose is well below 10% of the central dose in the field, and
therefore this effect may be neglected as the difference is at most 1% of the dose in the field.
Inside the field the maximum deviation in the scatter contribution was 5%. This deviation
was found on the beam axis. There the contribution of scatter to the total dose is about 10%.
This means that the maximum deviation between a CCD/scintillator measurement and a dose
profile is at most 0.5–1% of the maximum dose, inside and outside the field respectively.
5. Conclusions
We have found that the LSF of the scintillating screen and the CCD camera can be described
by a Gaussian distribution with σ = 0.22 mm. This spatial response enables direct use at
field sizes larger than 4 mm whereas profiles in fields down to 2 mm can be measured with
a small (<3%) correction. This makes the scintillating screen a very suitable instrument for
dosimetry in small fields and it also allows accurate validation measurements of Monte Carlo
simulations.
The GEANT simulations show a very good agreement with the measurements with the
CCD/scintillator system. From the simulation it follows that in our scatter foil/collimator
system the entrance face scatter is the most important scatter contribution to the dose
distribution, but it is important to note that it has no influence of any meaning on the penumbra.
The influence of the collimator scatter on the RBE is at most 1% at 1.25 behind the collimator,
although the dose inhomogeneity from the entrance face scatter is about 20% there.
The influence of air scatter in the beamline is the major contributor to the penumbra.
Compared with a geometrical (vacuum) penumbra of 0.3 mm at the isocentre, the presence
of air causes the penumbra to increase to 1.1 mm. The combination of collimator scatter, air
scatter and geometry results in a trade-off between penumbra sharpness and field homogeneity.
In our set-up the optimum occurs at a distance of 4–5 cm behind the collimator, where the
20–80% penumbra is 0.5 mm.
We have shown that the Monte Carlo simulation is a useful and reliable tool for
investigating different properties of small irradiation fields in detail. We expect to find more
hints on penumbra improvement from these simulations.
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IX. A future perspective: plan accuracy
The results presented so far, including the papers II till VII, are all concerned with calculation
accuracy in one beam or with elements thereof. For the purpose of verification, the ‘physicist
point of view’, this is a natural starting point as this is the proper way to identify any possible
shortcoming in the calculation algorithms and their implementation. However, what
ultimately counts is the discrepancy in a complete treatment plan. From a clinical point of
view, the requirement might even be further specified as the total discrepancy in a region, a
target volume or an organ-at-risk, because an error might be more critical in some regions
than in others. Benefits can be expected from such a presentation of treatment planning errors
already during treatment planning, thus prior to and independent of any check at the treatment
machine. It should be noted that any treatment planning discrepancy in dose and/or position
presents a systematic error in the treatment, and as such deserves proper attention.
Measurements that are made for the purpose of verifying calculations of a treatment
system are usually done in a single-beam setup. In a recent study,  the spread in isodose1
distances, between various calculated and measured profiles in fields defined by collimators
as well as MLC and blocks, has been used to construct an indication of uncertainty in the 95%
isodose surface. However, the presented uncertainty represents the variation in accuracy in
that isodose position over the set of profiles that was considered, rather than defining the error
in an individual treatment plan at all relevant isodose levels. No clear link exists so far
between single-beam verification results and the presentation of accuracy in a complete
calculated treatment plan. In practice, a detailed reconstruction of error contributions is
seldom made; often it is the ‘expert opinion’ of a clinical physicist who is aware of
shortcomings in the calculations, upon which an estimate of a total plan (in)accuracy is based.
To overcome the inherent subjectivity in this practice, in this section the feasibility is studied
of a presentation of the total plan uncertainty based on the available verification data.
For the purpose of the feasibility study an extension to the regular verification software
was made, Fig. 1. For each beam in the treatment plan, a set of the most similar beams is
selected in the profile database, smaller as well as larger field sizes. The calculated and
measured profiles are scaled to the actual SSD and interpolated to the actual field size. By
interpolation, dose matrices are calculated in each CT plane for each beam, and these are
added using the beam weights in the actual treatment plan. Thus two dose distributions result,
one based on calculated profiles (CPD) and another distribution based on measured profiles
(MPD). The CPD is then assessed on agreement with the dose distribution calculated by the
treatment planning system (TPD). If a reasonable close agreement, e.g. ± 5%, exists between
TPD and CPD the difference CPD-MPD is taken as a representative estimate of dose
discrepancy (EDD) in the calculated dose. The EDD can also, similar to the field accuracy
concept in a single-beam setup, be converted to estimated plan accuracy (EPA), with pseudo-
unit [%;mm]. Furthermore, by selective sampling in regions-of-interest, regional EDD and
EPA distributions can be summarized as EDD and EPA volume histograms, respectively.
An example of such a presentation is created in the case of a prostate treatment based on
a CT-scan. A PTV has been drawn, for which the protocol defined by Zelefski et al.  was2
used, i.e by application of a 10 mm margin around the prostate, and 6 mm on the dorsal side
near the rectum. A treatment plan with three equally weighted partially wedged 15 MV-X
fields, one frontal and two lateral fields was created on the treatment planning system. In each
beam individual blocks were inserted to cover the PTV closely by the 95% isodose surface,
with 100% dose at the isocentre. The dose distribution as well as the delineated regions-of-
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Fig. 1 Schematic illustration of an extension of the regular verification program, Fig. 3 of
Chapter I. From a treatment plan created on the treatment planning system the relevant data are
exported. The treatment plan parameters are used to select the most similar single-beam cases from
the profile database. In the plan comparison module calculated and measured profiles are
interpolated and weighted alike to create two dose distributions, CPD and MPD, respectively. The
difference between these two is taken as an estimate of the discrepancy in the treatment planning
calculation, if the CPD is close enough to the dose distribution calculated by the treatment planning
system, TPD. The estimates may also be presented in terms of plan accuracy, the plan equivalent of
field accuracy of a beam, and be specified per region-of-interest.
interest, rectum and bladder, were exported from Helax-TMS 5.1.1. In this study no
distinction is made between rectum and bladder and their respective contents. The grid used
for the calculation was 1.0 mm to minimize grid interpolation artefacts. Because of memory
restrictions all comparisons were done at a 1.5 mm grid size.
The dose distributions TPD and CPD, the EDD distribution and the corresponding
estimated plan accuracy distribution are shown in Fig. 2 in an axial plane centrally in the PTV.
Note that the EDD includes all dose discrepancies, in ‘classical’ terms beam output, depth
dose and off-axis ratios, and thus represents absolute dose differences. Due to limited out-of-
beam lengths of measured scans in the profile library, dose distributions have been clipped
where insufficient profile length for any beam was available. The largest dose difference
CPD-MPD amounts 8.5% and is found at the dorsal field edge region in the rectum, Fig. 2c.
This corresponds to a small value of the distance-to-agreement and the discrepancy thus
decreases numerically to 2.0 [%;mm] in the plan accuracy distribution, Fig. 2d. The positive
EDD values in the rectum correspond to a CPD-dose that is higher than the MPD-dose. It can
thus be concluded that the dose in the rectum as calculated by the treatment planning system,
TPD, is overestimated by this amount. The overestimation is less than the discrepancies
shown in Chapter I, Fig. 2d because of the compensatory effect of discrepancies in blocked
fields with, Fig. 2d, and without, Fig. 2c, a wedge. However, other cases may be encountered
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Fig. 2 (a) Calculated dose distribution (TPD) in the central axial plane of a prostate treatment plan. The
delineated structures represent prostate, PTV, and rectum. (b) Dose distribution (CPD) constructed from
calculation profiles. The dose distribution (MPD) constructed from measured profiles looks much similar
and is therefore not shown. (c) Distribution of estimated dose discrepancy, EDD (d) Estimated plan
accuracy, EPA. The colour scales indicate percent dose, percent dose, percent dose difference, and
[%;mm], respectively. The minimum and maximum values are -0.9% and 8.5% in (c) and -0.7 [%;mm]
and 2.0 [%;mm] in (d). 
where such compensatory effects are absent, and this EDD presentation can then reveal
inaccuracies which have to be accounted for in the assessment of a treatment plan. 
In Fig. 3a the EDD volume histograms of PTV and rectum are shown. The average
values of the EDD are 0.6%, 1.4% and 0.5%, for PTV, rectum and bladder, respectively, the
minimum values are -0.1%, -0.9% and -0.8%, respectively. The maximum values are 2.4%,
8.5% and 3.2% respectively. The maxima are all located in the penumbra, for which
geometrical criteria are more appropriate. This is taken into account in Fig. 3b, where the
estimated plan accuracy (EPA) volume histogram of the rectum is show, which has an average
of 0.4 [%;mm], a -0.7 [%;mm] minimum and a 2.0 [%;mm] maximum. In this example, at
least for the indicated regions-of-interest, the treatment plan thus completely complies to the
±2% or 2 mm criterion mentioned in section 2 of Chapter I.
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Fig. 3 (a) Estimated dose discrepancy (EDD) volume histogram of PTV (thick line) and rectum
(thin line) corresponding to the same study as shown in Fig. 2. (b) Estimated plan accuracy (EPA)
in the rectum of this study. The delineated rectum volume was 99 cm .3
The relevance of this estimated dose discrepancy has been assessed by calculation of the
normal tissue complication probability (NTCP) for the rectum using the Lyman-Kutcher
model  with parameters from Burman et al.  (n=0.12, m=0.15, TD =80 Gy) corrected  for the3 4 550
dose per fraction (d =2.0 Gy, "/$=3.0 Gy ). Assuming a specified dose of 70 Gy in 2 Gystd -1
fractions, the NTCP corresponding to the TPD was 3.6%. After correction of the TPD by the
EDD, an NTCP value of 3.0% was found. This difference in NTCP is equivalent to a global,
prescription dose difference of 1 Gy or 1.4%, thus well within current criteria. As stated
before, other combinations of beams are likely to exist without mutual error compensation,
where discrepancies in dose or NTCP have clinical meaning and should be taken into account.
In the present feasibility study only a few corrections on the retrieved database profiles
are applied. Under circumstances this might be a crude approximation, comparable to
corrections applied in ‘classical’ treatment planning systems. For those systems it has been
shown in the past that omitted or simplified corrections may produce errors in dose
calculations of, for example, up to 7% in an obliquely incident beam.  In the build-up region6
discrepancies of up to 20% have been reported.  As an internal check, the correspondence6
between CPD and TPD within ± 5%, has therefore been included to assess the validity of the
EDD results. In the example case the CPD only failed this test in parts of the entrance regions
of the beams. These regions were already excluded as one or more profiles of the other beams
had limited length, indicated by the clipped distributions in Fig. 2b-d.
The calculations in a plan comparison like this study can be considered sufficiently
accurate when reasonably similar profiles exist in the profile database. Especially near the
beam weight point many possible errors cancel out due to the applied normalization.
Moreover, even in case of, for example, 5% discrepancy between CPD and TPD, the identical
handling of CPD and MPD results in merely 5% error in the estimated error in calculated
dose, i.e. 5% relative error in the EDD, which can still be considered as a good estimate of
plan dose discrepancy. 
It should be noted that calculation of EDD distributions does not render verification of
calculations in phantom situations superfluous, as such phantom verification might provide
clues for ‘dust traps’ that were not yet discovered by the combinatorial verification, thus
adding extra ‘grid points’ to be included in ‘verification space’.
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The intention of this study is not, as might be criticised, to build a kind of classical
treatment planning system for the purpose of verification of a modern treatment planning
system. It is meant to be a feasible way to convert verification results into a clinically
appreciable format. Furthermore, in conjunction with a monitor unit check program, which is
indeed an independent miniature planning system, a more comprehensive check might also be
performed of a dose distribution rather than just dose to a point. This could in particular be a
valuably extension for pre-treatment verification of IMRT plans, outside the central axis and
outside uniform dose regions which are limitations in recent publications.  7,8
In this section it has been shown that a comprehensive presentation of treatment plan
discrepancies during treatment planning is possible. Improvements are needed, for example to
overcome the clipping in Fig. 2. However, the EDD and EPA distributions and corresponding
volume histograms shown here present promising tools to prevent systematic treatment
planning errors at an early stage, during treatment planning.
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X. Discussion and conclusions
Knowledge about treatment planning accuracy is shown in the introductory section of this
thesis to be a crucial requirement for the enhancement of treatment planning capabilities, and
thus an essential condition to achieve the expected benefits of conformal radiotherapy.
In this thesis research has been performed to define the accuracy of dose and volume
calculations that are essential for conformal radiotherapy treatment planning. This concerns
especially the region where highest benefits are to be expected: the edges and shielded parts of
the beams. 
In Chapter III dose distributions calculated with pencil beam kernels in blocked fields
without a wedge have been verified and found to be correct mostly within ±3 [%;mm]. This
study defines the dosimetric basis of the first achievement, in historical perspective, of
conformal treatment: an improved confinement of the treated volume to the PTV by the
application of individual shielding blocks designed in Beam’s-Eye-View. It has been
documented that considerable errors can be found in blocked field calculations in current
treatment planning systems.  However, Chapter III shows that the investigated pencil beam1
model has an associated dose calculation accuracy in these cases that falls well within
accepted accuracy criteria of ±3% or 3 mm. In subsequent versions of the treatment planning
system the beam model has been further generalized, allowing broader applications to be
calculated with high accuracy,  however, at the expense of somewhat less accuracy in2,3
‘classical’ situations. This development and distinct energies explain the difference between
the Fig. 3a in Chapter III and Fig. 2c in Chapter I.
In Chapter IV a lung tumour geometry has been studied by phantom measurements, one
of the most challenging geometries in treatment planning. Large discrepancies, up to 21% in
megavoltage photon dose, between current pencil beam calculations and measurements were
found. The pencil beam model clearly does not properly take into account the increased
penumbra width in low density material and thus yields possibly a too low dose in, for
example, the PTV of a lung tumour. The classical approach to compensate for this effect is to
increase margins in lung tumour treatment, at the expense of unwanted normal tissue dose.4
This drawback is minimized in another approach, in which the beam size is reduced by
compensation of the penumbra.  However, in the lack of sufficient accuracy in current5,6
algorithms, the amount of compensation is usually based on general, and thus approximate
rules that have been derived for a limited set of geometries. In Chapter II the same lung tumour
geometry has been used to verify calculations with a point spread kernel algorithm. This
algorithm produces much better results, mostly within ±2% dose accuracy. This accuracy
allows more accurate, individual penumbra compensation in lung tumour geometries to be
based directly on treatment planning calculations.
In Chapters V and VI methods have been developed for high-resolution measurements
of beam edges with current ionization chambers, thus in particular suited for routine
verification measurements. By correction for the spatial response of such an ionization
chamber with the derived line spread functions, an improvement of up to 2 mm in accuracy in
the description of megavoltage photon penumbras (20%-80%) is achieved. This is
approximately 1 mm better than a correction function based on detector geometry  achieves.7
Note that 1 mm artificial penumbra broadening corresponds to an increase in volume of 12%
of a 25 mm radius sphere, representing, for instance, a planning target volume. The correction
functions derived in Chapters V and VI are currently applied on a routine basis for verification
measurements of treatment planning calculations.
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In Chapter VII a 2D detector, consisting of a scintillating screen and a CCD camera has
been verified for dosimetry purposes in proton beams. A line spread function was found to be
described by a Gaussian distribution with a standard deviation of 0.22 mm. This detector has
been applied to verify results of a Monte Carlo study into the contribution of collimator scatter
to the dose in small proton beams. Scatter on air is found to be the major contribution to the
extent of the penumbra. Nevertheless, very sharp penumbras (20%-80%) of 0.5 mm and less
could be created, allowing a dose deposition that is very sharply confined to the target volume.
In Chapter VIII the accuracy of grid-based volume sampling has been shown to be
dependent on the shape of the sampled structure. For a typical prostate, with volume 77 cm ,3
1050 grid points were required to obtain a 1% relative uncertainty in the sampled volume,
corresponding to a 4 mm grid size. Note that in the treatment planning systems that is used at
our hospital (Helax-TMS), volumes are sampled on a plane-by-plane basis in the dose
calculation planes, whereas separate grids for volume and dose volume histogram sampling
are used. In that case the results of area sampling, also described in Chapter VIII, should be
applied. Note furthermore that dose surface histograms and dose wall histogram have recently
been promoted  to sample hollow organs as bladder and rectum. The obvious advantage of8,9
these techniques is that a more evenly distributed set of sampling points can be obtained, thus
necessitating less points for the same accuracy. However, the data on rectum wall sampling in
Chapter VIII indicate that 1% and 5% relative uncertainty in the sampled wall volumes require
cubic grid sizes of approximately 2 mm and 4 mm, respectively, values that comply with the
normal usage of a treatment planning system.
With these fundamental issues in treatment planning accuracy defined, a comprehensive
procedure has been developed for the verification of treatment planning calculation accuracy,
and for the presentation of systematic dose calculation errors during treatment planning.
Important elements in this procedure are the concepts of combinatorial verification and field
accuracy. Combinatorial verification aims at discovering all possible ‘dust traps’ that might be
hidden in ‘verification space’. The multitude of field parameter combinations that has to be
explored, is handled via the implementation of a profile database and a comparison facility.
The field accuracy concept aims at simultaneous verification of dose and positional accuracy
criteria. A survey of available literature lead to the conclusion that accuracy criteria for
treatment planning calculations would ideally be 2% or 2 mm, whereas 3% or 3 mm is often
seen as presently acceptable. The field accuracy concept has proven to be a valuable
assessment tool to check compliance to these criteria. 
A new, extended application of this combinatorial verification is the presentation of
discrepancy estimates for entire treatment plans. The feasibility of this application has been
investigated in the case of a conformal prostate treatment plan. The results obtained in this
case have proven the possibility of a comprehensive presentation, in a clinically easily
appreciable way, of an estimated distribution of discrepancies in an entire treatment plan,
based on verified treatment planning accuracies. 
Summarizing, this thesis provides the knowledge that was required to define and
improve the accuracy of treatment planning calculations for conformal radiotherapy.
Furthermore, a verification programme has been designed to explore the combined influence
of beam parameters on calculation accuracy, commonly encountered in clinical treatment
plans. Finally, the feasibility has been confirmed of the presentation of the calculation
accuracy in individual treatment plans. 
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A literature survey in Chapter I of this thesis reveals that knowledge about treatment planning
accuracy is a crucial requirement for the enhancement of treatment planning capabilities, and
thus an essential condition to achieve the expected benefits of conformal radiotherapy. This
survey also indicates that accuracy criteria for treatment planning calculations would ideally
be 2% or 2 mm, and 1% or 1 mm in specific circumstances, whereas 3% or 3 mm is often
seen as presently acceptable.
Objective
The objective of this thesis is to define the accuracy of dose and volume calculations that are
essential for conformal radiotherapy treatment planning. This concerns especially the region
where the highest benefits are to be expected: the edges and shielded parts of the beams.
Results that were obtained apply to megavoltage photon beams in homogeneous and
heterogeneous tissue geometries, to proton beams, and to dose-volume representations.
Research
The context of this research is a verification programme that is conducted prior to the clinical
use of dose calculations performed by the applied treatment planning system. This programme
has to cover all combinations of beam parameters that are clinically applied, i.e., a so-called
combinatorial verification is required. The design and implementation of this programme is
described in Chapter I. Furthermore it has to be adapted to the characteristics of the treatment
planning system and its beam model. Chapter II describes how this has been achieved. 
In Chapter III dose distributions are calculated with pencil beam kernels in fields that
are partly shielded by a block. These distributions have been verified with measurements in a
water phantom and found to be correct mostly within ±3% or 3 mm, thus in compliance with
currently accepted accuracy criteria. A ‘field accuracy’ concept is presented which has proven
to be a valuable assessment tool to check compliance common accuracy criteria. 
In Chapter IV a lung tumour geometry has been studied by phantom measurements. This
presents one of the most challenging geometries in treatment planning. Large discrepancies,
up to 21% in megavoltage photon dose, between current pencil beam calculations and film
measurements were found. The pencil beam model clearly does not properly take into account
the increased penumbra width in low density material and thus yields possibly a too low dose
in, for example, the target volume of a lung tumour. In Chapter II the same lung tumour
geometry has been used to verify calculations with a point spread kernel algorithm in the same
TPS. This algorithm produces much better results, mostly within ±2% dose accuracy.
In Chapters V and VI methods have been developed for high-resolution measurements
of beam edges with current ionization chambers, thus in particular suited for routine
verification measurements.  In Chapter V analytical calculations are described that model the
transport of Compton recoil electrons. The model is verified with measurements with a
diamond detector in 6 MV-X and 25 MV-X photon beams in a telescopic slit geometry. It is
shown that the model is able to describe within 0.1 mm full-width at half-maximum the
primary dose profiles of an elementary slit x-ray beam. In Chapter VI this model is extended
to calculate detector response profiles of a thimble ionization chamber in megavoltage photon
beams. Electron travelling directions and energy upon incidence on the ionization chamber
and extra generation of Compton electrons in detector wall and central electrode are taken into
account. The model is verified with measurements with an ionization chamber in a telescopic
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slit beam geometry. It is shown that the model is able to describe detector response profiles in
an elementary slit beam within 0.2 mm and 0.3 mm for a 6 MV-X and a 25 MV-X beam,
respectively. The combination of dose profiles and detector response profiles yields the line
spread function for this type of detector. A maximum likelihood reconstruction technique and
a fit to a function based on the physical detector dimensions yielded parametric descriptions of
the line spread functions. By correction for the spatial response of such an ionization chamber
with the derived line spread functions, an improvement in accuracy of up to 2 mm in
megavoltage photon penumbras (20%-80%) is achieved. The correction functions derived in
Chapters V and VI are currently applied on a routine basis in the context of the verification of
treatment planning calculations.
In Chapter VII a 2D detector, consisting of a scintillating screen and a CCD camera has
been verified for dosimetry purposes in proton beams. A line spread function was found to be
described by a Gaussian distribution with a standard deviation of 0.22 mm. This detector has
been applied to verify results of a Monte Carlo study into the contribution of collimator scatter
to the dose in small proton beams. Scatter on air is found to be the major contribution to the
extent of the penumbra. Nevertheless, very sharp penumbras (20%-80%) of 0.5 mm and less
could be created, allowing a dose deposition that is very sharply confined to the target volume.
In Chapter VIII the accuracy of grid-based volume sampling has been studied. Such
volume sampling lies at the basis of a dose-volume histogram, an indispensable tool to
evaluate dose distributions in three dimensions. In a number of well-defined structures, a
sphere, a cylinder and a cube, an analytical description of the sampling accuracy could be
derived. These mathematically defined cases were used to verify a Monte Carlo model of
volume sampling. For typical clinical structures like a prostate and a rectum wall, cubic grid
sizes of 4 mm and 2 mm, respectively, were found to be required to obtain a 1% relative
uncertainty in the sampled volume. These grid sizes comply with current usage of treatment
planning systems.
A future perspective: plan accuracy
With these fundamental issues in treatment planning accuracy defined, the feasibility
has been investigated of the presentation of systematic dose calculation errors in entire
treatment plans during treatment planning. Important elements in this procedure are the
concepts of combinatorial verification and field accuracy. The results obtained in the case of a
conformal prostate treatment, Chapter IX, have proven that a comprehensive presentation can
be provided, in a clinically easily appreciable way, of an estimated distribution of
discrepancies in a treatment plan, based on verified treatment planning accuracies. 
Conclusion
Concluding, this thesis provides the knowledge that was required to define and improve
the accuracy of treatment planning calculations for conformal radiotherapy. Furthermore, a
verification programme has been designed to explore the combined influence of beam
parameters on calculation accuracy, commonly encountered in clinical treatment plans.
Finally, the feasibility has been confirmed of the presentation of the calculation accuracy in
individual treatment plans. 
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Samenvatting
Toelichting van enkele begrippen
Het doel van een radiotherapiebehandeling is vanouds het leveren van een voldoend hoge
stralingsdosis op het doelgebied (tumor met marge) met daarbij sparing van zoveel mogelijk
gezond weefsel. Alleen wanneer aan beide voorwaarden gelijktijdig wordt voldaan in een
lokaal proces, is er sprake van een succesvolle behandeling. Momenteel geneest in Nederland
ongeveer 50% van alle kankerpatiënten, van wie de helft door radiotherapie alleen of in
combinatie met chirurgie. Verdere verbetering is in een aantal gevallen mogelijk wanneer het
hoge-dosis gebied nog beter kan samenvallen (conformeren) met het doelgebied. Deze zgn.
conformatie radiotherapie heeft een eerste impuls gehad in de jaren ‘80 van de vorige eeuw,
met de introductie van de ‘Beam’s-Eye-View’, een mogelijkheid tot het projecteren van het
doelgebied per bundelrichting in het bestralingsplanningsysteem. Hiermee kan de dosis in
weefsels buiten het doelgebied worden gereduceerd door individueel gevormde afscherming. 
Een bestralingsplanningsysteem speelt een belangrijke rol in de voorbereiding van een
radiotherapiebehandeling. Op dit systeem worden bestralingsplannen ontwikkeld die zijn
toegesneden op de ligging en vorm van doelgebied en kritieke organen in een individuele
patiënt. Het planningsysteem moet daarbij alle vrijheidsgraden van het bestralingstoestel,
doorgaans een lineaire versneller, kunnen benutten, en tevens de dosisverdeling met hoge
nauwkeurigheid berekenen. Voorafgaand aan klinische toepassing van zulke berekeningen
dient hun nauwkeurigheid te worden vastgesteld. Dit proces heet verificatie. 
Verificatie kan nooit nauwkeuriger zijn dan de metingen die daarvoor worden gebruikt.
Het oplossend vermogen van de detector waarmee wordt gemeten is daarom van groot belang.
Nauwkeurige kennis van de ruimtelijke resolutie van de gebruikte detectoren is hiervoor
onmisbaar. De resolutie van een detector wordt beschreven door de zgn. lijn-respons functie,
de respons van de detector op een signaal van verwaarloosbare breedte.
Doel van dit proefschrift
Het doel van dit proefschrift is het bepalen van de nauwkeurigheid van dosis- en volume-
berekeningen bij bestralingsplanning die essentieel zijn voor conformatie radiotherapie. Dit
betreft in het bijzonder dosisberekeningen nabij de rand (penumbra) van de bestralingsbundels
en de dosis onder individuele afscherming (blokken).
Context van het onderzoek 
In hoofdstuk I wordt aangegeven dat een hoge nauwkeurigheid van dosisberekeningen een
voorwaarde is om de effectiviteit van radiotherapie verder te vergroten. Uit de literatuur kan
worden afgeleid dat de nauwkeurigheid voor berekeningen van een bestralingsplanning-
systeem idealiter voldoet aan criteria (1 standaarddeviatie) van 2% in dosis of 2 mm in positie,
terwijl vooralsnog 3% of 3 mm als acceptabel wordt gezien.
De context van het onderzoek is een verificatieprogramma waarin de nauwkeurigheid
van het gebruikte bestralingsplanningsysteem wordt vastgesteld. Het aantal controles dat in dit
programma moet worden uitgevoerd neemt sterk toe met het aantal vrijheidsgraden van een
bestralingsplanningsysteem en het spectrum aan klinische toepassingen. Niet alleen iedere
vrijheidsgraad, maar ook alle relevante combinaties van de veldparameters moeten worden
onderzocht. Het is nl. wel denkbaar, hetgeen ook met een voorbeeld wordt aangetoond, dat
voor iedere parameter afzonderlijk een acceptabele rekennauwkeurigheid wordt behaald,
terwijl de nauwkeurigheid niet acceptabel is bij de combinatie van parameters.. De inhoud en
de implementatie van deze zgn. ‘combinatorieke verificatie’ worden beschreven in hoofdstuk
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I. Daarnaast moet het verificatieprogramma worden toegesneden op de eigenschappen van het
gebruikte bestralingsplanningsysteem. Hoofdstuk II beschrijft hoe dit is gerealiseerd.
Experimenten
In hoofdstuk III wordt verslag gedaan van berekeningen van dosisverdelingen in een
gedeeltelijk afgeblokt fotonenveld met een zgn. ‘pencil beam model’, het standaardmodel in
het gebruikte bestralingsplanningsysteem voor de berekening van dosisafgifte. Deze
berekeningen blijken grotendeels binnen 3% of 3 mm in overeenstemming met metingen. In
dit hoofdstuk wordt ook het ‘field accuracy’ concept, met pseudo-eenheid [%;mm],
geïntroduceerd. Dit is een gecombineerde maat van afwijkingen in dosis en positie, waarmee
op eenvoudige wijze kan worden weergegeven of aan gangbare nauwkeurigheidscriteria wordt
voldaan.
In hoofdstuk IV worden berekende dosisverdelingen onderzocht van fotonenbundels in
een geometrie die model staat voor een longtumor. Het pencil beam model van het planning-
systeem is hierbij gebruikt. Zoals op basis van de beperkingen van het model kan worden
verwacht, geven de berekeningen grote afwijkingen, tot 21%, met de metingen te zien. De
berekeningen zijn herhaald met een zgn. ‘point spread model’, waarmee excellente resultaten
werden behaald, grotendeels binnen  ± 2%, zoals weergegeven in hoofdstuk II. In
tegenstelling tot het pencil beam model is met het point spread model een goede conformatie
van de dosisverdeling rond het doelgebied van een longtumor mogelijk.
In de hoofdstukken V en VI zijn methoden ontwikkeld om in de penumbra van
fotonenbundels met hoge resolutie dosimetrie te kunnen bedrijven met het meest gangbare
type detector, een ionisatiekamer. De beoogde toepassing hiervan is combinatorieke
verificatie. Dit brengt een zodanig grote hoeveelheid meetwerk met zich mee dat een
routinematig bruikbaar instrument als een ionisatiekamer daarvoor het meest geëigend is.
Echter, een ionisatiekamer heeft onvoldoende resolutie voor gebruik in de penumbra. Dit
wordt veroorzaakt door de ruimtelijke afmetingen van de detector en de daarin aanwezige
materialen die de meetomgeving beïnvloeden. Een voldoende nauwkeurige correctie hiervoor
was tot op heden niet beschikbaar. In hoofdstuk V wordt een analytisch rekenmodel
beschreven dat het transport van in water verstrooide Compton electronen beschrijft. De
uitkomsten van dit model zijn geverifieerd door metingen met een diamantdetector in
spleetvormige fotonenbundels (6 MV-X en 25 MV-X) in telescoopgeometrie. Gemeten en
berekende dosisprofielen bleken binnen 0.1 mm overeen te stemmen. 
In hoofdstuk VI wordt dit model uitgebreid zodat detector-responsprofielen van een
cylindrische ionisatiekamer in megavolt fotonenbundels kunnen worden berekend. Het model
is geverifieerd door metingen met een ionisatiekamer in dezelfde geometrie. Het model blijkt
in staat om detector-responsprofielen met een nauwkeurigheid van 0.2 mm (6 MV-X) en 0.3
mm (25 MV-X) uit te rekenen. Uit de combinatie van dosisprofielen en detector-
responsprofielen zijn de lijn-responsfuncties van de ionisatiekamer bepaald. De toepassing
van deze lijn-responsfunctie geeft een verbetering tot 2 mm in de beschrijving van megavolt-
fotonenpenumbra’s. Ter vergelijking, een afwijking van +1 mm in de bestraling van een
bolvormig doelgebied van 50 mm diameter leidt reeds tot een ongewenste toename van het
bestraalde volume van 12%. Met correctie voor de gevonden lijn-responsfuncties is de
onderzochte ionisatiekamer bruikbaar voor de beoogde hoge-resolutiedosimetrie.
Een verdere verbetering in conformatie radiotherapie kan worden bereikt door de
toepassing van protonenbundels. Zoals wordt beschreven in hoofdstuk VII kunnen daarmee
penumbra’s (20%-80%) van 0.5 mm en kleiner worden gemaakt. Dicht bij de laatste
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afblokking wordt de collimatorverstrooiing van belang. De bijdrage daarvan is bepaald met
Monte Carlo berekeningen. De berekeningen zijn geverifieerd met een twee-dimensionale
detector bestaande uit een scintillerend scherm en een CCD-camera. De lijn-responsfunctie
van deze detector is geverifieerd met metingen met een diamantdetector. De lijn-
responsfunctie bleek beschreven te kunnen worden met een Gaussische verdeling met een
breedte van 0.22 mm. De schermdetector blijkt een betrouwbaar gereedschap voor dosimetrie
in kleine protonenvelden.
Beoordeling van drie-dimensionale dosisverdelingen wordt aanzienlijk vereenvoudigd
door het gebruik van dosis-volumehistogrammen. Zulke histogrammen leveren vaak een
doorslaggevende bijdrage aan klinische beslissingen. De voor deze histogrammen uitgevoerde
berekening is een volumebemonstering van de dosis in een aangegeven structuur. De
bemonstering zelf geschiedt doorgaans op basis van een regelmatig rooster van punten. In
hoofdstuk VIII wordt de nauwkeurigheid van deze bemonstering bestudeerd. In een aantal
wiskundig gedefinieerde structuren, een bol, een cylinder en een kubus, is een analytische
beschrijving van de nauwkeurigheid afgeleid. Deze wiskundige modellen dienden vervolgens
om een Monte Carlo model voor bemonstering te verifiëren. Met dit model wordt aangetoond
dat voor een representatieve prostaat en endeldarmwand roosterafstanden van resp. 4 mm en 2
mm nodig zijn om met 1% relatieve onnauwkeurigheid het volume te bepalen. Dit valt binnen
de reguliere mogelijkheden van huidige bestralingsplanningsystemen.
Een vooruitblik: de totale nauwkeurigheid in een bestralingsplan
De resultaten van deze experimenten worden toegepast in het verificatieprogramma van het
gebruikte bestralingsplanningsysteem. Enkele sleutelbegrippen daarbij zijn lijn-
responsefunctie, combinatorieke verificatie en field accuracy. Een uitbreiding van dit
verificatieprogramma moet het mogelijk maken om geconstateerde afwijkingen in berekende
dosisverdelingen direct bij een individueel bestralingsplan te kunnen presenteren. Iedere
afwijking in een bestralingsplan veroorzaakt immers een systematische fout in de bestraling,
en ook kleine afwijkingen verdienen dus gepaste aandacht. Een volledige presentatie op het
niveau van bestralingsplannen is tot op heden niet beschikbaar. In voorkomende gevallen
interpreteert de klinisch fysicus de bundel-georiënteerde verificatieresultaten en geeft op basis
daarvan een schatting van de afwijkingen in een bestralingsplan. Aan de hand van een
bestralingsplan van een prostaatcarcinoom is in hoofdstuk IX de haalbaarheid aangetoond van
een direct te interpreteren presentatie van afwijkingen in de berekende dosisverdeling. De
basis hiervoor is een bibliotheek van geverifieerde dosisprofielen.
Conclusie
Concluderend levert dit proefschrift de benodigde kennis om de nauwkeurigheid te bepalen en
te verbeteren van berekeningen voor bestralingsplanning van conformatie radiotherapie, in het
bijzonder op de gebieden waar de belangrijkste winst van conformatie radiotherapie ligt: de
randen en de afgeblokte delen van de bestralingsbundels. De verkregen resultaten zijn van
toepassing op megavolt-fotonenbundels in homogene en heterogene geometrieën, op
protonenbundels en op dosis-volume histogrammen. Tevens is een verificatieprogramma
opgezet om de gecombineerde invloed van bundelparameters op de nauwkeurigheid van de
berekeningen te onderzoeken. Tenslotte is de haalbaarheid bevestigd van een presentatie van




De laatste hoofdstukken van een proefschrift worden om hun toegankelijkheid in het
algemeen het best en het meest gelezen, juist ook door niet-ingewijden in het vakgebied. Waar
de samenvatting een overzicht geeft van wat er is onderzocht, geeft het nawoord een indruk
van de wijze waarop het is verricht, en vooral van wie daaraan hebben bijgedragen. Ook al
ontstaan veel proefschriften op spreekwoordelijke zolderkamertjes, juist de rol van de diverse
‘contribuanten’ wordt niet snel overschat.
Allereerst wil ik uiteraard graag mijn promotor bedanken. Ben, je was je wel bewust dat
je als medicus een fysicus niet over de volle breedte van het onderzoek zou kunnen
begeleiden, toch heb je geen moment geaarzeld toen ik je vroeg, en ik heb van mijn keuze
geen moment spijt gehad, integendeel. In “der Beschränkung zeigt sich erst den Meister”:
jouw nimmer aflatend enthousiasme heeft steeds aanstekelijk gewerkt. Je persoonlijke
benadering en belangstelling heb ik als zeer waardevol en stimulerend ervaren. Een
“promotor” (bevorderaar) in de ware zin van het woord.
Vakinhoudelijk, maar ook persoonlijk ben ik veel dank verschuldigd aan mijn
begeleidingscommissie: Diek, Harm en Marco. Diverse inhoudelijke discussies hebben mij
geholpen richting te geven aan vooral het laatste stuk van mijn onderzoek. Jullie kritische
vragen over onderzoeksopzet en manuscripten waren immer opbouwend qua intentie en
uitwerking.
Bijzondere dank ook aan mijn directe collega, Peter van der Hulst. Op vele gebieden
heb je mij terzijde gestaan: bij het opzetten en uitvoeren van experimenten, als co-auteur van
diverse artikelen, met gedegen commentaar op manuscripten, als vervanger tijdens het
studieverlof waarin ik dit proefschrift kon afronden. Voor deze vervanging dank ik ook graag
Harm en Fokke voor hun bijdragen daarin.
Fokke Praamstra, jou ben ik zeer erkentelijk voor je hulp bij verificatie van
berekeningen van ons bestralingsplanningsysteem en bij veel experimenten, in avonduren en
soms ook weekeinden. Altijd consciëntieus en vasthoudend ook als apparatuur of
programmatuur niet direct meewerkte. Vooral bij de experimenten met de spleetbundel bleek
vasthoudendheid onmisbaar. Uiteindelijk bracht de door Peter van Luijk ontwikkelde
detectieketen hier de oplossing. Zo heeft het protonentherapieproject indirect al de
nauwkeurigheid van fotonenbestraling verbeterd. Peter, hartelijk dank voor je inzet. Daarnaast
heb ik van jou en Marco geleerd hoe uiterst nauwkeurig protonenbundels kunnen worden
berekend en toegepast. Dit roept om klinische toepassing.
Martijn Engelsman, jouw inbreng opende nieuwe perspectieven op nog deels
braakliggend terrein, verificatie in inhomogene media zoals longweefsel. Ik zal dit terrein
graag met jou nog wat verder ontginnen.
I would like to express my gratitude towards Anders Ahnesjö for several constructive
and helpful discussions about energy transport and dose deposition physics. Your contribution
to the theory of the slit beam experiments was of great value. 
Concerning the verification of our treatment planning system, the never ending
cooperation and support of physics and service personnel at Helax, now MDS Nordion, has
always been of fundamental importance and is highly appreciated. Modern radiotherapy
treatment planning cannot do without such skilled and helpful colleagues at the other end of
phone, e-mail and modem lines. When I mention in particular the names of Anders Murman
and Lars Weber for the physics contributions referred to in this thesis, I am well aware that
many other colleagues in Sweden, Germany and Belgium could be added for their support.
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Diverse andere collega’s ben ik dank verschuldigd. Ook wanneer de overlap tussen hun
werk en het werk beschreven in dit proefschrift wat kleiner is, het betreffen toch steeds
essentiële materiële of immateriële bijdragen. Alof Canrinus heeft voor mij het gebruik van
grote hoeveelheden computergeheugen ontsloten zonder welke de berekeningen aan
elektronentransport niet mogelijk zouden zijn geweest. Paul Leferink en Monique van den
Akker hebben een deel van de metingen voor de bibliotheek van verificatieprofielen voor hun
rekening genomen. Jaap van Essen, Herman Keizer, Peter Crol, Remkes Hogeveen en Wim
Alt hebben diverse voorzieningen gerealiseerd die voor de experimenten nodig waren,
variërend van extra goed afgeregelde linacs, bijzondere dosimetrievoorzieningen en speciaal
gegoten blokken. Ben Mijnheer heeft mij het spleetfantoom bereidwillig en langdurig
uitgeleend. Vele collega’s hebben tijdens weekeinden en vakanties hun PC’s aan mij
beschikbaar gesteld om mijn rekenhonger te stillen, en hebben enige onvermijdelijke overlast
daarbij voor lief genomen. De belangrijkste bijdrage in dit verband is echter immaterieel en
van alle collega’s van onze afdeling: de collegiale en open sfeer. 
Teruggaand naar de achtergrond voor mijn compassie met bestralingsplanning denk ik
speciaal aan Iaïn Bruinvis en Tom Minderhoud. Jullie introduceerden mij in dit vakgebied en
samen verkenden wij vanaf 1990 een nieuwe dimensie in bestralingsplanning en de noodzaak
tot verificatie daarvan.
Bovenal, meer dan enkele woorden op deze plaats uit kunnen drukken, ben ik mijn
familie erkentelijk voor alles wat zij voortdurend, ook tijdens het werk voor dit proefschrift,
voor mij hebben betekend en betekenen. Mijn ouders voor de basis die zij in velerlei opzicht
hebben gelegd. Atie voor de voortdurende steun, het opvangen van mijn (mentale)
afwezigheid, het luisterend oor en de oprechte pogingen om te begrijpen wat me nu weer
bezighield en waar het eventueel wat minder liep. Bij Atie, Elianne en Menno sta ik in het
krijt voor de vele uren dat ik mijn snor drukte en mijn zolderkamer verkoos boven jullie
gezelschap elders.
Tenslotte uit ik hier de hoop dat het werk dat in dit boekje is beschreven, zal bijdragen
aan het doel waar ieders activiteiten op een afdeling radiotherapie op zijn gericht, een
optimale bestralingsbehandeling voor mensen met een bedreigende ziekte.
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De auteur van dit proefschrift studeerde Experimentele Natuurkunde met bijvakken Medische
Fysica en Moleculaire Biofysica aan de Rijksuniversiteit te Utrecht (destijds RUU). In 1987
werd het doctoraal examen behaald. Daarna werd bij de Wetenschapswinkel Natuurkunde van
de RUU tot 1989 onderzoek uitgevoerd (vervangende dienstplicht) naar de effecten van
trillingen op de menselijke wervelkolom. Tot 1990 werd aan de RUU gewerkt bij het Instituut
voor Onderwijs in de Natuurkunde (practicumontwikkeling) en bij de vakgroep Biofysica
(fluorescentieonderzoek aan modelmembranen). In september 1990 volgde een aanstelling als
klinisch fysicus in opleiding bij de afdeling Radiotherapie van het Nederlands Kanker
Instituut te Amsterdam. Na het behalen van de registratie, eind 1993, wordt sinds 1994 de
functie vervuld van klinisch fysicus bij de afdeling Radiotherapie van het Academisch
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introductie van een nieuw drie-dimensionaal bestralingsplanningsysteem maakte het
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